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Summary 
Asthma is one of the most common chronic immunological diseases in 
humans, affecting approximately 300 million people worldwide. Asthma 
pathology is related to inflammation, which leads to high levels of toxic 
reactive oxygen and nitrogen species (RONS). One consequence of 
RONS is the induction of potentially cytotoxic DNA damage. 
Nevertheless, little is known about the potential for RONS to damage 
DNA during asthma. In my first project, I employed a house dust mite 
(HDM) asthma mouse model to study the role of DNA damage and 
repair in modulating asthma pathology. To study DNA repair, I 
exploited NU7441, an inhibitor of DNA-PKcs, which is essential for 
repair of double-strand breaks (DSBs) via the non-homologous end 
joining (NHEJ) pathway. I observed increased oxidative stress in 
asthma, increased DNA DSBs in the bronchial epithelium and elevated 
levels of DNA repair proteins in tissues, as well as a rise in apoptosis in 
asthmatic lungs. Importantly, inhibition of NHEJ resulted in increased 
DNA damage and apoptosis in vivo, and augmented proinflammatory 
	 	 	vii 
cytokine production in human bronchial epithelial cells in vitro. These 
studies open the possibility that inefficient DNA repair may be a yet 
unrecognized susceptibility factor for asthma-induced morbidity and 
mortality. In my second project, I investigated the genotoxic and 
cytotoxic effects of aeroallergens on human bronchial epithelial cells in 
vitro. Inasmuch as the bronchial epithelium is the primary site of injury 
in asthma, I exposed isolated human bronchial epithelial cells, BEAS-
2B, to HDM and measured DNA damage and cytotoxic endpoints. The 
studies showed that HDM induces DNA DSBs in human bronchial 
epithelial cells, stimulates cellular ROS production, increases 
nitrosative and mitochondrial oxidative stress as well as alters 
antioxidant gene expression. HDM exposure also reduces cell 
proliferation and induces cell death. Importantly, HDM-induced 
genotoxicity can be prevented by catalase or glutathione, suggesting 
that HDM exposure induces RONS formation in cells, and that RONS 
can be neutralized by antioxidants. Our findings call attention to the 
production of RONS, DNA damage and cytotoxic liability upon direct 
aeroallergen exposure in bronchial epithelium, and also suggest that 
antioxidants may be a potential therapeutic agent to protect airway 
cells from the damaging effects of environmental tissue-damaging 
agents. My third project aims to elucidate the genome protective effects 
of an anti-malarial drug, artesunate, in an experimental allergic asthma 
model. In this study, I have shown that artesunate protects bronchial 
epithelium from DNA DSBs induced by asthma. Additionally, 
	 	 	viii 
artesunate reduces cell death in asthmatic lungs. Interestingly, the 
levels of DNA repair proteins are not altered by artesunate 
treatment, suggesting that artesunate treatment does not augment the 
level of DNA repair proteins, thus pointing to an alternative protective 
mechanism. This study suggests a novel role for artesunate in 
protecting bronchial epithelial cells from asthma-induced DNA 
damage. Taken together, this thesis highlights the importance of DNA 
damage in bronchial epithelial cells, DNA repair in asthma-associated 
pathophysiology and calls attention to antioxidants as potential 
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1 Chapter 1: Introduction  
1.1  Motivation and goal 
This thesis is motivated by the convergence of three factors: the 
increasing prevalence of asthma, the urgent need to elucidate the 
underlying mechanisms that drive asthma pathogenesis and the 
importance of deoxyribonucleic acid (DNA) damage and DNA repair in 
inflammatory disease development. The Wong laboratory has 
previously established a robust mouse model of allergic airway 
inflammation using house dust mite (HDM), one of the most clinically 
relevant aeroallergens that causes allergic asthma (Ho et al., 2012; 
Peh et al., 2015). This model has proven to be an acceptable surrogate 
for the study of specific aspects of human allergic asthma, as it has 
successfully captured the essential clinical phenotypes of allergic 
asthma such as the T-helper type 2 (Th2)-mediated airway 
inflammation, goblet cell hyperplasia, mucus hypersecretion, and 
airway hyperresponsiveness (AHR). On the other hand, the Engelward 
laboratory has successfully demonstrated the contributory roles of DNA 
damage and DNA repair in various inflammation-driven disease models 
such as cancer (Kiraly et al., 2015), influenza virus infection (Li et al., 
2015) and Streptococcus pneumoniae infection (Rai et al., 2015). Thus, 
the overarching goal of my project is to understand the role of DNA 
damage and DNA repair in HDM-induced allergic asthma, both in vivo 
and in vitro. This research endeavor would not only further our 
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knowledge of the underlying molecular pathology in asthma 
development, but more importantly, it would reveal an unexplored 
avenue in asthma drug development and biomarker discovery.  
 
1.2  Scope 
The scope of the problem of asthma is highlighted by both its 
complexity and its prevalence. Among various types of asthma, I focus 
on allergic asthma, as it is one of the most common forms of asthma 
(Sleiman et al., 2010). In Chapter 1, I will discuss the molecular 
mechanisms that drive the development of allergic asthma to allow a 
better understanding on how various cell types, including the immune 
cells and airway resident cells, come together to drive the onset of 
inflammation in asthma. I will also describe the oxidant-antioxidant 
imbalance in asthma, a process that plays critical role in the driving the 
disease (Comhair and Erzurum, 2010). Reactive oxygen and nitrogen 
species (RONS)-induced oxidative damage on cell macromolecules 
such as lipid, protein and DNA will be elaborated as well. DNA damage 
responses (DDRs) that detect, signal and repair DNA lesions, will also 
be explained in detail. I will further discuss the current evidence on 
DNA damage in asthma, and how our studies can fill in the existing 




This thesis aims to present observations in the host response towards 
allergen exposure, especially in the bronchial epithelium. The sentinel 
role of the airway epithelium in asthma pathogenesis will be highlighted 
in this thesis. In Chapter 3, I will present an in vivo study using mouse 
allergic asthma model to investigate DNA damage and DNA repair 
induced by HDM exposure, focusing mainly on the airway epithelium. 
In this chapter, I will measure airway inflammation and oxidative stress, 
as these are the critical pathophysiological factors that drive asthma 
development. I will also quantify DNA DSBs in bronchial epithelium and 
investigate the importance of DNA DSB repair in modulating asthma-
associated pathophysiology. 
 
In Chapter 4, I will investigate the genotoxic effects of HDM allergen 
exposure on human bronchial epithelial cells in vitro. Mechanisms of 
action of HDM-induced genotoxicity in cells will be elucidated. I will 
measure RONS formation and antioxidant responses in bronchial 
epithelial cells exposed to HDM. I also measure the intricate network of 
DDRs including DNA repair, cell cycle arrest and cell death to evaluate 
the biological consequences of HDM-induced DNA damage in 
bronchial epithelial cells. 
 
In the last part of the thesis (Chapter 5), I study the potential role of 
artesunate (ART), an anti-malarial drug with anti-inflammatory and anti-
oxidative stress properties, in mitigating HDM-induced DNA damage in 
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bronchial epithelial cells, using both in vivo and in vitro models. Finally, 
in Chapter 6, I will conclude the thesis by summarizing the key findings 
from each project, and will discuss the limitations that I have faced and 
will suggest potential future works to overcome these limitations.  
 
1.3  Asthma 
Asthma is a chronic inflammatory disorder of the conducting airways 
characterized by airway inflammation, goblet cell hyperplasia, mucus 
hyper-secretion, airway remodeling and AHR (Lambrecht and Hammad, 
2015). These conditions lead to recurrent episodes of coughing, 
wheezing, shortness of breath and chest tightness in asthma patients 
(Lambrecht and Hammad, 2015). Such chronic airway inflammatory 
condition is a result of a complex interplay between environmental 
triggering factors and host immune responses (Fahy, 2015).  
 
Despite being one of the most common chronic immunological 
diseases in both children and adult, the progress in developing novel 
strategies to treat asthma has been relatively slow (Fahy, 2015). Most 
asthma patients develop Th2 immune responses, though, treatment 
strategies targeting the Th2 cytokines or mediators have not been as 
effective as predicted, calling attention to their limitations and the need 
for improved therapies (Lloyd and Saglani, 2010). Currently, the most 
effective therapeutic option is a combination of inhaled corticosteroids 
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and short- or long-acting β2-adrenoreceptor agonists. However, in 5-
10% of patients with severe asthma or who are also smokers, airway 
inflammation is refractory to corticosteroid treatment. This group of 
patients contributes to ~50% of healthcare costs for asthma (Barnes, 
2012). 
 
Asthma is a heterogeneous disease driven by multiple players, 
including infiltrated immune cells, airway resident cells, and most 
importantly it is closely linked to environmental factors (Sleiman et al., 
2010). Understanding how these factors interact with each other and 
how they drive the disease development, should provide new insights 
on how to mitigate asthma. Studies have revealed the presence of 
multiple asthma phenotypes that drive distinct pathological 
mechanisms, and many of these involve airway epithelium (Lloyd and 
Saglani, 2010).  Hence, it is logical to consider airway epithelium as a 
potential key driver of allergic responses, and rethink the pre-clinical 
models of the disease. The traditional focus of asthma treatment was 
mainly on monitoring disease severity and reducing immune responses. 
In fact, asthma research should move toward understanding the direct 
impact of triggering factors such as aeroallergens on airway epithelium 
and the discovery of novel therapeutic targets in epithelium to 




1.4  Epidemiology of asthma 
According to The Global Asthma Report 2014, 334 million people or 5-
16% of the population worldwide suffer from asthma, and ~250,000 
asthmatic die from asthma every year (Bush and Zar, 2011; Martinez 
and Vercelli, 2013). Around 14% of children globally had asthma 
symptoms in 2013, making it one of the most common illnesses among 
children. It is currently the 14th most important disease in the world, in 
terms of the extent and duration of the disability, and it is associated 
with enormous economic burden, mostly from direct medical costs and 
indirect costs incurred due to disability (Croisant, 2014). 
 
The prevalence of asthma is higher in developed countries, such as in 
the United Kingdom (>15%), New Zealand (15%), Australia (14.7%), 
Ireland (14.6%), Canada (14.1%) and the United States (US) (10.9%) 
(Braman, 2006) (Figure 1.01). With increased Westernization and 
urbanization, asthma prevalence has increased considerably in 
developing countries such as Africa (10-20%), Central and South 
America (>20%), Asia (<5%) and the Eastern Europe (<5%) (Braman, 
2006) (Figure 1.01). In Singapore, around 20% of children and 5% of 
adults suffer from asthma (Singapore_Health_Promotion_Board, 2015). 
It is estimated that the prevalence of asthma will increase by another 




Asthma has imposed enormous economic burdens, mostly from direct 
healthcare cost and indirect cost from the loss of productivity. In the US, 
about $56 billion was incurred in 2007, whereas, asthmatic cost in 
Europe was €17.7 billion (Barnett and Nurmagambetov, 2011; Braman, 
2006). In 2008, more than 50% of children and 30% of adults missed 
school or work due to an asthma attack (Sadatsafavi and FitzGerald, 
2014). The increased prevalence, morbidity, mortality and economic 
burden from asthma are cause for alarmed, point to the need to search 





















1.5  Asthma phenotype and asthma endotype 
Asthma is a condition of heterogeneous airway inflammation with a 
number of distinct clinical phenotypes (Wenzel, 2012a). There are 
several ways to cluster asthma patients based on clinical, physiological 
and pathological characteristics. These phenotypes may affect the 
choice of diagnostic test and pharmacotherapies. The most widely 
accepted way of phenotyping is according to the patients’ atopic status, 
which divides patients into extrinsic (allergic) and intrinsic (non-allergic) 
asthma (Wenzel, 2012b).  
 
Allergic asthma is the most common form of asthma, comprising 
roughly 50% of the adults with asthma (Lambrecht and Hammad, 2015; 
Sleiman et al., 2010). Patients with allergic asthma usually develop this 
disease early in life. They are allergic to common airborne allergens 
with the presence of Immunoglobulin (Ig) E specific to identifiable 
allergens in blood (Wenzel, 2012b). On the other hand, intrinsic asthma 
(non-allergic asthma) is characterized by later onset in life, high 
prevalence in females and a higher degree of severity. Intrinsic asthma 
can be exacerbated by bacterial endotoxins, ozone inhalation and viral 
infection. It is strongly associated with cigarette smoking and distinct 
genetic factors as well as prior rhinitis (Borish and Culp, 2008; Douwes 
et al., 2002; Sleiman et al., 2010).  
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In addition, asthma phenotyping based on inflammatory biomarkers is 
also commonly used, as it reflects the underlying disease progression 
and provides information to predict responses to therapy. For example, 
blood eosinophilia is often associated with severe asthma with a late-
onset (van Veen et al., 2009), Th2-associated asthma is strongly linked 
to eosinophilic inflammation, type 1 hypersensitivity reaction and 
responsiveness to corticosteroid treatment (Wenzel, 2012b). 
Neutrophilic inflammation is often seen in the worsening of existing 
asthma, is triggered by cigarette smoke or airway microbiome such as 
viruses and bacteria, and is often non-Th2-dependent. In addition, 
various classification of phenotypes have been proposed, some are 
based on the distinction between Th2-high asthma and non-Th2 
asthma, early or late-onset of allergic responses, while some are based 
on the type of triggers, such as exercise-induced asthma, obesity-
related asthma or smoking-related asthma (Wenzel, 2012b).  
 
In the last few years, the concept of classifying asthma into endotype 
has received tremendous attention (Anderson, 2008; Lotvall et al., 
2011; Wenzel, 2012a). It is a classification method that subdivides 
asthma phenotype based on distinct functional or pathophysiological 
mechanism, matching biology, genetics, or response to certain 
treatments (Anderson, 2008; Lotvall et al., 2011). A successful 
definition of an endotype should eventually link the key pathogenic 
mechanism with a clinical phenotype of asthma. For example, Lotvall et 
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al. have selected 7 parameters, namely the clinical characteristics, 
biomarkers, lung physiology, genetics, histopathology, epidemiology 
and treatment responses, to define each endotype (Lotvall et al., 2011). 
More recently, Wenzel described the evolving 5 endotypes in relation to 
severe asthma: early onset of allergic reaction, persistent eosinophilia, 
allergic bronchopulmonary mycosis, obese-female and neutrophilic 
severe asthma (Wenzel, 2012a). This integration of genetics, biology, 
clinical characteristics and laboratory tests can substantially enhance 
the ability to develop personalized medicine where treatment scheme 
will be based on individual biological data. Some success has been 
achieved in targeted treatment based on asthma endotypes. For 
example, anti-IgE omalizumab, has shown higher efficacy in treating 
patients with difficult-to-treat childhood asthma in which interleukin (IL)-
4 and IL-13 signaling pathways predominate (Kuhl and Hanania, 2012).  
Another successful treatment example is bronchial thermoplasty, which 
removes airway smooth muscle in patients with extensive airway 
remodeling (Castro et al., 2010). Asthma endotyping enables the 
identification of targeted patients that may be benefited from a specific 
approach to therapy. It is believed that methodology to tailor treatment 





1.5.1  Allergic asthma  
Allergic asthma is a Th2-dependent and IgE-mediated allergic disease 
resulting from an inappropriate immune response towards normally 
innocuous allergens (Martinez and Vercelli, 2013). It constitutes an 
overactive allergic response characterized by mucus cell hyperplasia 
and immune cell infiltration, particularly CD4+ T cells, eosinophils and 
mast cells. Allergic asthma starts with a sensitization stage when 
susceptible patients are first exposed to non-infectious environmental 
allergen that can trigger IgE production, followed by subsequent re-
exposure that can induce immediate allergic reaction (Galli et al., 2008). 
The allergen sensitization stage can be affected by various factors 
such as the type of allergen, the allergen concentration, the frequency 
and route of exposure, the presence of other components in allergen 
such as bacteria and the host genetic factors, which can either 
enhance or reduce the sensitization process (Galli et al., 2008). For 
instance, genetic factors that affect permeability of airway epithelium to 
allergens, the abundance and type of receptors present on the 
epithelial cell membrane and the repair capacity after epithelial cell 
damage, are some of the host genetic factors that determine the 
development of Th2-cell responses towards allergens (Cookson, 2004; 
Schleimer et al., 2007).  
 
Allergens are mostly proteins (Cookson, 1999). Examples of allergens 
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include the HDM, animal dander, fungal spores, tree pollens, or certain 
foods such as peanuts (Galli et al., 2008). The major allergen, HDM or 
Dermatophagoides pteronyssinus (Der p), possesses proteolytic 
capability and bacterial constituents such as lipopolysaccharide (LPS) 
(Hammad and Lambrecht, 2008). Upon inhalation, these allergens can 
directly reduce epithelial barrier function and activate various receptors 
on the surface of the airway epithelium such as the Toll-like receptor 
(TLR) class of pattern recognition receptor (PRR) and initiate allergic 
responses (Hammad and Lambrecht, 2008). 
 
1.5.2  Development of allergic airway inflammation 
Strong evidence suggests that complex crosstalk between the innate 
and adaptive immune system is required for the development of allergic 
asthma (Deckers et al., 2013). During the sensitization stage, allergen 
activates TLR expressed on the epithelial cells, leading to the release 
of cytokines and chemokine including granulocyte-macrophage colony-
stimulating factor (GM-CSF), IL-25, IL-33, thymic stromal lymphopoietin 
(TSLP) that are capable of inducing the production of Th2 cytokines by 
immune cells (Erle and Sheppard, 2014) (Figure 1.02).  
 
Another important player in the sensitization stage of allergic reaction is 
the lung dendritic cell (DC). Lung DCs express various receptors such 
as TLRs, Nod-like receptors and C-type lectin receptors that can bind 
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and be activated by allergens. Allergens in the airway lumen are 
captured by DCs, which form a network lining the basement membrane 
of the epithelium layer (Lambrecht and Hammad, 2009). DCs process 
the allergens, migrate to draining lymph nodes and present antigenic 
molecules to T cell, via the major histocompatibility complex (MHC) 
class II, which can activate naïve CD4+ T cells to an IL-4 competent 
state (Deckers et al., 2013; Hammad and Lambrecht, 2008). This 
antigenic presentation process is crucial for the activation of Th2 
adaptive immunity, as demonstrated in Figure 1.02.  
 
Activated T cells will then migrate to B cell zones where they 
differentiate into T follicular helper cells before entering the blood 
circulation and maturing as Th2 cells (Fahy, 2015). Allergic-specific 
Th2 cells will produce IL-4, IL-5 and IL-13 to mediate IgE class-
switching in B cells maturation and to induce the production of allergen-
specific IgE antibodies. Mature Th2 cells will also move to airway 
epithelium and secrete IL-4, IL-5, IL-9 and IL-13 to perpetuate allergic 
inflammation mediated by eosinophils and IgE-mediated mast cell 
degranulation (Devereux, 2006). 
 
Another important player in allergic asthma is the mast cell (Kalesnikoff 
and Galli, 2008). In sensitized patients, allergen-specific IgE binds to 
high-affinity IgE receptor (FcεR1) on mast cell surface. During 
subsequent allergen exposure, allergens crosslink the adjacent IgE 
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molecules and aggregate FcεR1 on mast cells. This triggers the 
activation of mast cells and causes them to degranulate to release 
biologically active products such as lipid-derived mediators, cytokines, 
chemokine and growth factors. These mediators can cause broncho-
constriction, vasodilation, increased vascular permeability and 
increased mucus production (Bradding et al., 2006). Some mast cell-
derived mediators can affect the biology of structural cells including 
epithelial cells, fibroblasts, smooth muscle cells as well as nerve cells 
(Caughey, 2007; Schleimer et al., 2007). Hence, repeat allergen 
exposure will eventually result in airway remodeling, mucosal edema, 
mucus hypersecretion and epithelial cell shedding into the airways 





















Figure 1.02 | Allergen sensitization in the airway. Allergens are 
sampled by DCs in the airway lumen and gain access into tissue 
through disrupted epithelial tight junction. DCs then migrate to lymph 
nodes where they present the antigen peptides to naïve T cells causing 
them to acquire the characteristic of Th2 cells. Th2 cells produce IL-4 
and IL-13 that mediate immunoglobulin class switching in B cells for 
IgE production. Allergen-specific IgE bind to FcεR1 on mast cells, 
sensitizing them to respond to subsequent exposure. Figure adapted 

















Figure 1.03 | Allergen-induced allergic inflammation. Allergen-
induced airway inflammation involves both innate and adaptive immune 
cells such as eosinophils, neutrophils, mast cells, monocytes and 
basophils that have been recruited to the airway, as well as the tissue 
resident cells that secrete inflammatory mediators, which together 
cause broncho-constriction and tissue damage. Figure adapted from 






1.5.2.1  Eosinophilic inflammation 
Eosinophilic airway inflammation characterizes the clinical phenotype 
of early-onset of allergic asthma. During allergic airway inflammation, 
activated eosinophils from the bloodstream are recruited to the airway 
by C-C motif chemokines (CCL)-11 and CCL-24 produced by the 
airway epithelial cells, a process driven by IL-33 (Zimmermann et al., 
2003). Eosinophils secrete cytokines (e.g. IL-13, IL-5, transforming 
growth factor (TGF)-β, osteopontin), chemokines (e.g. CCL-11, CCL-
12), matrix metalloproteinases (MMPs) as well as leukotriene (LTC4, 
LTB4) (Figure 1.04), which together contribute to allergic airway 
inflammation (Walsh et al., 2010).   
 
Accompanying the influx of eosinophils into the airways, highly charged 
basic proteins such as eosinophil cationic proteins (ECPs), eosinophil-
derived major basic proteins (MBPs) and eosinophil-derived neurotoxin 
and peroxidase (EPO) are deposited into the airways. Eosinophil MBPs 
and EPO are cytotoxic to epithelial cells (Ahlstrom-Emanuelsson et al., 
2004; Fulkerson and Rothenberg, 2013; Kephart et al., 2010). Although 
eosinophil-derived neurotoxin and eosinophil cationic proteins serve as 
a host defense by protecting the lung from virus invasion, they are toxic 
to airway epithelium and contribute tissue remodeling (Fulkerson and 
Rothenberg, 2013). Hence, long-term exposure to eosinophil MBPs 


















Figure 1.04 | Recruitment of eosinophils in asthma. Eosinophils 
release granule proteins such as ECP, EPO and MBP upon recruitment 





1.5.2.2  Neutrophilic inflammation 
Neutrophils are commonly found in sputum, bronchial biopsies, and 
bronchoalveolar lavage (BAL) fluid of asthma patients (Ennis, 2003; 
McDougall and Helms, 2006). Although the neutrophil count is 
relatively low compared to eosinophils, it can be significantly increased 
in the late-phase asthmatic response of fatal asthma, nocturnal asthma 
and chronic asthma as well as steroid-resistant asthma (Fahy, 2009; 
Lambrecht and Hammad, 2015; Saffar et al., 2011). Neutrophilic 
inflammation is strongly correlated with airway remodeling, through 
expression of proteins such as TGF-β and MMP and elastases. 
 
In my studies, I have shown that neutrophils are one of the first 
immune cells recruited to the airway. Neutrophils are important in 
causing initial tissue damage and in subsequent development of 
severe chronic asthma, as well as in the onset of sudden asthma 
attack. In vitro stimulation of neutrophils triggers the release of 
mediators such as thromboxane A (TXA), myeloperoxidase (MPO), 
reactive oxygen species (ROS) and MMP-9.  In vivo, neutrophils are 
able to attract eosinophil through chemoattractant IL-8, and are 
capable of inducing eosinophils degranulation by secreting elastase 
and neutrophilic lactoferrin (Monteseirin, 2009). In addition, neutrophils 
are the main source of MMP-9 (Kelly et al., 2000). MMP-9 promotes 
the movement of eosinophils towards the lumen by allowing them to 
migrate more easily through sub-epithelial basement membrane and 
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epithelial layer, hence worsening pulmonary eosinophils inflammation 
(Monteseirin, 2009). MPO levels were found to be elevated in BAL fluid 
of asthma patients. MPO reacts with hydrogen peroxide (H2O2) 
generated during respiratory burst to form hypochlorous acid (HOCl) 
from chlorides (Monteseirin, 2009). Hence, neutrophils are one of the 
major sources of superoxide anion (O2·-), H2O2 and HOCl. Neutrophils 
retrieved from asthmatic lungs were capable of producing higher levels 
of oxidative radicals as compared to neutrophils from healthy lungs 
(Monteseirin et al., 2002). Studies have shown that neutrophilic 
proteases such as elastase, cathepsin G and proteinase-3 act together 
with oxidants to cause oxidative damage in tissue by inactivating anti-
proteases and by altering the protein structure, making it more 
susceptible to proteolytic attack (Fahy, 2009).  
 
1.5.3 House dust mite (HDM) allergen 
HDM (Dermatophagoides pteronyssinus and Dermatophagoides 
farinae) is a major source of allergen that is strongly associated with 
the development of allergic asthma (Andiappan et al., 2014; De Alba et 
al., 2010). Around 65 to 130 million people worldwide and 50% to 85% 
of asthmatic patients are allergic to HDM (Calderon et al., 2015; 
Gregory and Lloyd, 2011). In Singapore, a total of 70% to 80% of the 
population react against HDM, explaining the high prevalence of 
allergic airway diseases in Singapore (Andiappan et al., 2014).  
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HDM allergenic potential lies with the dust mites themselves as well as 
their fecal pellets (Gregory and Lloyd, 2011; Thomas et al., 2002). Dust 
mite fecal pellets consist of food, debris and proteolytic enzymes that 
were bound together by mucus. In a lifetime of 10 weeks, HDM 
produces more than 2000 fecal pellets with size around 10 to 40 μm in 
diameter, small enough to be inhaled easily and deposited onto the 
airway (Gregory and Lloyd, 2011; van Bronswijk and Sinha, 1971). In 
addition to Der p allergens, lipopolysaccharide (LPS), β-glucan found in 
HDM extract and chitin present in the exoskeleton of HDM, are also 
sources of innate PRR ligands that can activate immune response 
(Fahlbusch et al., 2003). Once inhaled, HDM and HDM-associated 
ligands can bind to various PRRs such as TLRs expressed on the 
epithelial cells, which can then activate the epithelial cells and drive 
allergic inflammation in asthma (Figure 1.05) (Hammad et al., 2009). 
Activated epithelial cells are capable of coordinating the innate and 
adaptive responses to the inhaled allergen by releasing cytokines such 
as TSLP, GM-CSF, IL-6, IL-8, IL-33 and IL-25 which can induce Th2 
responses and immunoglobulin production (Gregory and Lloyd, 2011).   
 
In the thesis, I use HDM as the main allergen to induce allergic airway 
inflammation in asthma mouse model and to stimulate isolated human 

















Figure 1.05 | Activation of airway epithelial cells by HDM. HDM 
binds various PRRs expressed on epithelial cells and leads to the 
release of various proinflammatory cytokines and chemokines. Figure 







1.6  Airway epithelium in asthma 
The airway epithelial cells have an estimated area of 100 m2 and they 
come in contact with 10,000 L inhaled air everyday (Holgate, 2007). 
Airway epithelial cell is more than just a physical barrier against 
environmental insults such as allergens, pathogens, cigarette smoke 
and pollutant; it is also a key player in the activation of immune 
responses (Hammad and Lambrecht, 2008; Lambrecht and Hammad, 
2009; Lloyd and Saglani, 2010). Airway epithelial cells express different 
PRRs that recognize pathogen-associated molecular patterns (PAMPs) 
expressed by microbes and damage-associated molecular patterns 
(DAMPs) released when the epithelial layer is damaged. Epithelial cells 
also express TLRs that have been shown to react functionally to 
various TLR ligands. TLRs signal through a series of adaptor proteins, 
leading to the activation of nuclear factor-κB (NF-κB)  and interferon 
regulatory factors 3 and 7 (IRF-3 and IRF-7) which have important 
roles in the development of asthma. Epithelial cells regulate airway Th2 
inflammation as well, through the release of TSLP, IL-25, IL-33 and CC 
family chemokines, which are important proximal events in initiating 
Th2 inflammation (Fahy and Locksley, 2011) (Figure 1.06).  
 
Strong evidence has shown that asthmatic airway epithelium has 
higher susceptibility towards environmental insults, oxidant-induced 
damage and apoptosis as compared to normal epithelium (Bucchieri et 
al., 2002; Truong-Tran et al., 2003). The asthmatic epithelial layer is 
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intrinsically defective in tight gap junctions, which enables easier 
penetration of inhaled allergens into the airways to trigger the activation 
of DCs which are in abundant beneath the epithelial layer (Xiao et al., 
2011). HDM allergen is able to increase the permeability of bronchial 
epithelium, as shown by Wan et al. (Wan et al., 1999) in their 
measurement of the transepithelial electrical resistance after HDM 
exposure. At the same time, HDM, cockroach, animal dander and 
fungal allergens possess proteolytic capability and are able to disrupt 
epithelial tight junctions (Leino et al., 2013). Disruption of epithelial tight 
junction leads to impaired barrier function and allows easier penetration 
of inhaled substances into the airway. At the same time, damaged 
epithelial cells generate growth factors that promote airway remodeling 
(Holgate, 2007).  
 
Asthma is often described as a chronic wound of the airways, with 
desquamation of the airway epithelium being one of the pathological 
features in bronchial biopsies from asthmatic patients (Hogg, 1993). In 
asthmatic lung, impaired proliferation of basal cells have been 
observed, as revealed by the reduction in cell proliferating markers 
Ki67 and proliferating cell nuclear antigen (PCNA) (Fedorov et al., 
2005; Holgate, 2008). This suggests that when there is epithelial injury, 
asthmatic epithelium is unable to completely repair the injury, 
contributing to the chronic wound scenario observed in asthma. 
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Furthermore, shedding of epithelial cells can contribute to airway 
hyper-responsiveness (Barnes, 1998).  
 
Abnormalities in airway epithelium both structurally and functionally 
drive the development of asthma. Hence, understanding how airway 
epithelium responds to environmental stimuli and how these 
environmental stimuli affect integrity of epithelial cells, could open up 
new approaches to disease prevention and treatments focused on 






Figure 1.06 | The airway epithelium in asthma. Airway epithelial 
cells express various receptors such as TLRs, protease-activated 
receptor-2 (PAR-2), C-type lectin receptors and NOD1/2 receptor. 
Allergen binds to epithelium surface receptors and activates 
downstream inflammatory signaling pathways. DCs capture allergen 
and present antigenic peptide to T cell, facilitate its transformation to 
Th2 cell and promote B cells to produce IgE. Figure adapted from 






1.7  Asthma and oxidative stress 
One of the most prominent features of the asthmatic airway is oxidative 
tissue damage (Ciencewicki et al., 2008). Inflammatory cells that 
infiltrate into the airways, such as the eosinophils and neutrophils, have 
an exceptional capacity in producing ROS and reactive nitrogen 
species (RNS). Substantial data reveal increased oxidative stress in 
the lungs of asthma patients, suggesting a potential role for oxidants in 
driving asthma pathogenesis (Comhair and Erzurum, 2010).  
 
ROS include O2·-, H2O2 and hydroxyl radical (OH.), while RNS include 
nitric oxide (NO) and its derivatives such as nitrogen dioxide radical 
(.NO2) and peroxynitrite (ONOO-) (Dedon and Tannenbaum, 2004; 
Hoshino et al., 2008). These RONS have important roles in host 
defense and cell signaling mechanisms such as apoptosis and 
regulation of gene expression. However, excessive ROS production 
has the potential to cause a number of deleterious events, which 
include collateral damage to cellular macromolecules and cell death 
(Hoshino et al., 2008).  
 
There are multiple ways to measure oxidative stress in asthma patients. 
Exhaled breath condensate (EBC) is a standard and non-invasive 
method to study volatile and non-volatile molecules in the lung air 
(Kharitonov and Barnes, 2001). H2O2 and NO are capable of diffusing 
out from the lining fluid of the airways into the expired air and be 
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measured, serving as a reliable marker that reflects overall oxidative 
stress in the airways. Several studies have shown that in asthma 
patients, H2O2 levels are elevated in the EBC as compared to healthy 
controls (Antczak et al., 1997; Dohlman et al., 1993; Jobsis et al., 
1997) and reduced in patients who were responsive to glucocorticoid 
treatment, suggesting that disease severity and oxidant level is directly 
proportional in asthma development. In addition, increased O2·- 
production from blood leukocytes and increased nitrate/nitrite levels in 
plasma were observed in asthma patients as compared to healthy 
subjects (Nadeem et al., 2003; Shanmugasundaram et al., 2001). All of 
these observations suggest a strong correlation between oxidative 
stress and asthma. 
 
1.7.1  ROS 
ROS such as O2·-, H2O2 and OH• can be released by inflammatory cells 
in response to environmental exposures (allergens or microbial 
infections) and these ROS are deleterious to cells, as shown in Figure 
1.07. O2·- is generated from molecular oxygen (O2) through reactions 
catalyzed by several enzymes such as nicotinamide adenine 
dinucleotide phosphate (NADPH) oxidase (Vignais, 2002), 
cyclooxygenase (COX), xanthine oxidase (XO) (Jankov et al., 2008) 
and nitric oxide synthase (NOS) (Vasquez-Vivar et al., 1998) (Comhair 
and Erzurum, 2002) (Reaction 1). O2·- is also produced during the 
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mitochondrial respiratory chain reaction and during the respiratory 
burst of activated phagocytes, such as neutrophils, macrophages and 
monocytes, via the NAD(P)H oxidase enzymatic system (Henricks and 
Nijkamp, 2001). In fact, increased spontaneous production of O2·- by 
plasma neutrophils in asthma patients has been reported (Teramoto et 
al., 1996). O2·- is then catalytically converted to H2O2 and water by 
superoxide dismutase (SOD) (Reaction 2). 
 
 
O2  + e-              O2·-      Reaction 1 
 
O2·- + O2·- + 2H+  à  H2O2 + O2    Reaction 2 
 
In the presence of redox active metal ions, O2·- and H2O2 can be 
converted to highly reactive OH• through Haber-Weiss and Fenton 
chemistry reactions (shown below). O2·- can also react with NO to 
produce highly unstable ONOO- (Reaction 3). Both OH• and ONOO- 
are reactive radicals that can induce oxidative cellular damage.  
 
O2·- + Fe3+ à  Fe2+ + O2    Haber - Weiss Reaction 
H2O2 + Fe2+ à  Fe3+  + OH• + OH•    Fenton Reaction 








H2O2 can be produced by xanthine oxidase, monoamine oxidase and 
amino acid oxidase (Comhair and Erzurum, 2010). Once formed, the 
oxidizing potential of H2O2 can be amplified by lysosomal peroxidases 
such as MPO and EPO that catalyze the formation of hypobromous 
acid (HOBr) and hypochlorous acid (HOCl) during reaction with 
bromide (Br-) and chloride (Cl-) ions, respectively (Comhair and 
Erzurum, 2010) (Reaction 4 and 5). MPO and EPO are abundant in 
peripheral blood, induced sputum and BAL fluid of asthma patients 
(Sahiner et al., 2011). The main function of these eosinophil- and 
neutrophil-derived EPO and MPO is host defense, by inflicting 
oxidative damage on invading parasites and pathogens. However, 
reactive species formed by these peroxidases can also induce 
oxidative damage to proteins, lipids and DNA in asthmatic airways. 
Eosinophil-derived HOBr and neutrophil-derived HOCl react readily 
with a variety of nucleophilic targets such as thiols, animes, 
unsaturated groups and aromatic compounds (Marcinkiewicz and 
Kontny, 2014). Elevated levels of halogenated tyrosine residues such 
as 3-bromotyrosine, a specific response to the release of oxidants from 
eosinophils, were detected in lung lysate from asthma patients 
(Pattison and Davies, 2004).   
 
H2O2    + Br- à  HOBr + H2O     Reaction 4 
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Figure 1.07 | Production of RONS in lung and the molecular 
consequences of oxidative stress. O2- is transformed into potent 
RONS such as HOCl, OH• and ONOO-, through a series of enzymatic 
and non-enzymatic steps. These RONS are deleterious to cells as they 
can cause destruction of biomolecules. Adapted from (Rahman, 2009). 
 
1.7.2 RNS 
NO production is found to be increased in the sputum and EBC from 
asthmatic patients (Do et al., 2008), suggesting that NO affects many 
aspects of asthma pathophysiology. NO is produced by NOS that 
converts the amino acid L-arginine to L-citrulline (Prado et al., 2011) 
(Figure 1.08). There are three forms of NOS, the inducible NOS 
(iNOS), neuronal NOS (nNOS) and endothelial NOS (eNOS). nNOS 
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and eNOS are constitutively expressed in neuron and endothelial cells, 
whereas nNOS can also be found in the nerve plexus of the trachea 
(Sugiura and Ichinose, 2008). On the other hand, iNOS is present 
mainly in pathophysiology situations, expressed by epithelial cells, 
macrophages, neutrophils, eosinophils and mononucleated cells 
(Prado et al., 2005; Prado et al., 2006). The proinflammatory role of 
iNOS has been reported in various disease models. Its activity is 
inducible by LPS, oxidant, allergen and proinflammatory cytokines such 
as tumor-necrosis factor (TNF)-α  and interferon (IFN)-γ. Once 
stimulated, iNOS produces high levels of NO. NO reacts with O2·- 
released by inflammatory cells to form ONOO-, a highly genotoxic and 
proinflammatory molecule (Sugiura and Ichinose, 2008).  
 
Nitrosative stress had been found to induce airway inflammation in 
ovalbumin (OVA)-induced allergic asthma model in guinea pig (Sugiura 
et al., 1999). In addition, RNS such as ONOO- caused lung cells injury 
and contributed to airway remodeling in asthma (Sugiura et al., 2006). 
These highly bioactive NO and NO-derived RNS can also damage the 
DNA, protein and lipid of targeted cells, further fuelling the tissue 




























Figure 1.08 | Overview of the signal transduction pathway of iNOS 
and NO. Stimuli such as LPS, allergens, bacteria and viruses can 
activate tyrosine kinases and lead to increased expression of iNOS, via 
the NF-κB pathway. iNOS catalyzes the formation of L-arginine to L-
citrulline and produce NO, which plays a key role in various cellular 
processes. Adapted from (Ricciardolo et al., 2004). 
 
 
1.7.3  Mitochondrial oxidative stress 
Mitochondrial respiratory chain is a major source of intracellular ROS 
production. The mitochondrial electron transport chain contains redox 
centers that leak electrons which will react with O2 to form O2·-, the 
precursor of many ROS (Orrenius et al., 2007) (Figure 1.09). This 
process occurs primarily at Complexes I (NADH:uniquinone 
oxidoreductase) and III (ubiquinol:cytochrome c oxidoreductase; 
cytochrome bc1 complex) in the electron transport chain, generating 
high level of  O2·- in both sides of the inner mitochondrial membrane 
(Ott et al., 2007) (Figure 1.09). In addition, ubiquinone (Ub), which 
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connects Complex I with III and Complex II with III, is also one of the 
major players in the production of O2·-. The oxidation of ubiquinone 
leads to a reaction known as Q-cycle, which leads to O2·- formation. 
Mitochondrial dysfunction is often associated with increased ROS 
production by mitochondria itself (Murphy, 2013). Knowing that 
oxidative stress is implicated in the development of asthma, 
mitochondrial dysfunction could be one of the mechanisms that 
contributes to increased oxidative stress in asthma.  
 
Many lines of evidence suggest that mitochondrial oxidative stress 
plays a role in in cell death and the pathogenesis of diseases such as 
cancer, neurodegenerative diseases, Parkinson disease and ageing 
(Cui et al., 2012; Henchcliffe and Beal, 2008; Lin and Beal, 2006; 
Norberg et al., 2010; Reddy, 2011). Recently, mitochondrial 
dysfunction and mitochondrial ROS have been shown to play critical 
roles in the development of allergic asthma (Kim et al., 2014; 
Mabalirajan et al., 2008). Mitochondrial ROS modulates NLRP3 
inflammasome activation and induces airway inflammation in allergic 
asthma (Kim et al., 2014). Inhibition of mitochondrial ROS reduced 
MPO activity in asthmatic lung tissue, suggesting the direct role of 
mitochondrial ROS in modulating the activation of immune cells (Kim et 
al., 2014). In addition, the number of mitochondria was increased in the 
bronchial epithelium of asthmatic mice and in asthmatic children, 
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suggesting that mitochondria may involve in the development of 













Figure 1.09 | Formation of superoxide radicals by mitochondrial 
respiratory chain. Figure adapted from (Orrenius et al., 2007). 
 
1.8  Altered antioxidant defenses in asthmatic lungs  
Many studies have shown that an imbalance in oxidants and 
antioxidants is a major factor in driving airway inflammation and airway 
hyperresponsiveness (Sugiura and Ichinose, 2008). Lung tissue is 
constantly exposed to oxygen during gas exchange. The moist 
mucosal epithelial layer facilitates diffusion of oxygen and penetration 
of other airborne reactive pollutants into the lung, making the lung 
particularly susceptible to environmental oxidant-mediated injury. To 
protect lung from these constant oxidative insults from the environment, 
healthy lung is constantly in reducing state, attributed to the abundance 
of endogenous antioxidant activities (Comhair and Erzurum, 2010). 
These protective antioxidant systems (as shown in Figure 1.10) are 
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divided into enzymatic and non-enzymatic antioxidant defenses. The 
enzymatic antioxidant includes SOD, catalase (CAT), glutathione 
peroxidase (GPx), heme oxygenase (HO) and thioredoxin as well as 
peroxiredoxin (Comhair and Erzurum, 2010). While the non-enzymatic 
antioxidants include the glutathione (GSH), antioxidants from food such 
as vitamin C or ascorbic acid, vitamin A, vitamin E, β-carotene and 









Figure 1.10 | Antioxidants in redox reactions. Figure adapted from 
(Comhair and Erzurum, 2010). 
 
1.8.1  SOD 
SOD is present in essentially every cell and plays an important role in 
antioxidant defense mechanism. Altered SOD antioxidant defense has 
been reported in asthma patients (Table 1). In severe asthmatic lungs, 
impaired SOD activation was associated with airflow obstruction, 
increased AHR and airway remodeling (Chung and Marwick, 2010; 
Comhair et al., 2000). In addition, SOD levels were reduced in 
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epithelial cells of asthmatic patients (Smith et al., 1997). It is believed 
that excessive ROS and RNS cause modifications in the SOD proteins 
and damage their capacity to catalyze the conversion of O2·- to H2O2 
and water (Comhair and Erzurum, 2010). There are three forms of 
SOD: SOD1, soluble (CuZn SOD), SOD2, mitochondrial (Mn SOD) and 
SOD3, extracellular (EC SOD). SOD1 is located in the cytosol, while 
SOD2 is localized mainly in the mitochondria of epithelial cells, 
macrophages, neutrophils, endothelial cells and smooth muscle cells 
(Sugiura and Ichinose, 2008). SOD3 is extracellular and abundantly 
present in blood vessels and the airways, and its expression is induced 
by IFN-γ, but reduced by TNF-α , TGFβ and IL-1α in fibroblasts 
(Marklund, 1992). Pretreatment with SOD1 reduced AHR in cat asthma 
model, suggesting that O2·- is associated with the induction of AHR 
(Smith et al., 1997). 
Table 1 | Altered antioxidant responses in asthmatic lung.  Table 
adapted from (Barnes et al., 2009; Sugiura and Ichinose, 2008). 
Enzyme Lung localization Function Expression
/ Activity 
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1.8.2  Glutathione (GSH) 
GSH, a reduced-form of glutathione, is an important antioxidant in the 
lungs (Biswas and Rahman, 2009). It is present in abundance in the 
fluid lining of the respiratory tract, with around 95% in its reduced form 
(Comhair and Erzurum, 2010). Reduced (GSH) and oxidized (GSSG) 
forms of glutathione act in concert with other redox-active components 
such as NAD(P)H to regulate and maintain cellular redox status. H2O2 
is reduced to water by GPx, and the same time GSH is oxidized to 
GSSH. Owning to its strong reducing properties, the GSH system has 
received tremendous attention as a potential target for pharmacological 
intervention. GSH levels in cells and tissues in an organism can be 
increased using supplementation with precursors, such as N-acetyl-L-
cysteine (NAC). However, reports on the GSH levels in asthma patients 
have shown contradicting results. GSH levels in EBCs of children with 
asthma were lower as compared to those from healthy children, and 
were increased after oral glucocorticoid treatment (Corradi et al., 2003). 
In some studies, however, increased total GSH concentrations was 
observed in BAL fluid of mild asthma patients (Smith et al., 1993). 
Nevertheless, all these studies point to the impairment of the GSH 




1.8.3  Catalase 
Half of asthma patients have been reported to have lower catalase 
activity in BAL fluid and in red blood cells, as compared to healthy 
controls (Novak et al., 1991). This loss of catalytic activity is probably 
due to the oxidative and nitrative modifications of tyrosine residues in 
catalase (Comhair and Erzurum, 2010). Catalase scavenges H2O2 by 
converting it into oxygen and water. Studies have shown that catalase 
treatment prevented H2O2-induced DNA strand breaks in airway 
epithelial cells (McDonald et al., 1993). Reduction in ciliary beat 
frequency is an indicator of epithelium disruption by activated 
eosinophils. Catalase treatment inhibited the reduction in ciliary beat 
frequency and reduced in the number of cilia on tracheal epithelial that 
were stimulated with platelet activating factor-activated guinea pig 
eosinophils, suggesting that catalase may be able to prevent 
epithelium damage observed in asthma (Yukawa et al., 1990).  
 
1.8.4  Nrf2 
Nuclear erythroid 2-related factor 2 (Nrf2) is a redox sensitive 
transcription factor that regulates many antioxidant genes (Sporn and 
Liby, 2012). Nrf2 controls GSH production and utilization by regulating 
glutathione S-transferases (GST) and GPx levels. Nrf2 also regulates 
NAD(P)H and HO production as well as many other antioxidant 
pathways (Gorrini et al., 2013). It has been shown that disruption of 
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Nrf2 gene leads to severe allergen-driven airway inflammation and 
AHR in mice (Rangasamy et al., 2005; Williams et al., 2008). 
 
1.9  Oxidative damage to DNA, lipid and protein  
RONS are highly reactive and thus difficult to quantify (Woolley et al., 
2013). One feasible way to quantitate the relative level of RONS is 
through measurement of the oxidative damage on biological molecules 
such as lipids, DNA or protein residues (Figure 1.11). Oxidative 
damage to these cellular macromolecules arises through 
overproduction of RONS, reduced antioxidant defense and inefficient 
DNA repair. In asthma and other inflammatory lung diseases such as 
chronic obstructive pulmonary disease (COPD), these oxidative 
damage markers have been used as indicators of disease progression. 
In Wong’s laboratory, we have previously demonstrated significant 
increases in the levels of 3-nitrotyrosine (3-NT), 8-isoprostane and 8-
hydroxy-2-deoxyguanosine (8-OHdG) in OVA-induced airway 
inflammation model (Ho et al., 2012). 3-NT, 8-isoprostane and 8-OHdG 
are surrogate markers for nitrosative protein damage, lipid peroxidation 



























Figure 1.11 | Effects of ROS on cellular functions and the 
induction of cell death. Figure adapted from (Ott et al., 2007). 
 
1.9.1  Protein nitration 
Excessive production of NO during inflammation can cause oxidative 
stress when NO reacts with O2·- to form ONOO-. ONOO-, an extremely 
powerful oxidant, is responsible for many adverse effects caused by 
RNS (Sugiura and Ichinose, 2011). Excessive RNS causes nitration of 
tyrosine residues to form 3-NT (Figure 1.12), a biomarker for 
nitrosative damage. Increased 3-NT formation has been observed in 
various inflammatory lung diseases including asthma (Kharitonov et al., 
1994), COPD (Hirano et al., 2006; Sugiura et al., 2004) and idiopathic 
pulmonary fibrosis (Saleh et al., 1997). In asthmatic airways, increased 
3-NT is more evident when catalase activity is low, suggesting that 3-
NT level is correlated to the antioxidant level. In addition, high 3-NT 
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Figure 1.12 | Structure of 3-nitrotyrosine (3-NT). 
 
 
1.9.2  Oxidative DNA damage 
DNA is a vulnerable target for oxidation (Zeyrek et al., 2009; Sawa et 
al., 2006). RONS induce oxidative base damage in DNA, which can 
contribute to mutagenesis, carcinogenesis and cell death. Oxidative 
damage to DNA can cause modifications on both purine and pyrimidine 
bases as well as on the deoxyribose backbone to cause crosslinking 
damage and single- and double-strand breaks (DSBs) (Jackson and 
Bartek, 2009). 8-OHdG is an abundant marker for oxidative DNA 
damage (Valavanidis et al., 2009) (Figure 1.13). It occurs at an 
average steady-state frequency of 2400 lesions per cell. Elevated 
levels of 8-OHdG have been reported in asthma, COPD and in lung 
cancer patients (Yano et al., 2009). Since 8-OHdG is mainly repaired 
by DNA base excision repair (BER) mechanisms (Scott et al., 2014), a 
sudden elevation in 8-OHdG levels may also implicate a reduction in 








Figure 1.13 | Structure of 8-Hydroxy-2'-deoxyguanosine (8-OHdG). 
  
1.9.3  Lipid peroxidation 
The unsaturated bonds of lipids are susceptible to free radical attack to 
form peroxidation products that can diffuse into the blood, urine and 
EBC. 8-Isoprostane is a prostaglandin-F2α  isomer produced by 
random oxidation of tissue phospholipid by oxygen free radical (Figure 
1.14). 8-Isoprostane functions biologically as a pulmonary and renal 
vasoconstrictor (Banerjee et al., 1992). Its level in plasma, urine and 
EBC has been found to be elevated in oxidative stress. Therefore, 8-
Isoprostane has been commonly used as a marker to quantitate 
oxidative damage in vivo (Montuschi et al., 2004; Montuschi et al., 
2000b). Exhaled 8-Isoprostane is elevated in smoke-induced COPD 
and in cystic fibrosis, as well as in children during asthma exacerbation 
(Baraldi et al., 2003; Biernacki et al., 2003; Montuschi et al., 2000a; 
Montuschi et al., 2000b). Measurement of isoprostane levels not only 
provides a reliable marker for monitoring disease progression, but also 
allows the study of mechanisms causing oxidative damage in tissue 









Figure 1.14 | Structure of 8-Isoprostane. 
 
1.10  DNA damage response (DDR) 
Genome integrity is constantly undermined by endogenous and 
exogenous DNA-damaging agents such as RONS, ultraviolet (UV) 
radiation, ionizing radiation and mutagenic chemicals (Jackson and 
Bartek, 2009). To mitigate the effects of DNA damage, cells have 
developed a highly effective network, known as the DNA damage 
response (DDR) to detect, signal and repair DNA lesions (Figure 1.15). 
These processes are vital in maintaining normal cell function, as 
disruption of these processes has been associated with genome 
instability, developmental defects, immune deficiency, 
neurodegenerative disease and premature aging (Jackson and Bartek, 
2009). 
 
DNA DSBs and DNA replication-blocking lesions are powerful 
activators of DDR because they compromise structural stability of the 
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chromosome. Hence, upon formation, these lesions are recognized 
very rapidly and a cascade of signaling events is initiated. These 
events include cell cycle arrest (as a result of check-point activation), 
activation of appropriate DNA repair mechanisms, and eliminating of 
cells with irreparable DNA lesions through activation of cell death 
pathways.  
 
Ataxia-telangiectasia mutated (ATM) and the ataxia telangiectasia and 
Rad3-related (ATR) are the central regulators of DDR (Marechal and 
Zou, 2013). DSBs and single-strand breaks (SSBs) are rapidly 
recognized by ATM and ATR, respectively, which mediate local 
phosphorylation of many DDR proteins (d'Adda di Fagagna, 2008). 
Phosphorylated DDR proteins will further elicit cascades of post-
translational modifications, including phosphorylation, ubiquitylation, 
and SUMOylation that orchestrate the aforementioned processes. The 
importance of ATM and ATR kinases in coordinating the DDR is 
demonstrated by their mutations in ataxia-telangiectasia (A-T) disorder 















Figure 1.15 | The framework of DDR signaling pathway. DDR 
consists of sensors, transducers and effectors that involve in a cellular 
processes such as DNA repair, cell–cycle arrest and cell death that are 
important in maintaining genome stability of cells. Figure adapted from 
(Marechal and Zou, 2013). 
 
1.10.1  DNA repair 
Different DNA lesions are repaired by distinct DNA repair pathways 
(Figure 1.16). DNA SSBs occurring during oxidative attack by 
endogenous ROS or base lesions caused by oxidation, alkylation, 
deamination and depyrimidination damage can be repaired by BER 
(Caldecott, 2008; Robertson et al., 2009). Bulky DNA adducts are 
repaired by nucleotide excision repair (NER) (Aziz et al., 2012), while 
DNA base mismatches can be corrected by mismatch repair (MMR). 
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Figure 1.16 | Different types of DNA lesions and their respective 
repair pathways. SSBs and base damage are generally repaired by 
BER, while bulky lesions and crosslink are repaired by NER. DR 
repairs small chemical changes affecting single base such as the 
O6MeG and MMR repairs mismatches. Finally, DBS is repaired by two 
pathways, HR and NHEJ. BER, base excision repair; NER, Nucleotide 
excision repair; O6MeG, O6-methylguanine; DR, Direct repair; MMR, 
Mismatch repair; HR, homologous recombination; NHEJ, non-






1.10.1.1 DNA DSB repair 
DNA DSBs are caused by many processes including exposure to 
ionizing radiation (IR) and when DNA is attacked by free radicals 
(Lieber, 2010). They can also be formed when DNA replication forks 
collapse and during V(D)J recombination or isotype recombination in 
lymphocytes (Chapman et al., 2012; Jackson and Bartek, 2009). DSBs 
are among the most toxic forms of DNA damage because they can 
cause genome rearrangement and cell death (Chapman et al., 2012). 
Hence, the maintenance of chromosomal integrity and cell survival are 
dependent on the efficient repair of DNA DSBs. Failure to repair DNA 
DSBs can cause developmental disorders, pre-mature aging, cancer 
predisposition, immunodeficiency, neurodegeneration and other 
serious diseases (Jackson and Bartek, 2009). Since DSBs are life-
threatening lesions, multiple DNA repair pathways have evolved to 
counteract them. In mammalian cells, DSBs are repaired by two major 
repair pathways: the homologous recombination (HR) and non-
homologous end joining (NHEJ) (Figure 1.17). HR predominates in S 
or G2 cell cycle phase and requires an undamaged homologous 
sequence as template; while NHEJ predominates in G1 phase and 
joins broken ends independent of homology (Chapman et al., 2012).  
 
DNA DSBs trigger a signaling cascade that leads to the rapid formation 
of repair complexes at the break site. DSBs are first recognized by the 
MRE11-RAD50-NBS1 (MRN) complex, which assists in many aspects 
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of DSB processing: from initial detection, to triggering of signaling 
pathways and to facilitating repair process (Williams et al., 2010). The 
MRN complex activates ATM, ATR and DNA-dependent protein kinase 
(DNA-PK), and brings them together in different combinations to 
prepare DNA for subsequent repair processes (Stracker and Petrini, 
2011). Meiotic recombination 11 (MRE11), in addition to stabilizing 
DNA ends, it has endonuclease and exonuclease activities for the 
initial steps of DNA end resection, which are essential for HR and 
contribute to NHEJ. Nijmegen breakage syndrome 1 (NBS1) protein 
associates with ATM and promotes the recruitment of ATM to DSBs, 
where ATM is activated by the MRN complex (Stracker and Petrini, 
2011). Activated ATM phosphorylates repair mediator proteins, and 
recruits them to the sites of DNA damage. One of the earliest events in 
the damage response is phosphorylation of histone 2AX (H2AX) at 
Ser139 to form γH2AX (Kuo and Yang, 2008). H2AX phosphorylation 
spreads for distances up to 1–2 megabases around DSBs, allowing 
them to be identified easily by staining with antibodies and making 
γH2AX a reliable and sensitive indicator of DSBs.  
 
DNA repair proteins assemble to form DDR foci at the DNA damage 
site. Each DDR focus represents a single DNA lesion (d'Adda di 
Fagagna, 2008). Once the DNA lesion is repaired, DDR foci 
disassemble. Hence, promptly repaired lesions have relatively small 









































more protracted DDR signaling and extensive γH2AX spreading, hence 














Figure 1.17 | DNA DSB repair pathways. HR and NHEJ are the two 
main DNA DSB repair pathways in mammalian cells. Efficient repair of 
DNA DSBs will lead to cell survival; inefficient repair will cause cell 
cycle arrest, mutations or chromosomal instability.  
 
1.10.1.1.1 HR 
HR promotes accurate DSB repair by using an extended, undamaged 
homologous sequence as template (Figure 1.17, left). The HR 
pathway uses the information contained in the homologous 
chromosomes or sister chromatids to restore the information lost during 
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DSBs. Since it uses a homologous DNA strand as template, it operates 
preferentially in the S and G2 phase during which homologous 
sequences are in close vicinity (Renkawitz et al., 2014). Once the DNA 
ends are resected by MRN complex, they are bound by replication 
protein A (RPA), an evolutionarily conserved single-strand DNA 
(ssDNA)-binding protein that stabilizes the ssDNA. RPA is then 
replaced by RAD51, which forms nucleoprotein filaments to invade the 
homologous template (Chapman et al., 2012). This process eventually 
primes DNA synthesis to copy and ultimately restore genetic 
information that was disrupted by DSBs. HR is a more accurate repair 
system, but it only happens in cells in the S or G2 phase.   
 
1.10.1.1.2 NHEJ 
NHEJ is an efficient DSB repair pathway that functions throughout the 
cell cycle, predominately in G1 and M phase (Weterings and Chen, 
2008). NHEJ restores DNA integrity by joining the two ends and does 
not require a homologous DNA segment (Figure 1.17, right). Although 
it is more error-prone due to the loss of genetic information and 
translocation that may occur, it operates in non-replicating cells where 
it is more beneficial than leaving the breaks unrepaired. The classical 
effectors of NHEJ are the DNA-dependent protein kinase catalytic 
subunit (DNA-PKcs) and KU70/KU80 heterodimer. KU70/80 
heterodimer binds to the two ends of DSBs and recruits DNA-PK to the 
				
52 
break site. This process leads to activation of DNA-PK as a 
holoenzyme through auto-phosphorylation of DNA-PKcs (Weterings 
and Chen, 2008). Activated DNA-PK can phosphorylate endonuclease 
Artemis as well as other downstream DSBs response proteins such as 
XRCC4 and DNA Ligase IV (Lees-Miller and Meek, 2003) to ligate the 
termini and complete NHEJ.  
 
P53-binding protein 1 (53BP1) is an important mediator of NHEJ. It 
promotes NHEJ by increasing the stability and mobility of DSBs, as 
well as to inhibit 5’ end resection that is needed for the HR pathway 
(Zimmermann et al., 2013). 53BP1 forms complexes around DSBs, 
which can be visualized as discrete nuclear foci by microscopy.  
 
HR and NHEJ both cooperate with each other at DSBs to facilitate 
efficient repair and to safeguard genomic integrity. Nevertheless, 
competition between HR and NHEJ has been reported (Kass and Jasin, 
2010). The DNA end resection process in HR prevents the binding of 
KU proteins and therefore prevents NHEJ (Aylon and Kupiec, 2004; Ira 
et al., 2004). The mechanisms that influence the choice between 
competing DSB repair pathways are tightly regulated. Such regulations 




1.10.2  Cell cycle arrest 
DNA damage checkpoint is a tightly regulated cellular surveillance and 
network of signaling pathways that respond to DNA defects during 
DNA synthesis and chromosome aggregation. DDR regulates DNA 
repair enzymes to arrest the cell division in cycling cells, by activating 
G1/S or G2/M cell cycle checkpoints and to allow DNA repair to take 
place before their transmission division into the daughter cells (Branzei 
and Foiani, 2008).  
 
The choice of DNA repair depends on both the type of DNA lesions and 
the cell cycle phase (Branzei and Foiani, 2008). For example, DNA 
DSBs in S and G2 phase are readily repaired by HR because of the 
presence of sister chromatids. However, if the damaged cells have 
progressed into G2/M phase, chromosome condensation makes it 
more difficult to identify the homologous strand for HR, and, NHEJ 
repair pathway is thus preferred.  
 
Checkpoint proteins will be recruited to the DNA lesion site to form 
repair complexes. In the case of DNA DSBs, the MRN complex will be 
recruited and a long ssDNA is formed as an intermediate DNA 
structure to activate the checkpoint responses (Ira et al., 2004; 
Jazayeri et al., 2006). Phosphoinositide 3-kinase (PI3K) related 
kinases ATM, ATR and DNA-PK are the central components of the 
DNA checkpoint machinery. ATM and DNA-PK are activated by DNA 
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DSBs, while ATR responds primarily to stalled replication forks 
(Branzei and Foiani, 2008). ATM and ATR phosphorylate checkpoint 
kinase-1 (CHK1) and CHK2, which coordinate DNA repair with DNA 
damage checkpoints. CHK1 and CHK2 together with ATM and ATR, 
reduce cyclin-dependent kinase (CDK) activity by various mechanisms, 
which in turn slow down or arrest cell-cycle progression (Bartek and 
Lukas, 2007). At the same time, other DDR proteins will also undergo a 
series of post-translational modifications such as acetylation, 
ubiquitylation or SUMOylation, to elicit cell cycle arrest, DNA repair and 
cell death mechanisms (Huen and Chen, 2008).  
 
If DNA lesions can be successfully repaired in these processes, DDR 
will be terminated and normal cell functions will be resumed. In contrast, 
severe and irreparable DNA damage will drive the DDR signaling 
towards cell death programs, such as apoptosis and autophagy, or 
towards the induction of cellular senescence (d'Adda di Fagagna, 
2008).  
 
1.10.3  DNA damage-induced cell death 
Severe and irreparable DNA injury shifts the cellular response towards 
different modes of cell death such as apoptosis, mitotic catastrophe, 
autophagy or necroptosis (Surova and Zhivotovsky, 2013) (Figure 
1.18). In asthma, airway epithelial cell death accounts for the excessive 
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epithelial loss and, if the lung fails to re-epithelialize, this could result in 
lung injury. This may be the main mechanism for molecular 
pathogenesis of allergic asthma (White, 2011). In this thesis, I 
hypothesize that DNA damage in airway epithelial cells is one of the 




Irreparable DNA DSBs activate apoptotic pathways through ATM, the 
checkpoint activator. ATM phosphorylates and stabilizes p53, leading 
to the upregulation of p21, which arrests the cells at G1 and S phase 
(Rich et al., 2000). Low levels of DSBs drive the transcription of the p21 
gene and the cell cycle arrest for repair processes to occur. On the 
other hand, high levels of DSBs induce p53 accumulation and the 
activation of pro-apoptotic genes such as BAX, p53-upregulated 
modulator of apoptosis (PUMA) and apoptotic peptidase activating 
factor 1 (Apaf1) to regulate the intrinsic apoptotic pathway (Roos and 
Kaina, 2006). DNA DSBs can also promote the extrinsic apoptotic 
pathway by up-regulating the tumor necrosis factor-related apoptosis-
inducing ligand (TRAIL) receptors, death receptor-4 and death 
receptor-5 (KILLER), as well as CD95 receptor (Fas/Apo-1) and its 
ligand (Hock and Vousden, 2012). Both pathways will eventually lead 
to the activation of executor caspase-3, which cleaves the Inhibitor of 
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Caspase-Activated DNase  (ICAD) to release Caspase-Activated 
DNase (CAD) which cleaves chromosomal DNA in a caspase-
dependent manner (Elmore, 2007).  
 
Apoptosis and loss of adhesion of bronchial epithelial cells in asthma 
have been shown to link to asthma severity and lung remodeling 
(Kuwano, 2007; Trautmann et al., 2005). Although studies on the level 
of p53 expression in asthmatic bronchial epithelium showed variable 
results (Cohen et al., 2007; Vignola et al., 2001), increased apoptotic 
epithelial cells demonstrated by TUNEL labeling were consistently 
observed in severe asthmatic (Cohen et al., 2007; Trautmann et al., 
2002). In fact, polymorphism analysis had demonstrated that asthmatic 
children exhibited higher frequency of arginine genotype in p53 codon 
72, which is associated with higher induction of apoptosis (Saccucci et 
al., 2014). On the other hand, oxidants present in asthmatic lungs are 
able to disrupt the tight junctions between epithelial cells, leading to 
decreased barrier functions and predisposing the epithelial cells to 
apoptosis (Holgate, 2007). Evidence of increased apoptosis in asthma 
biopsies further underscores asthma as a disease of dysfunctional 







1.10.3.2  Necroptosis 
Necroptosis is a TNF receptor 1 (TNFR1)-mediated regulated necrosis, 
which can be activated by PAMPs and DNA damage (Vandenabeele et 
al., 2010). Necroptosis in response to DNA damage requires the 
activation of poly(ADP-ribose) (PAR) polymerase 1 (PARP-1) (Zong et 
al., 2004). PARP-1 plays an important role in repairing alkylation DNA 
damage (Zong et al., 2004). Massive PARylation of target proteins, 
which can be triggered by ROS-induced DNA damage, depletes 
nicotinamide adenine dinucleotide (NAD)+ and consequently ATP, 
resulting in a bioenergetic crisis and necroptosis (Pasparakis and 
Vandenabeele, 2015). At the same time, PAR accumulation stimulates 
the release of apoptosis-inducing factor (AIF) from mitochondrial 
intermembrane space (Baritaud et al., 2012). AIF will then translocate 
into nuclear compartments to activate a caspase-independent DNA 
fragmentation, which, in turn, further stimulates PARP activation to 
cause a vicious cycle. In fact, AIF has been found to associate with 
γH2AX to form a DNA degrading complex that provokes 
chromatinolysis and necroptosis (Baritaud et al., 2012). This process is 
dependent on ATM and DNA-PK phosphorylation of H2AX protein 
(Baritaud et al., 2012). Importantly, necroptosis plays an essential role 
in inflammatory diseases. Necroptosis could increase plasma 
membrane permeabilization and lead to the exposure of DAMPs 
(Kaczmarek et al., 2013). In asthma, necroptosis of eosinophils may 
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implicate in the progress of allergic inflammation, by releasing 













Figure 1.18 | Various modes of cell death induced by DNA 
damage. Depending on the cell type and the severity of stimulus, DNA 
damage can induce different type of cell deaths. Adapted from (Surova 
and Zhivotovsky, 2013). 
 
1.10.4  DNA damage-induced cellular senescence 
Cellular senescence is characterized by irreversible cell-cycle arrest 
that can be induced by DDR signaling (d'Adda di Fagagna, 2008). 
Although these cells are metabolically active, they do not proliferate 
and are associated with premature aging in lung diseases such as 
COPD and idiopathic pulmonary fibrosis (Chilosi et al., 2013). Similar to 
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apoptosis, p53 activation plays a central role in initiating DNA damage-
induced senescence response. However, the switch that decides 
between the two modes of cellular responses upon DNA damage, 
apoptosis or cellular senescence remains unclear. It has been 
suggested that different cell types and the intensity of DNA damage 
determine if the cells are to enter apoptosis or cellular senescence. 
Epithelial cells and stromal cells will usually undergo senescence after 
encountering severe DNA damage, whereas lymphoid cells will usually 
undergo apoptosis (Surova and Zhivotovsky, 2013). Recent studies of 
epithelial cells obtained from asthma patients revealed that cellular 
senescence may be an important process in driving airway remodeling 
and airway hyperresponsiveness (Wu et al., 2013). In addition, age-
related decline in immune function, known as “immunosenescence”, 
may contribute to the pathogenesis of pulmonary diseases such as 
asthma and COPD (Murray and Chotirmall, 2015). These studies 
postulate that both epithelial cell and immune cell senescence could 
implicate in the development of asthma. 
 
1.11 DNA damage and repair in allergic asthma 
To date, there are less than ten studies that have investigated the 
relationship between DNA damage and asthma development 
(Chapmana et al., 2014; Dilek et al., 2015; Hasbal et al., 2010; Ho et 
al., 2012; Zeyrek et al., 2009). Four studies reported increased DNA 
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damage level in peripheral blood lymphocytes of asthma patients and 
in experimental asthma model (Chapmana et al., 2014; Dilek et al., 
2015; Hasbal et al., 2010; Zeyrek et al., 2009). Increased DNA damage 
in peripheral blood lymphocytes of asthma patients was correlated to 
the increased total oxidant status (TOS) and decreased total 
antioxidant status (TAS) (Dilek et al., 2015). At the same time, DNA 
damage levels in children with asthma were significantly decreased 
after GSH treatment, suggesting that DNA damage in asthma is 
associated with increased oxidative stress and might be prevented by 
antioxidant treatment (Hasbal et al., 2010; Zeyrek et al., 2009). 
However, all these studies focused only on peripheral blood of asthma 
patients, and none of the studies focus on the lung resident cells, 
especially the bronchial epithelium. Using an experimental asthma 
model, Ho et al. and Chapmana et al. observed significant increases in 
oxidative DNA damage in asthmatic lung tissue, suggesting that 
asthma can be genotoxic to lung tissues (Chapmana et al., 2014; Ho et 
al., 2012). Shedding of the bronchial epithelial cells is one of the main 
characteristics of severe asthma (Holgate, 2008). Hence, it is 
imperative to identify the source of damage in asthmatic airway 
epithelium and how this plays a role in asthma disease etiology.   
 
Several studies point to reduced DNA repair capacity as a susceptibility 
factor to lung carcinogenesis (Frosina, 2007; Liu et al., 2005). In 
particular, deficient DNA repair may have serious consequences in 
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organs constantly exposed to oxygen fluxes, such as the lung. In 
COPD patients, excessive DNA damage and inefficient DNA repair 
contributes to the pathogenesis of COPD (Aoshiba et al., 2012; 
Neofytou et al., 2012). In asthma, the relationship between DNA 
damage, DNA repair and asthma development remains understudied. 
Unveiling the mechanisms underlying asthma-induced genotoxicity in 
airway epithelium provides a new framework to identify new therapeutic 
strategies to mitigate the disease.  
 
1.12  Current therapies for asthma 
Currently available clinical interventions for allergic asthma focus on 
two major therapeutic strategies: the control of airway inflammation and 
the reduction of bronchoconstriction (Blakey et al., 2013). 
Corticosteroids are used as a first-line control therapy to suppress 
inflammation and airway hyperresponsiveness (AHR), while, β2-
adrenoreceptor agonists relieve the bronchospasm through the dilation 
of bronchioles and increasing the airflow into the lungs. Corticosteroids 
can up-regulate β2-adrenoreceptor expression to maximize airway 
smooth muscle relaxation (Townley & Suliaman, 1987). Hence, 
corticosteroids and β2-agonists are often prescribed together to reduce 
inflammation and to promote bronchodilation. Nevertheless, 
corticosteroid treatment is not curative and, in fact, is ineffective in 
controlling neutrophilic inflammation observed in severe asthma. In 
addition, diverse side effects associated with oral corticosteroids 
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preclude for long-term treatment (Sovijärvi et al., 2003). There are 
about 5-10% of severe asthmatics who respond poorly to 
corticosteroids, but account for ~50% of total healthcare cost in 
managing asthma (Barnes, 2012). Moreover, corticosteroid resistance 
in asthma remains as an unsolved problem, and is being investigated 
intensively for re-sensitization of steroid actions.  
 
Recent advances in understanding the molecular and cellular 
mechanisms in asthma pathobiology reveal many potential targets for 
the development of new therapies. One important discovery that drives 
the potential pharmacological manipulation is the use of antioxidants to 
regulate airway inflammation and lung injury.  
 
1.12.1  Antioxidants in asthma treatment 
Oxidative stress is reported in patients with severe asthma (Lee and 
Yang, 2012; Sugiura and Ichinose, 2008). An imbalance between 
oxidants and antioxidants causes oxidative stress, leading to 
dysfunction in cell signaling and arachidonic acid metabolism, which in 
turn contributes to airway inflammation (Moreno-Macias and Romieu, 
2014). This suggests that certain antioxidants could be used to 
scavenge RONS to prevent oxidative damage in lung cells and at the 
same time, fundamentally modulate inflammatory events that are 




In animal models, inhibiting the synthesis of RONS or scavenging 
radical species with SOD ameliorates allergen-induced and ozone-
induced airway hyperresponsiveness (Sugiura et al., 2006; Takahashi 
et al., 1993). Antioxidant supplements such as vitamin E and C, have 
been shown to reduce airway inflammation in asthma patients (Jiang, 
2014). Vitamin E treatment down-regulates mitogen-activated protein 
kinases (MAPK), NF-κ B, IL-8, vascular cell adhesion protein-1 
(VCAM-1) and intercellular adhesion molecule-1 (ICAM-1) in airway 
epithelial cells stimulated with TNF-α (Ekstrand-Hammarstrom et al., 
2007). It has been suggested that vitamin E prevents increases in the 
pulmonary permeability index, modulates lung lymph flow, reduces 
plasma nitrotyrosine and increases PaO2/FiO2 ratio (Morita et al., 2006). 
Moreover, increases in cellular levels of GSH by NAC attenuate airway 
inflammation and airway hyperresponsiveness by reducing ROS 
generation and by decreasing the activation of NF-κB and hypoxia-
inducible factor-1 (HIF-1) (Lee et al., 2007). Thioredoxin is a redox 
sensor in the oxidoreductase family and plays an important role in 
regulating redox-sensitive pathways such as NF-κB, activator protein 
1 (AP-1), MAPK and c-Jun N-terminal kinases (JNK). Kobayashi et al. 
showed that thioredoxin is able to reduce airway inflammation by 
suppressing eosinophil functions (Kobayashi et al., 2009). Resveratrol 
is a natural polyphenol found in skin of red fruits such as red grapes. 
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The presence of conjugated double bonds makes resveratrol a potent 
antioxidant. Several studies have revealed the protective effects of 
resveratrol by demonstrating its ability to suppress airway 
hyperresponsiveness, eosinophilia, mucus hypersecretion and collagen 
deposition in allergic asthma model (Lee et al., 2009; Royce et al., 
2011). Nrf2 activators, such as sulforaphane (isolated from broccoli) 
and synthetic triterpenoid 1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-
28-oyl) imidazole, have shown beneficial effects in treating lung 
disease (Sussan et al., 2009). In addition, our laboratory has previously 
reported that the traditional Chinese medicine andrographolide (Bao et 
al., 2009), the anti-malarial drug artesunate (Cheng et al., 2011; Ho et 
al., 2012) and the antioxidant supplement vitamin E γ-tocotrienol (Peh 
et al., 2015) are able to ameliorate airway inflammation and reduce 
oxidative stress in allergic asthma.  
 
Most epidemiologic studies report beneficial results in asthma-related 
phenotypes when antioxidants are consumed. Increased dietary intake 
of fruits and vegetable are associated with decreased prevalence of 
asthma (Romieu et al., 2006). In addition, high-antioxidant diets reduce 
inflammation, improve lung function in asthmatic patients and reduce 
the rate of asthma exacerbation (Eiberger et al., 2008; Moreno-Macias 
and Romieu, 2014; Wood et al., 2012). Meta-analysis also revealed a 
significant association between low dietary intake of vitamin A and C 
and a higher rate of asthma incidence (Allen et al., 2009). A vitamin E 
				
65 
rich-diet during pregnancy was found to reduce the risk of wheezing in 
children (Nurmatov et al., 2011). These studies suggest the therapeutic 
potential of antioxidants to treat asthma.  
 
1.12.2  Artesunate 
Artesunate is a semi-synthetic derivative of artemisinin, an active 
compound derived from a traditional Chinese medicine herb, Artemisia 
annua, also known as qinghao (青蒿) (Ho et al., 2014) (Figure 1.19). 
Artemisinin is known to have a good safety profile and is highly 
effective against the human malaria parasite Plasmodium falciparum 
(Li et al., 1994; Woodrow et al., 2005). However, due to its poor 
bioavailability, water-soluble derivatives such as artesunate, 
artemether and arteether were synthesized for easy oral administration. 
Artesunate is a stable sesquiterpene lactone that can be metabolized 
into dihydroartemisinin (DHA) (Zhu et al., 1983). In addition to its anti-
malarial effects, artesunate also possesses anti-viral, anti-parasitic, 
anti-inflammatory and anti-cancer properties (Ho et al., 2014; Krishna 
et al., 2008; Li et al., 2008). Our group has previously demonstrated 
the anti-inflammatory effects of artesunate in both OVA-induced and 
HDM-induced allergic asthma models (Cheng et al., 2011; Ho et al., 
2012). Artesunate dose-dependently suppresses airway inflammation, 
mucus hypersecretion and airway hyperresponsiveness in 
experimental allergic asthma models (Cheng et al., 2011). Artesunate 
also possesses anti-oxidative stress effects and ameliorates oxidative 
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Artemisinin     Dihydroartemisinin      Artesunate 
lung damage in allergic asthma (Ho et al., 2012). These two studies 
provide the key fundamental underpinning of my studies, which 
explores the potential of artesunate to mitigate aeroallergen-induced 
DNA damage in vivo and in vitro. I have shown that artesunate protects 
bronchial epithelium from DNA DSBs induced by HDM exposure in an 
allergic asthma mouse model. My findings fill one of the knowledge 





Figure 1.19 | Molecular structures of Artemisinin, 




1.13  Conclusions 
The association between airway inflammation, oxidative stress and 
DNA damage responses in allergen-induced asthma has not been fully 
elucidated. In this thesis, I hypothesize that DNA damage responses 
plays an important role in asthma development. To test the hypothesis, 
I used both in vivo and in vitro approaches and measured various 




In Chapter 3, I developed an in vivo HDM-induced asthma mouse 
model and quantified airway inflammation, macromolecules oxidative 
damage and bronchial epithelium DNA DSBs in asthmatic airways. In 
addition, I investigated the importance of DNA repair in regulating 
asthma pathogenesis using NU7441, an inhibitor of DNA-PK that plays 
a central role in NHEJ DSB repair pathway. I found that HDM exposure 
induces extensive DNA damage in bronchial epithelium both in vivo 
and in vitro. I have also shown that DNA repair is important in 
regulating inflammatory responses and cell death in bronchial epithelial 
cells exposed to allergen. 
 
In Chapter 4, I exposed isolated human bronchial epithelial cells to 
HDM allergen and measured genotoxic and cytotoxic end points, in 
vitro. I measured RONS production, mitochondrial oxidative stress, 
nitrosative stress and antioxidant responses in cells exposed to HDM. 
Correspondingly, I investigated the ability of the antioxidants 
glutathione and catalase to prevent the DNA damaging effects of 
allergen exposure on bronchial epithelial cells. I showed that HDM 
induces DNA damage and RONS production, that it alters antioxidant 
responses in bronchial epithelial cells. These damaging effects can be 
prevented by antioxidants, implicating oxidants as the source of DNA 




In Chapter 5, I explored the genome protective potential of artesunate, 
in both in vivo and in vitro models. I discovered that artesunate protects 
bronchial epithelium from DNA DSBs induced by HDM, potentially by 
its anti-inflammatory and anti-oxidative stress effects. This study 
reveals a new use for artesunate, which potentially can be used to 
protect cells from the genotoxic effects of other environmental insults, 
such as chemical exposure or X-rays.   
 
This PhD project expands current knowledge on the molecular 
mechanisms underlying allergen-induced asthma, especially in the 
context of DNA damage responses, focusing on bronchial epithelium of 
asthmatic airway. The results of these studies highlight a novel role for 
DNA damage in asthma-associated pathophysiology and call for 
attention to DNA repair capacity as a potential modulator of asthma-
associated pathogenesis.  In addition, my findings also raise concerns 
on the production of RONS, DNA damage and cytotoxicity upon direct 
aeroallergen exposure to bronchial epithelium, suggesting that the 
epithelial cell is a key component in asthma pathology and can be an 
emerging target for novel therapies. My findings further suggest that 
antioxidants can prevent aeroallergen-induced DNA damage in 




2 Chapter 2: Materials and Methods  
2.1  Materials 
Table 2A | Commercial sources of chemicals and reagents 
Company Chemicals and Reagents 
1st BASE, 
Singapore 
Tris base, tris-acetate-EDTA (TAE), sodium 
dodecyl sulfate (SDS), phosphate buffered saline 
(PBS) 10x 
Advansta Inc., 
Menlo Park, CA, 
USA 
WesternBright Enhanced chemiluminescent (ECL) 






Anesthetic mixture (10 ml/g ketamine: 
medetomidine: H2O = 3:4:33), isoflurane 
Applied 
Biosystems, 
Foster City, CA, 
USA 










Bradford assay, DC protein estimation assay, 
Alkaline phosphatase (AP) conjugated substrate 
kit, agarose, blotting paper, polyvinylidene 
difluoride (PVDF) membrane, 
tetramethylethylenediamine (TEMED), 3,3’,5,5’-
tetramethylbenzidine (TMB) substrate kit, Triton 
X-100 
Biolegend; San 
Diego, CA, USA 




Target retrieval solution 10x, HRP-conjugated 
anti-mouse Ig and anti-rabbit Ig, AP- conjugated 





House dust mite (HDM), cockroach allergen 
extract (CAE), Aspergillus fumigatus (ASP), 
ragweed pollen extract (RWE) 
Hyclone, Logan, 
UT, USA 
Fetal bovine serum (FBS), trypsin, Roswell Park 




Island, NY, USA 
Diethylpyrocarbonate (DEPC)-treated water, 
Penicillin-streptomycin, L-glutamine, RPMI 
medium, Prolong Gold Anti-fade, secondary 
antibodies (Donkey or goat anti-primary host IgG 
(H+L)) for immunofluorescence, conjugated with 
Alexafluor-488, Alexafluor-546 and Alexafluor-
647, 4’,6 diamidino-2-phenylindole (DAPI), Normal 
melting point agarose, low melting point agarose, 




GelBond film, Bronchial Epithelial Cell Growth 
Medium (BEGM), BEGM SingleQuot Kit 























Quanta qScript cDNA Super Mix  
Sigma Aldrich, St 
Louis, MO, USA  
Harris Hematoxylin, eosin Y, 10% neutral buffered 
formalin, bovine serum albumin (BSA), skim milk, 
Tween 20, polyethylene glycol (PEG)400, triton X-
100, methyl green, methacholine, 
lipopolysaccharide (LPS), glutathione (GSH), 
catalase (CAT), S-S-Nitrosoglutathione (GSNO), 
2-Phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl 3-
oxide (PTIO), N-lauroylsarcosine, Na2EDTA, 
hydrogen peroxide (H2O2), NaOH, artesunate 






Bicinchoninic acid (BCA) protein assay kit, calf 
serum, RestoreTMPLUS western-blot stripping 
buffer, protease inhibitor cocktail, T-PER Tissue 
protein extraction reagent, M-PER Mammalian 




2.2 Animal treatments 
Female BALB/c mice, 6-8 weeks old weighing 20-25g (Animal 
Resources Centre, Canning Vale, WA, Australia) were housed in 
filtered cages in Animal Holding Unit (AHU) of NUS. AHU animal rooms 
were regulated by automated timer to provide cycles with 12-14 hr of 
light and 10-12 hr of dark. The average temperature in the animal is 
22°C. Mice were allowed to have free access of food and water as well 
as bedding changing once in three days. Standard meals for mice 
generally contain 4-5% of fat and 14% of protein. A minimal of 3 days 
of acclimatization was given for newly arrived mice to adapt to their 
new environment. All animal procedures stated here were approved by 
the Institutional Animal Care and Use Committee of the NUS. 
 
Purified HDM protein extract (Dermatophagoides pteronyssinus) (Greer 
Laboratories, NC, USA) stock solution and working solution were 
prepared as described in Table 2B. HDM working solution was 
prepared freshly before use. Mice were sensitized on Day 0 and 7 and 
challenged on Day 14 with 40 µl of 27 µg HDM protein via intratracheal 
(i.t) administration (Hammad et al., 2009) (Figure 2.01, A). DNA-PKcs 
inhibitor, NU7441 (NU) was prepared freshly before use (Table 2C). 
NU7441 was dissolved in 40% PEG400, sonicated for 1-2 min until 
dissolved, and given at 10 mg/kg intraperitoneally (i.p) twice daily on 
Day 13, 14, and on Day 1 and 2 post-HDM challenge, 40% PEG400 in 
				
72 
saline was administered as vehicle control (Figure 2.01, B). For drug 
treatment, artesunate (ART) was prepared freshly before 
administrating into mice. Artesunate was first dissolved in dimethyl 
sulfoxide (DMSO) and was further diluted with saline to reach the 
administration dosage of 30 mg/kg in 100 µl (Table 2D). Artesunate 
was administered into mice via i.p injection once daily on Day 6, 7, 8, 
13, 14 and Day 1 post-challenge (Figure 2.01, C). 5% DMSO was 
injected as vehicle control. Dexamethasone (DEX) was dissolved in 
saline and administered at 1 mg/kg (Table 2E) using the same drug 
administration regime.  Mice were sacrificed on Day 1, 3 and 5 post-
challenge.  
 
Table 2B | Preparation of HDM (Stock solution: Keep in -20oC) 
HDM protein (mg) Saline (µ l) HDM concentration (mg/ml) 
4.57 680 6.72 
 
HDM working solution (Prepared fresh before use, keep on ice): 
HDM  
(Stock 









Amount of HDM in 
40 µ l administered 
(μg) 











(µ l ) 
Saline 
(µ l ) 
Total 
volume 




Amount of NU in 100 
µ l  administered into 
20g mouse (mg/kg) 
2 400 600 1000 40 10 
 






(µ l ) 
Total 
volume 




Amount of ART in 100 
µ l  administered into 
20g mouse (mg/kg) 
6 50 950 1000 5 30 
 




(µ l ) 
Amount injected 
(µ l) 
Amount of DEX administered into 20g 
mouse (mg/kg) 





HDM          HDM           HDM       Sample collection 
   0                 7               14   1       3       5                  10 
Sensitization Challenge
Day Day post-challenge (d.p.c) 
NU7441 (10 mg/kg)
  
HDM          HDM           HDM        
      




Artesunate      (30 mg/kg)
  
HDM          HDM           HDM        
      






































Figure 2.01 | HDM-induced airway inflammation model. (A) Mice 
were sensitized on Day 0 and 7 and challenged on Day 14 with 27 µg 
HDM. 1, 3 and 5 days after challenge, blood, BAL fluid and lung tissue 
were collected. In control mice, mice will receive saline during 
sensitization and challenge stage. (B) Treatment regime for NU7441 
(10 mg/kg), administered twice daily on day 13, 14, day 1 and 2 post-
challenge (d.p.c). (C) Treatment regime for artesunate (30 mg/kg), 






2.3  Bronchoalveolar lavage (BAL) fluid cells count 
Mice were anesthetized and sacrificed on 1, 3 and 5 days after HDM 
challenge and BAL was collected. In brief, the trachea was exposed by 
blunt dissection, a 22-gauge cannula was inserted into the trachea, and 
lungs were gently flushed with 500 µl PBS for 3 times, collecting 1.5 ml 
of PBS at the end of the procedure. Total BAL cell number was 
measured using hemocytometer by two independent researchers, 
blinded (without knowing the treatment group). Differential immune cell 
count was determined using BD Fortessa FlowCytometer and analyzed 
with Flowjo software (Treestar Inc., San Carlos, CA). Immune cells 
were identified as CD45+, macrophage as CD11c+/Siglec F+, 
eosinophils as CD11c-/Siglec F+, neutrophils as GR-1+/CD11b+ and T 
cells as CD3+/CD19-, T cells subset CD4+ and CD8+ T cells were 
identified using CD3+/CD19-/CD4+ and CD3+/CD19-/CD8a+ 
antibodies respectively (Table 2F). 
Table 2F | Panel antibodies for differential immune cell count 
Surface marker Fluorochrome Company 
CD45 APC Miltenyi Biotec 
CD11b Pe-Cy7 ebioscience 
GR-1 PerCp5.5 ebioscience 
Siglec F PE BD Biosciences 
CD11c PB/ eFlour 450 Biolegend 
CD4 BV 786 (Qdot 705) BD Biosciences 
CD3 BV 605 (Qdot 605) BD Biosciences 




2.4  Lung tissue processing 
Lungs were carefully excised from mice during sample collection, 
blotted dry and fixed in 10% formalin for at least 48 hr. Lung tissues 
were then processed in a tissue processor (Leica Instruments; 
Oberkochen, Germany). The tissues were first dehydrated with ethanol, 
in progressively increasing concentration, from 70% to 80% to 90% 
each for 30 min and then in 100% ethanol for 2 hr. The samples were 
then dewaxed in Histoclear (National Diagnostics) for 10.5 hr, 
impregnated with molten paraffin wax for 3 hr and last step was to 
embed in paraffin wax. The lung samples were sectioned into 4.5 µm 
using a rotary microtome (Leica Instruments; Oberkochen, Germany) 
and were dried and fixed on poly-L-lysine coated glass slides, ready to 
be stained.  
 
2.5  Hematoxylin and Eosin (H&E) staining 
Tissue sections were stained with H&E to assess cell infiltration into 
lungs. Briefly, the tissues were deparaffinized in Histoclear twice for 5 
min each, followed by rehydration in ethanol in decreasing 
concentrations (100% à 100% à 90% à 70%, for 2 min each) and 
finally in deionized water. Lung tissue sections were submerged in 
Mayer Hematoxylin (DAKO, Carpinteria, CA, USA) for 7 min and 
washed in deionized water before differentiating with 0.3% acid alcohol 
for 30 sec. Tap water was used to wash samples before 
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counterstaining with alcoholic eosin for 30 sec. Samples were washed 
in deionized water and dehydrate in ethanol (70% à 90% à 100% à 
100% for 30 sec each). Finally the samples were immersed in 
Histoclear for 10 min before mounting with Histomount. Pictures of 
bronchioles in the stained lung tissue were taken using light 
microscope camera (Nikon DSRi1, Japan) at 200X magnification. In 
each lung sections, about 20 images of the bronchioles were captured. 
 
Quantification of inflammation score was performed in a blind manner 
(treatments marking on the slides were re-coded with numbers) and 
scored based on a 5-point system described in Myou et al. (Myou et al. 
2003). The inflammation scoring system was as followed: 0, no 
inflammatory cells; 1, occasional cuffing with few inflammatory cells; 2, 
most bronchi or vessels surrounded by a ring of cells one cell layer 
deep; 3, a thick layer (2-4 cells layer deep); 4, a ring of cells more than 
4 cells layer deep. Scoring of inflammatory cells was performed in all 
pictures taken on each lung section; at least 3 mice per treatment 
group. The average score of each group of animals was calculated. 
 
2.6  Detection of 8-OHdG/8-oxoG, 8-isoprostane and 3-
nitrotyrosine 
8-isoprostane and 8-OHdG/8-oxoG (Cayman Chemical, Ann Arbor, MI) 
levels in BAL fluid were quantified using competitive enzyme 
immunoassays. The basis of this assay is competitive binding process 
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between 8-isoprostane / 8-OHdG/8-oxoG in BAL fluid and their 
respective tracers (8-Isoprostane-acetlycholinesterase / 8-OH-dG-
acetylcholinesterase) provided by the kits. A known concentration of 
tracer was mixed with fixed volume of BAL fluid. The amount of tracer 
that can bind to the monoclonal antibody is inversely proportional to the 
concentration of 8-isoprostane / 8-OHdG/8-oxoG in the sample. This 
antibody-oxidatively damaged target complex binds to the mouse anti-
rabbit IgG that is pre-coated on the bottom of the 96-well plate. After 
overnight incubation in 4oC, plate was washed and Ellman’s Reagent 
(containing the substrate to acetylcholinesterase) was added. The 
product of this enzymatic reaction was yellow in color and the 
absorbance was measured spectrophotometrically at 412 nm after 30-
60 min. The absorbance readings were inversely proportional to the 
actual amount of 8-Isoprostane/8-OHdG in the BAL fluid. Standard 
curves were plotted to determine the exact concentration. 
 
Lung level of 3-NT (Cell Biolabs, San Diego, CA) was measured using 
a competitive enzyme immunoassays. Snap-frozen lung tissues were 
first homogenized in HEPES buffer using a silicon bead-based 
homogenizer Precellys 24 lysis/homogenizer (Bertin Technologies, 
France), and centrifuged to retrieve the supernatant. Protein level in the 
supernatant was calculated and normalized with Bradford assay before 
measuring 3-NT levels. Normalized supernatant was added into 96-
well plate pre-coated with nitrotyrosine, and incubated for 10 min, 
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followed by adding of anti-nitrotyrosine antibody, incubated for 1 hr. 
Plate was then washed and incubated with secondary antibody 
conjugated with horseradish peroxidase (HRP), incubated for another 
hr before adding of 3,3',5,5'-Tetramethylbenidine (TMB) Substrate 
Solution. This enzyme reaction was stopped by adding Stop Solution 
(2N sulfuric acid), and absorbance was measured 
spectrophotometrically at 450 nm. The absorbance readings were 
inversely proportional to the actual amount of 3-NT in lung tissue 
supernatant. Standard curve was plotted to determine the exact 
concentration. 
 
2.7  2,7-dichlorodihydrofluorescein diacetate (DCFH-DA) assay 
BAL fluid was incubated with 10 mM DCFH-DA (Invitrogen, Grand 
Island, NY, USA) for 20 min at 37oC. BAL fluid was then spun down to 
collect the cells. BAL cells were re-suspended in RPMI medium and 
fluorescence signal released by DCFH-DA upon oxidation is measured 
using a spectrophotometer with excitation at 492 nm and emission at 
525 nm. 
 
2.8 Human sample 
Paraffin-embedded human lung sections were purchased from United 
State Biological (Salem, MA). Asthma lung sections (T5595-5112M) 
were obtained from a 63-year-old female with a clinical diagnosis of 
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asthma with unknown cause of death. Normal lung section (T5595-
4977) was obtained from a 83-year-old female who passed away due 
to disease not related to lung. Human lung lysate were purchased from 
Genetex (San Antonio, TX). Asthmatic lung lysate (GTX25167), used 
for immunoblotting, was obtained from a 85-year-old female patient 
that had been diagnosed with asthma for 25 years, and died of asthma. 
Donor for normal lung lysate (T5595-6535) is from a normal, 66-year 
old male donor. All other information is inaccessible.  
 
2.9  Immunofluorescence staining of lung section 
Mouse lung tissues were processed as described in Section 2.4 and 
immunofluorescence staining was performed as described by Yamada 
et al. (Yamada et al., 2012). Lung sections were cut 4.5 µm thick, 
dewaxed, rehydrated in 100%, 90% and 70% absolute ethanol. Target 
antigen retrieval was performed using citrate buffer pH 6.0 (DAKO, 
Carpinteria, CA, USA). Buffer was pre-heated using medium high 
power microwave for 5 min and slides were immersed in sub-boiling 
antigen retrieval buffer for 30 min in microwave with low power. After 
three washing with 1X PBS, slides were blocked with 10% serum 
(same host as secondary antibody) for 1 hr at room temperature. This 
is followed by incubation with primary antibody in closed humidified 
chamber for overnight at 4oC.  The next day, after washing, slides were 
incubated with secondary antibody conjugated with fluorochrome at 
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room temperature for 1 hr and protected from light, followed by 4’,6 
diamidino-2-phenylindole (DAPI) staining for 5 min before mounting in 
SlowFade Gold anti-fade reagents (Life Technologies, Gaithersburg, 
MD). 
 
Lung sections were immunofluorescence stained for γH2AX (Cell 
Signaling Technology, Beverly, MA, USA), 53BP1 (Santa Cruz 
Biotechnology), 8-OHdG (Abcam, Cambridge, MA) or Club cell 10 kD 
(CC10) (Santa Cruz Biotechnology) primary antibodies. Micrographs 
were taken using Zeiss inverted fluorescence microscope (Carl Zeiss, 
Inc., Thornwood, NY, USA) in a blinded fashion and quantified using 
Bitplane Imaris 5.7 software (Bitplane AG, Zurich, Switzerland).  
 
2.10  Immunoblotting of lung lysate 
Mouse lungs were isolated and cleaned of connective tissues and 
bronchial lymph nodes before being snapped frozen in liquid nitrogen. 
Immunoblotting was performed as described previously (Ho et al., 
2012). Snapped frozen lung were grinded using tissue homogenizer 
machine Precellys 24 lysis/homogenizer (Bertin Technologies, France) 
prior to protein extraction. Total proteins were extracted from 
homogenized lung in T-PER tissue protein extraction reagent (Thermo 
Scientific Inc, Waltham, MA, USA). Protein quantification was 
performed according to the instruction in the Bradford protein assay 
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(Bio-Rad, Hercules, CA) to ensure equal protein loading into gel. 50 µg 
protein per lane were separated using sodium dodecyl sulfate 
polyacrylamide gel electrophoresis (SDS-PAGE) (Bio-Rad, Hercules, 
CA). The proteins were transferred to PVDF membranes (Bio-Rad, 
Hercules, CA) in transfer buffer at 100V for 30 min with a wet 
electrophoretic transfer system (Bio-Rad, Hercules, CA). Immunoblots 
were then blocked with 5% nonfat milk (Sigma Aldrich, St Louis, MO) in 
PBS with 0.05% Tween 20 at room temperature for 2 hr and probed 
with primary antibody at 4oC overnight. Immunoblots were developed 
using enhanced chemiluminescence HRP substrate (Advansta Inc., 
Menlo Park, CA, USA). Antibodies used were targeted at KU70, γH2AX, 
cleaved caspase-3, CAD (Cell Signaling Technology), RAD51 (Santa 
Cruz Biotechnology, Santa Cruz, CA), PARP (Abcam, Cambridge, UK), 
PAR (Calbiochem, San Diego, CA), or β-actin (Abcam, Cambridge, 
UK). 
 
2.11  TUNEL assay 
Apoptotic cells were detected in situ on lung sections using Apotag 
Peroxidase Terminal deoxynucleotidyl transferase dUTP nick end 
labeling (TUNEL) assay (Merck Millipore, Billerica, MA), according to 
the manufacturer’s instruction. Briefly, random sections were obtained 
from three animals per treatment group, dewaxed, rehydrated, and 
incubated in 20 µg/ml proteinase K (Merck, Darmstadt, Germany) for 
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10 min to retrieve antigen. The slides were immersed in 3% H2O2 for 5 
min to quench endogenous peroxidase. This is followed by labeling of 
fragmented DNA by nick end-labeled with a mixture of terminal 
deoxynucleotidyl transferase (TdT) reaction buffer for 60 min at 37°C. 
The reaction was stopped by stop buffer provided by the kit. Detection 
was made by streptavidin-conjugated peroxidase, followed by 15 min 
incubation in DAB substrate. The sections were then counterstained 
with 5% methyl green (Sigma Aldrich, St Louis, MO). Positive control 
sections were pre-treated with DNase I (25 U/µl) (Life Technologies, 
Gaithersburg, MD) for 10 min to induce universal DNA nicking before 
labeling by dUTP. Quantification of TUNEL-positive cells was done 
manually and in a blinded fashion. In negative control experiments, 
slides were incubated without TdT while all other steps remained the 
same.  
 
2.12  Measurement of airway hyperresponsiveness (AHR) 
Development of AHR was measured by increased airway resistance 
(RI) and decreased dynamic lung compliance (Cdyn) in response to 
methacholine (1 - 32 mg/ml; Sigma-Aldrich) recorded using a 
wholebody plethysmograph chamber (Buxco, Sharon, CT). Rl is 
defined as the ratio of driving pressure to the rate of airflow; Cdyn is 
defined as the ability of lungs to stretch during a change in volume 
relative to an applied change in pressure. AHR was measured on Day 
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3 post-last HDM challenge. Mice were anesthetized and tracheotomy 
was performed where a small transverse incision was made on the 
exposed trachea. Each mouse was placed on a warmed holder in the 
whole body plethysmograph chamber and the trachea was connected 
to a Y shape cannula and attached to pneumotach, ventilator and 
nebulizer, at a tidal volume of 200 μl/breath and a breathing rate of 
150/min. Methacholine was stored in -20°C and dissolved in PBS 
before using. Mice were challenged with aerosolized 10 µl increasing 
dose of methacholine for 3 min, and bronchoconstriction was recorded 
for subsequent 5 min. Results are percentage as a fold change of the 
respective basal values in response to PBS. 
 
2.13 Cell culture and treatment 
Human bronchial epithelial cells, BEAS-2B and human alveolar epithelial 
cell lines, A549 were obtained from American Type Culture Collection 
(ATCC, Rockville, MD). Both cells were grown in RPMI medium 1640 
(Invitrogen) supplemented with 10% FBS (Hyclone, Logan, UT, USA) and 
100 unit/mL penicillin-streptomycin (Invitrogen). BEAS-2B cells were also 
grown in Bronchial Epithelial cell Growth Medium (BEGM) (Lonza, 
Hopkinton, MA, USA) supplemented with BEGM SingleQuot Kit 
Supplement & Growth Factor (Lonza). Cells at 3 x 105 were plated on 6-
well plate and left to adhere for at least 4 hr or overnight before being 
exposed to HDM protein (2, 20, 200 µg/ml) (Greer Laboratories) (dissolved 
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in culture medium) for 6 or 20 hr.  
 
For NU7441 treatment, BEAS-2B cells were pretreated with NU7441 (2.5 
µM) for 3 hr, washed off before replenishing with 100 µl BEGM medium 
containing HDM (2, 20, 200 µg/ml) and incubated for 20 hr at 37oC. As 
vehicle control, same concentration of DMSO was used to replace 
NU7441 treatment. Supernatant was collected, spun down to remove cell 
debris and kept for cytokine profiling assays.  
 
In antioxidant treatment, cells were exposed to 200 µg/ml of HDM in the 
presence of glutathione (0.1, 1, 10 mM) (Sigma-Aldrich) or catalase (2, 20, 
200 U/ml) (Sigma-Aldrich) for 6 hr. Untreated control was replenished with 
fresh culture medium.  
 
2.14  Cytokine profiling with ELISA 
Levels of human cytokines in cell culture supernatant were determined 
using sandwich ELISA kits for IL-4, IL-5, IFN-γ (OptEIA, BD 
Biosciences), IL-13, IL-33 and TSLP (Duoset, R&D system, 
Minneapolis, MN, USA), according to manufacturer’s instruction. All 
samples were assayed in duplicated. In brief, 96-well immunoplate was 
coated with 100 µl of target capture antibody overnight at 4oC. The 
plate was washed three times with wash buffer provided in Duoset 
Ancillary Reagent kit 2 (R&D system, Minneapolis, MN, USA), and non-
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specific binding was blocked with assay diluent at room temperature for 
1 hr. After three washing cycles, 100 µl of supernatant samples or 
standards were added into each well and incubated for 2 hr at room 
temperature. Plate was washed 5 times, and incubated with respective 
biotinylated-detection antibody for 2 hr, followed by washing and 
incubating with streptavidin-HRP conjugate (R&D system) for 30 min to 
1 hr at room temperature. Reaction was stopped with 2 N H2SO4 (R&D 
system). The absorbance was read at 450 nm within 30 min of 
stopping reaction. Standard curve for each assay was plotted and the 
concentrations of each cytokines were determined.   
 
2.15  Alkaline comet assay 
Arrayed microwells were prepared on molten 1% normal melting point 
agarose (Omnipur, Invitrogen) using a polydimethylsiloxane (PDMS, 
Dow Corning Corporation) mold consists of patterned negative 
microwells fabricated from silicon wafer (WaferNet Inc., San Jose, CA, 
USA) as described (Olive and Banath, 2006). After the agarose gel 
solidified, mold consisting negative microwells were removed gently, 
leaving chip gel consisting of arrayed microwells with 40 µm diameter 
each.  Bottomless 96-well plate (Greiner BioOne, Hopkinton, MA, USA) 
was gently pressed onto the chip gel and clamped with 1.5” binder clips 
to secure the plate on top of the gel. BEAS-2B cells were trypsinized 
from culture flask and re-suspended in RPMI media to obtain a final 
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concentration of 0.5 x 105 cells/mL. Cells were then loaded into the 
microwells by adding 100 µL of cell suspension into each well in 96-well 
plate. Cells were allowed to load into microwells by gravity force for 30 
min in 37oC incubator. Blinder clip was removed to allow excess cells to 
be washed off before chip gel was covered with a layer of 1% low 
melting point agarose and allowed to solidify at room temperature for 3 
min followed by 5 min in 4oC. New 96-well bottomless plate was then 
carefully aligned according to previous clamping and repressed on the 
gel chip, secured by binder clips.  
 
Cells trapped in microwells were then exposed to different treatment 
conditions, by adding 100 µL of chemical at desired dose to each well 
in 96-well plate. Cells were incubated with HDM (200 µg/ml) with or 
without the presence of TLR4 agonist (102, 103, 104 µg/ml) and TLR4 
antagonist (0.1, 1, 10 µg/ml) (InvivoGen, San Diego, CA) or 
antioxidants glutathione (0.1, 1, 10 mM) and catalase (2, 20, 200 U/ml) 
(Sigma-Aldrich, St. Louis, MO) for 6 hr, before the reactions were 
stopped by lysing the cells using lysis buffer (2.5 M NaCl, 100 mM 
Na2EDTA, 10 mM Tris, pH 10). Alkaline CometChip assay was then 
performed. Alkaline comet assay uses high pH to unwind DNA before 
electrophoresis and therefore is able to detect all kind of DNA lesions. 
Comet chips was placed into an electrophoresis tank filled with 
unwinding buffer (0.3M NaOH, 1mM Na2EDTA) for 40 min at 4oC 
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followed by electrophoresis at 1 V/cm with current of 300 mA for 30 min.  
 
Comet analysis was performed after electrophoresis. DNA was first 
stained with SYBR Gold (Invitrogen), followed by capturing of images 
using fluorescence microscope. Comet images were then analyzed 
using the Guicometanalyzer (Massachusetts Institute of Technology, 
Department of Bioengineering, Engelward Laboratory), a customized 
MATLAB (The Matworks, Beltsville, MD) software, which can analyze 
multiple comet images at the same time, as described by Wood et al. 
(Wood et al., 2010). 
 
2.16  Neutral comet assay 
Human alveolar epithelial cell lines, A549 (ATCC, Rockville, MD) was 
cultured in RPMI medium 1640 supplemented with 10% fetal bovine 
serum (Atlanta Biologicals) and 100 units/mL penicillin-streptomycin 
(Invitrogen). NU7441, DNA-PKcs inhibitor was prepared in DMSO, 
diluted to 5 µM in complete growth medium and exposed to cells for 2 
hr at 37oC before seeding the cells onto comet chip and after exposure 
to ionizing radiation (IR) to induce DNA DSBs. In untreated cells, same 
concentration of DMSO was used instead of NU7441. Neutral 
CometChip assay was performed as described by Weingeist et al. 
(Weingeist et al., 2013). Comet chip was prepared using a mold 
fabricated from silicon wafer  (WaferNet), 1% normal melting point 
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agarose (Omnipur, Invitrogen), GelBond film (Lonza) and a bottomless 
96-well titer place (Greiner BioOne), as described above in section 
2.15. At least 10,000 A549 cells were added to each 96 wells and allow 
cells to settle by gravity in growth medium at 37oC. After washing the 
excess cells, microwells containing cells were enclosed with 1% low 
melting point agarose. Microwell gels were irradiated with a Cobalt-60 
irradiator (Gammacell 220 Excel, MDS Nordion, Ottowa, Canada) that 
delivers 50 Gy at 120 Gy/min. To study repair kinetics, cells exposed to 
IR were incubated in media to allow DNA repair to take place. Repair 
was stopped by lysis buffer at various time points after initiation of 
repair (2.5 M NaCl, 100 mM Na2EDTA, 10 mM Tris, 1% N-
Lauroylsarcosine, pH9.5 with 0.5% triton X-100 and 10% DMSO added 
20 min before use). After cell lysing and washing with electrophoresis 
buffer (90 mM Tris, 90 mM Boric Acid, 2 mM Na2EDTA, pH8.5), 
electrophoresis was conducted at 4oC for 1 hr at 0.6 V/cm and 6 
mA.  After electrophoresis, slides were stained with SYBR Gold. 
Images were captured using fluorescence microscope and analyzed 
automatically using customized software written in MATLAB. 
Experiments were repeated three times, and an average of the 




2.17  Immunofluorescence staining of cells 
Cells were grown on 8-well culture glass chamber slide until 70% 
confluent. Cells were exposed to HDM protein (2, 20, 200 µg/ml) for 6 
hr. Cells were then fixed in ice-cold methanol for 10 min at -20oC and 
permeabilized in 1% triton-X 100 in PBS at 37oC for 30 min. Cells were 
immunoblocked with 5% bovine serum albumin (BSA) for 1 hr at room 
temperature and then probed overnight at 4oC with primary antibodies 
targeting γH2AX or apoptosis-inducing factor (AIF) (Cell Signaling 
Technology) diluted in 1% BSA in PBS staining buffer. The next day, 
cells on chamber slides were washed with PBS.  Cells were then 
stained with secondary antibody conjugated with fluorochrome at room 
temperature for 1 hr and protected from light, followed by DAPI staining 
for 5 min before mounting in SlowFade Gold anti-fade reagents (Life 
Technologies, Gaithersburg, MD, USA). For CellROS and Mitotracker 
Red CM-H2Xros (Invitrogen) staining, slides were stained according to 
manufacturer’s instruction. All slides were mounted in SlowFade Gold 
anti-fade reagents (Invitrogen, Grand Island, NY, USA). Images were 
captured using the Zeiss inverted fluorescence microscope and 
quantitated using the Bitplane Imaris 5.7 software (Bitplane AG, Zurich, 
Switzerland).  
 
2.18  Quantitative real-time PCR analysis 
Total RNA was extracted from BEAS-2B cells with RNAzol® RT 
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(Molecular Research Center, Inc., Cincinnati, OH, USA). Complementary 
DNA (cDNA) was synthesized with qScript cDNA Supermix (Quanta 
Biosciences, Gaithersburg, MD, USA) and then subjected to quantitative 
RNA polymerase chain reaction (PCR). Briefly, template cDNA was mixed 
with SYBR Green Master Mix (Applied Biosystems, Carlsbad, CA, USA) 
and was amplified and quantitated using a sequence detector (ABI 7500 
Cycler; Applied Biosystems). The PCR conditions were as followed: 95oC 
for 10 min followed by 40 cycles of 95oC for 10 second and 60oC for 1 min, 
continued by a melting curve analysis, by ramping from 60oC to 95oC, at 
1.6oC/ second. The mRNA expression of antioxidant genes listed in Table 
2G was normalized to the level of the housekeeping gene GADPH. All 
primers were designed in-house using NCBI Primer Blast.  
 
Table 2G: Primer sequences for RT-PCR 
 
2.19  Immunoblotting of cells nuclear lysate 
BEAS-2B cells nuclear protein extraction was performed using a nuclear 
extraction kit (Active Motif, Carlsbad, CA, USA). Nuclear protein extracts 
Targets Forward Reverse 
SOD1 5-GTGGGCCAAAGGATGAAGAGA-3 5-ATAGACACATCGGCCACACC-3 
SOD2 5-AACCACGATCGTTATGCTGAGT-3 5-GTGACTAAGCAACATCAAGAAATGC-3 
SOD3 5-AGACACCCTCCACTCTGAGG-3 5-AGGATGGTGGGTCTCGGTAT-3 
Catalase 5-CTGACTACGGGAGCCACATC-3 5-AGATCCGGACTGCACAAAGG-3 
iNOS 5-CCCCATCAAGCCCTTTACTT-3 5-CACCTCCTGGTGGTCACTT-3 
GST 5-CCCCTCTCCGGAGCTCTTAT-3 5-GGATGTCCCAGTACCCCAGT-3 
GSR 5-TGCTGAAGTTCTCCCAGGTCAA-3 5-TATTCGGGACCCGCCCAATG-3 
NOQ1 5-GCCATGTATGACAAAGGACCC-3 5-CCACTCTGAATTGGCCAGAGA-3 
GADPH 5-ACAACTTTGGTATCGTGGAAGG-3 5-GCCATCACGCCACAGTTTC-3 
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(20 μg per lane) were separated by 10% SDS-PAGE as described in 
Section 2.10. Immunoblots were probed with anti-NRF2 antibody (Cell 
Signaling Technology) or anti-Lamin A/C antibody (Cell Signaling 
Technology). Immunoblots were developed using enhanced 
chemiluminescence HRP substrate (Advansta).  
 
2.20  Cell death and cell cycle staining 
Cell death was studied by staining cells with Alexa Fluor® 488 Annexin V/ 
Dead cell apoptosis kit (Thermo Scientific). After different treatments, 
BEAS-2B cells were trypsinized and collected together with supernatant, 
spun down and washed once with PBS. Cells were then centrifuged at 
4000 rpm at 4oC for 5 min, and cell pellet was re-suspended in 100 μl of 
Annexin V staining buffer containing 1 μl of 100 μg/ml PI and 5 μl of Alexa 
Fluor 488 ® Annexin V antibody, incubated for 15 min. Cell death was 
quantified using BD Fortessa FlowCytometer and analyzed with Flowjo 
software (Treestar Inc.). Dead cells were identified as Annexin V +/ PI – 
(early apoptosis) and Annexin V +/ PI + (late apoptosis) cells. For cell 
cycle analysis, BEAS-2B cells were fixed and permeabilized in 70% 
ethanol. Cells were stained with PI (6 μM) and cell cycle analysis was 





2.21  Nitrite assay 
Cellular nitrite levels were assayed as an indicator of iNOS activity using 
Measure-iT high-sensitivity nitrite assay kit (Molecular Probes, Invitrogen). 
BEAS-2B were plated on 48-well plates and stimulated with HDM for 6 hr. 
As positive control, cells were treated with NO donor, S-Nitrosoglutathione 
(GSNO) (Sigma Aldrich, ST Louis, MO), with or without 2 hr pre-treatment 
of NO scavenger, 2-Phenyl-4,4,5,5-tetramethylimidazoline-1-oxyl 3-oxide 
(PTIO) (Sigma Aldrich, ST Louis, MO) to serve as a negative control. 
Culture medium was collected and immediately assayed for nitrite level. 
Fluorescence values were determined at 365/450 nm using a 
spectrofluorometer.  
 
2.22  Cell proliferation assay  
Cell viability and cell proliferation was determined using XTT assay 
(Cell Signaling Technology). XTT assay is a colorimetric assay that is 
commonly used to quantify the number of viable cells by measuring the 
cleavage of tetrazolium salts XTT by viable cells, in the presence of an 
electron-coupling reagent that produces soluble formazan salt upon 
cleavage. Hence, the amount of formazan dye formed is directly 
proportional to the number of metabolically active cells in the culture. 
BEAS-2B was seeded on 96-well plate at a concentration of 10,000 
cells/ well and allowed to adhere overnight before exposing to HDM (2, 
20, 200 µg/ml). XTT labeling mixture was added into each well. 
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Formazan dye formed is quantified using spectrophotometer that 
measure absorbance at 450 nm, from 0 hr to 30 hr. The absorbance 
readings were directly correlated to the number of viable cells. From 
there, we can calculate the percentage cells growth. Cell proliferation 
and viability after artesunate treatment (30 and 60 µM) was measured 
using the same protocol. BEAS-2B was grown on 96-well plate and 
cells were incubated with artesunate or DMSO (vehicle control) for 
desired period of time. XTT assay was performed as described above.  
 
2.23  Statistical analysis 
All data are expressed as mean ± standard error of sample means 
(SEM). Statistical comparison of multi-group data were analyzed by 
one-way ANOVA followed by the Tukey’s or Bonferroni's for post-hoc 
analysis using PRISM (GraphPad 6, San Diego, CA, USA), with * P < 




3 Chapter 3: House Dust Mite-induced Asthma Causes 
Oxidative Damage and DNA Double Strand Breaks in the 
Lungs 
3.1 Abstract 
Background: Asthma is related to airway inflammation and oxidative 
stress. High levels of reactive oxygen and nitrogen species (RONS) 
can induce cytotoxic DNA damage. Nevertheless, little is known about 
the possible role of allergen-induced DNA damage and DNA repair as 
modulators of asthma-associated pathology.  
 
Objective: To study DNA damage and DNA damage responses 
induced by house dust mite (HDM) in vivo and in vitro.  
 
Methods: We measured DNA double-strand breaks (DSBs), DNA 
repair proteins and apoptosis in HDM-induced allergic asthma model 
and in lung samples from asthma patients. To study DNA repair, we 
treated mice with DNA-PK inhibitor, NU7441 as NHEJ inhibitor. To 
study the direct DNA damaging effect of HDM on human bronchial 
epithelial cells, we exposed BEAS-2B cells to HDM and measured DNA 
damage and ROS.  
 
Results: HDM challenge increased lung levels of oxidative damage to 
proteins (3-nitrotyrosine), lipids (8-isoprostane) and nucleic acid (8-
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oxoguanine). Immunohistochemical evidence for HDM-induced DNA 
DSBs was revealed by increased DSBs marker, γH2AX foci in 
bronchial epithelium. BEAS-2B exposed to HDM showed enhanced 
DNA damage as measured by comet assay and γH2AX staining. In 
human asthma lung tissue, we observed increased levels of DNA 
repair proteins and apoptosis as shown by caspase-3 cleavage, 
caspase-activated DNase (CAD) level and TUNEL staining. Notably, 
NU7441 augmented DNA damage, cytokine production in bronchial 
epithelium and apoptosis in the allergic airway, implicating DSB as an 
underlying driver of asthma pathophysiology.  
 
Conclusion: This work calls attention to RONS and HDM-induced 








Asthma is characterized by chronic inflammation of conducting airways 
resulting in bronchial obstruction and airway hyperresponsiveness 
(Lambrecht and Hammad, 2015). Allergic asthma, the most common 
form of asthma, can be triggered by allergens such as HDM (Sleiman 
et al., 2010). In asthma, immune cells generate genotoxic RONS, such 
as hydroxyl radicals (HO.), superoxide (O2.-), peroxides, peroxynitrite 
(ONOO-) and nitric oxide (NO). RONS can be measured in peripheral 
blood, induced sputum and bronchoalveolar lavage (BAL) fluid of 
asthmatic lung (Comhair and Erzurum, 2010; Sugiura and Ichinose, 
2011). RONS can damage lipids, proteins and nucleic acids (Ho et al., 
2012) and contribute to increased asthmatic severity (Comhair and 
Erzurum, 2010). Here, we reveal the genotoxic effects of aeroallergen-
induced airway inflammation and oxidative stress on lung cells, and a 
direct DNA damaging effect of aeroallergen on bronchial epithelium.  
 
We have previously shown that NO-induced base lesions and ONOO—-
induced single-strand breaks (SSBs) are central to large-scale 
sequence rearrangements (Kiziltepe et al., 2005; Mutamba et al., 2011). 
Among these DNA lesions, DNA double-strand breaks (DSBs) are the 
most cytotoxic forms and, if they are not properly repaired, they can 
lead to genomic rearrangements and cell death (Panier and Durocher, 
2013). DNA DSBs are predominantly repaired by two major DNA repair 
pathways, homologous recombination (HR) and non-homologous end 
				
98 
joining (NHEJ). HR ensures accurate repair of broken DNA by using a 
homologous strand as a template to restore lost genetic information 
(Krejci et al., 2012). This involves resection of the DNA end and 
formation of RAD51 nucleoprotein filament that is capable of homology 
searching. In contrast, NHEJ involves detection and direct joining of 
DNA ends, for which the DNA-dependent protein kinase catalytic 
subunit (DNA-PKcs) is essential (Panier and Durocher, 2013). 
Defective DNA DSB repair plays a causative role in several human 
diseases, including infectious disease, cancer risk, immune dysfunction 
and neurodegeneration (McKinnon and Caldecott, 2007). Here, we 
investigated the role DNA repair in asthma pathogenesis.  
 
The DNA damage response (DDR) involves the actions of sensors, 
transducers and effectors, that work together to modulate DNA repair, 
cell cycle arrest and cell death (Jackson and Bartek, 2009). A key early 
step in response to DNA DSBs is the modification of chromatin. 
Specifically, the histone variant H2AX is phosphorylated to become 
γH2AX in the vicinity of the breakpoint, which is then able to recruit 
downstream damage response and DNA repair factors (Mah et al., 
2010). DNA damage also causes induction of DNA repair proteins such 
as RAD51 and KU70 (Brown et al., 2000; Campbell and Romero, 1998; 
Vispe et al., 1998). RAD51 and KU70 are key components in HR and 
NHEJ repair pathways, respectively (Tarsounas et al., 2004; Weterings 
and Chen, 2008). Indeed, cells that are deficient in either RAD51 or 
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KU70 have an increased sensitivity to DNA damage-induced 
cytotoxicity (De Zio et al., 2011; Sonoda et al., 1998). 
  
Here, we show that HDM-induced asthma leads to a significant 
increase in DNA damage in lung tissues, especially in the bronchial 
epithelium. Furthermore, direct exposure of human bronchial epithelial 
cells to HDM allergen in vitro induces ROS production and DNA 
damage. Inhibition of DNA repair by NU7441 worsens DNA damage 
and augments apoptosis of asthmatic airway epithelium. NU7441 also 
exacerbates proinflammatory responses and enhances HDM-induced 
apoptosis in bronchial epithelial cells. Taken together, our findings 






3.3.1 HDM induces airway eosinophilic inflammation 
Mice were sensitized to 27 µg HDM on day 0 and 7, and challenged 
with HDM on day 14 to induce inflammatory responses to HDM (Figure 
3.01, A) (Hammad et al., 2009). We examined the inflamed airways up 
to 10 days post-challenge. HDM increased total infiltrated immune cell 
counts in BAL fluid, with rapid neutrophil influx followed by moderate 
increase in alveolar macrophages (Figure 3.01, B). The observed 
influx of neutrophils and their gradual replacement by eosinophils, 
which persisted up to 5 days post-challenge (Figure 3.01, B), 
resembles human allergic responses (Fahy, 2009). Histological 
analysis revealed classical features of bronchial inflammation with a 
high cell infiltration score surrounding the bronchioles on 1, 3, and 5 
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Figure 3.01 | HDM induces inflammatory cell recruitment to the 
airway. (A) HDM-induced experimental asthma model. (B) 
Quantification of immune cells in BAL fluid by flow cytometry up to day 
10 post-challenge. Total immune cells (Total), Alveolar macrophages 
(Alveo Φ), eosinophils (Eos), neutrophils (Neu), and T lymphocytes (T 
cells), were quantified. Values are mean ± SEM for n = 9 -13 for saline 
control (S), 1, 3, and 5 days post-challenge (d.p.c) and n = 5 for 10 
days post-challenge. (C) Representative histological images of H&E 
stained lung sections. Quantification of inflammatory cell infiltration in 
lung sections was based on the criteria reported previously reported by 
Bao Z, et al. Scoring of inflammatory cells was performed on at least 
10 different fields for each lung section. Mean scores were obtained 
from three animals. Micrographs were taken at 200x magnification.  P 
values were obtained by one-way analysis of variance. Significantly 
different from saline control, * P < 0.01, # P < 0.05. 
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3.3.2 HDM induces airway oxidative damage 
HDM exposure caused a significant increase oxidative stress in BAL 
fluid (Figure 3.02, A), as measured by oxidation-sensitive fluorescent 
probe, 2,7-dichlorodihydrofluorescein diacetate (DCFH-DA) (Li et al., 
2014). When the levels of RONS exceed antioxidant scavenging 
capacity, damage to cellular macromolecules may ensue (Comhair and 
Erzurum, 2010). 8-isoprostane, an indicator of oxidative damage to 
lipids (Montuschi et al., 2004) was significantly increased on 3 and 5 
days post-challenge (Figure 3.02, B). 3-nitrotyrosine (3-NT) is formed 
by the reaction of proteins with ONOO-, nitrogen dioxide (NO2), or 
oxidation of nitrite (NO2-) by myeloperoxidase (MPO) or eosinophil 
peroxidase (EPO), both of which are found in abundance in asthma 
(Brennan et al., 2002). Results showed that the levels of tissue 3-NT 
were two times higher on 1 and 3 days post-challenge as compared to 
saline control (Figure 3.02, C), indicative of significant nitrosative 
protein damage in lung cells. Finally, to quantify oxidative damage to 
nucleic acids, we measured 8-OHdG/8-oxoG levels in BAL fluid and in 
lung tissue. Levels of 8-OHdG were markedly increased on 1, 3 and 5 











































Figure 3.02 | Increased levels of ROS and oxidative damage in 
BAL fluid and lung tissues. (A) Level of ROS in the BAL fluid 
obtained from mice 3 days post-challenge (d.p.c) measured using 
DCFH-DA, presented as fold change as compared to saline (S) control. 
(B) Levels of 8-isoprostane in BAL fluid and (C) level of 3-nitrotyrosine 
in lung homogenate were measured using ELISA. (D) The level of 8-
OHdG/8-oxoG was measured using ELISA and (E) 
immunofluorescence (IF) staining of lung sections. Negative control (-
ve) indicates secondary antibody alone. Values are mean ± SEM for 
13-15 mice per group for ELISA, quantification of immunofluorescence-
stained images was performed on n = 3 mice per group, with 10 
images per lung section. P values were obtained by one-way analysis 
of variance. * P < 0.01, # P < 0.05 indicates significantly different from 






























































































3.3.3 HDM induces DNA DSBs in bronchial epithelium 
To learn about DNA damage in allergic airways, we measured the 
frequency of cells that are positive for DNA DBSs marker γH2AX. 
Extensive phosphorylation flanking the DSBs enables visualization of 
DSBs using immunofluorescence (Nakamura et al., 2010). Bleomycin, 
known to induce DSBs, caused a significant increase in γH2AX (green) 
(Figure 3.03, A). Club cells, also known as Clara cells, are nonciliated 
secretory epithelial cells lining the pulmonary airway (Singh and Katyal, 
1997). Co-staining with Club Cell 10 kD protein (CC10) showed that 
most of the DNA damage was in the bronchial epithelium. CC10 was 
used here as a marker to identify the airway epithelium layer.  
 
HDM exposure significantly increased the frequency of γH2AX-positive 
cells, especially in airway epithelium. Higher magnification revealed 
that most γH2AX-positive cells had a punctate pattern, indicative of 
repair foci (Figure 3.03, A, inset). The percentage of γH2AX-positive 
cells in asthmatic lung increased from 3% in day 1 to 5% in day 5 post-
challenge (Figure 3.03, B), significantly increased as compare to 
Saline (S) control, which has less than 0.5% γH2AX-positive cells. 
Immunoblotting of whole lung lysates showed a similar increase in the 
levels of γH2AX (Figure 3.03, C). Notably, DNA DSBs in the immune 
cells could also contribute to the increased γH2AX level in the whole 
lung lysate. It has been shown that in mice with influenza virus infection, 
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macrophages, CD3-positive T cells and polymorphonuclear cells in the 
BAL fluid formed γH2AX foci, suggesting that immune cells, too, are 
susceptible to DNA DSBs during the course of disease (Li et al., 2015). 
Nevertheless, in our study, both qualitative and quantitative analyses 
show a clear increase in DNA damage, as indicated by γH2AX, in 




















































































































Figure 3.03 | Asthma induces DNA damage in asthmatic mouse 
lungs. (A) Analysis of γH2AX (green), CC10 (red) and DAPI (blue) in 
lung sections from saline-treated mice (S) and from HDM asthma mice 
on 1, 3 and 5 days post-challenge (d.p.c). Samples from positive 
control (bleomycin) and secondary antibody alone (-ve) are indicated. 
(B) Quantification of γH2AX-positive cells (≥ 5 foci) in 20 fields per lung 
per treatment group, n=3 per group. (C) γH2AX protein levels 
measured by immunoblotting. Blots show representative results for one 
of three or more experimental replicates and were quantified using 
Image J. Immunofluorescence-stained images was performed on n = 3 
mice per group, with 10 images per lung section. P values were 
obtained by one-way analysis of variance. Significantly different from 





3.3.4 DNA DSBs are evident in lung tissues from human asthma 
Immunostaining of paraffin-embedded lung sections obtained from 
patient who suffered from chronic asthma revealed higher levels of 
DNA DSBs as shown by γH2AX staining (Figure 3.04, A). Quantitative 
results showed a significant increase in the frequency of γH2AX-
positive cells in human asthmatic lung (Figure 3.04, B). As these lung 
sections do not cut across bronchial airways, we could only confirm 
DNA DSBs in human peripheral lung. Nevertheless, immunoblotting of 
normal and asthmatic human lung lysates showed a marked increase 






























Figure 3.04 | Asthma induces DNA damage in human asthmatic 
lungs. (A) Analysis of γH2AX (green) in human normal and asthmatic 
lung tissue. E, (B) Quantification of γH2AX-positive cells (≥ 5 foci) in 
human lungs was performed by counting 20 fields per condition in a 
blinded fashion. (C) γH2AX protein levels quantified using 
immunoblotting, blots and were quantified using Image J. P values 
were obtained by one-way analysis of variance. Significantly different 
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3.3.5 HDM directly induces DNA DSBs in human bronchial 
epithelial cells 
To elucidate the direct DNA damaging effect of HDM on bronchial 
epithelial cells, BEAS-2B cells were exposed to HDM (2, 20 and 200 
µg/ml). DNA damage was analyzed by alkaline comet assay and 
staining of γH2AX. Alkaline comet assay is a single-cell gel 
electrophoresis assay for evaluation of a broad spectrum of DNA 
lesions in cells including SSBs and abasic site (Olive and Banath, 
2006). HDM concentration-dependently induced DNA damage in 
BEAS-2B cells, as revealed by the percentage of DNA in the comet tail 
(the amount of DNA in the tail is a reflection of DNA damage; Figure 
3.05, A) (Olive and Banath, 2006). Furthermore, HDM directly induced 
DNA DSBs in cells, as shown by γH2AX foci (green) staining (Figure 
3.05, B).  Quantification of γH2AX-positive cells (≥10 foci per nucleus) 
revealed more than 80% of the cells was severely damaged by HDM 
(200 μg/ml). These results clearly demonstrate the DNA damaging 






























































































































Figure 3.05 | HDM induces direct DNA DSBs in BEAS-2B cells. (A) 
BEAS-2B cells were exposed to HDM for 6 hr on chip, followed by 
alkaline comet assay to detect DNA damage. Microphotographs shown 
were representative images of comets from different treatment groups. 
Percentage of DNA intensity in comet tail was quantified using in-house 
analysis software and plotted as shown. (B) After HDM exposure, cells 
were immune-stained for γH2AX (green) and counterstained with nuclei 
stain, DAPI (blue). Cells with ≥10 foci were counted as positive. 
Positive control (+ve) was cells treated with Bleomycin (0.4 U/ml) for 30 
min prior to immunofluorescence staining and secondary antibody 
alone served as negative control (-ve). Quantification was performed 
using Image J in 10 random images taken per treatment group per 
experiment. All experiments were repeated at least 3 times and data 




3.3.6 HDM induces ROS formation in human bronchial epithelial 
cells 
To investigate the ability of HDM to induce the production of ROS in 
BEAS-2B cells, we measure ROS through fluorescence emission of 
CellROX dye. In cells exposed to H2O2 (100 µM), which serves as a 
positive control, 80% of the cells are stained positive for CellROX. 
Prolonged exposure to H2O2 (positive control) led to cell killing, which 
resulted in a reduction in cell confluency as observed in Figure 3.06. 
Hence, shorter exposure time or lower concentration of H2O2 should be 
used in the future experiment. Most importantly, increased CellROX 
fluorescence was also observed in cells exposed to HDM, in a 
concentration-dependent manner, suggesting that HDM stimulated 
cellular production of ROS (Figure 3.06). These results suggest that, 
even without the presence of immune cells, HDM on its own can trigger 
the ROS in bronchial epithelial cells. Importantly, HDM-induced ROS 































Figure 3.06 | HDM triggers ROS 
formation in BEAS-2B cells. 
Cells were exposed to HDM (2, 
20, 200 μg/ml) for 6 hr or H2O2 
(100 μM) for 1 hr before staining 
with 5 μM CellROX to measure 
oxidative stress level. Percentage 
of CellROX-positive cells was 
quantified in 10 random fields per 
treatment group per experiment. 
All experiments were repeated at 
least 3 times and data presented 
was mean ± SEM. Significantly 
different from untreated, * P < 































3.3.7 Asthma increases lung levels of DNA repair proteins 
To learn about DNA repair responses to asthma-induced DNA damage, 
we assessed the levels of two key DNA repair proteins, RAD51 and 
KU70 (involved in HR and NHEJ, respectively). HDM challenge 
resulted in a robust increase in both RAD51 and KU70 in mouse lung 
tissues (Figure 3.07, A). In response to SSBs, poly ADP-ribose 
polymerase 1 (PARP-1) catalyzes the synthesis of poly ADP-ribose 
(PAR) chain (Langelier et al., 2012). Notably, the levels of both PARP-1 
and PAR were strongly elevated in HDM-challenged lungs (Figure 
3.07, A). In parallel, we analyzed protein lysates from normal and 
asthmatic human lungs. The levels of RAD51, KU70 and PAR were 
augmented for at least two folds in asthmatic human lung samples as 
compared to healthy human lung samples (for technical reasons, 
PARP-1 was not analyzed in the human samples) (Figure 3.07, B). 
Taken together, in lungs of mice with HDM-induced asthma and in lung 
tissue from human asthma patients, the levels of key DNA repair 















































































































































































































































































Figure 3.07 | HDM induces DNA damage responses as indicated 
by increased levels of RAD51, KU70, PARP-1, and PAR in lungs of 
mice with HDM-induced asthma and in asthmatic patient. (A) 
Mouse lung protein extract were analyzed by western for RAD51, 
KU70, PARP-1 and PAR. (B) Human lung lysate from normal or 
asthmatic lung were immunoblotted with RAD51, KU70 and PAR 
antibodies. β -actin served as an internal control. Blots show 
representative results for one of three or more experimental replicates 
and all blots were quantified using Image J. * P < 0.01, # P < 0.05 






3.3.8 NU7441 inhibition of NHEJ augments DNA DSBs in allergic 
airways 
DSBs repair NHEJ pathway is initiated by the binding of KU70/80 
heterodimer to the broken DNA ends, and forming complex with DNA-
PKcs (Weterings and Chen, 2008). The observation that KU70 protein 
levels were elevated in asthmatic lung (Figure 3.07, A and B) raises 
the possibility that NHEJ may be important in repairing DSBs during 
asthma. We used NU7441, a well-characterized inhibitor of DNA-PKcs 
to study this possibility (Zhao et al., 2006). Neutral comet assay was 
used to confirm the potential of NU7441 in inhibiting DNA DSB repair 
(Olive and Banath, 2006). Ionizing radiation is a potent inducer of DNA 
DSBs (see tail length at time zero in Figure 3.08, A). Irradiated cells 
repaired damaged DNA rapidly as indicated by the reduction in tail 
length within 1 hr. Cells treated with NU7441 were unable to repair 
DNA DSBs (Figure 3.08, A). 
 
In mouse with HDM-induced asthma, NU7441 was given twice daily for 
2 days before and after the final HDM challenge (Chapter 2, Figure 
2.01, B). NU7441 markedly increased γH2AX level in allergic airway 
epithelium. Co-staining with CC10 indicated that DSBs were present in 
epithelial cells, and quantification revealed an increase in the frequency 
of γH2AX-positive cells, rising to significance on day 5 post-challenge 
































Figure 3.08 | DNA repair inhibitor increases DNA DSBs in 
bronchial epithelium of asthmatic lung. (A) Analysis of DNA DSBs 
using neutral comet analysis before and after exposure to 50 Gy of γIR. 
Tail length reflects the frequency of DNA DSBs. Error bars show 
standard deviation for three independent experiments. (B) Lung 
sections from mice on 5 days post-challenge (d.p.c) with or without 
NU7441 treatment were stained for γH2AX (green), CC10 (red) and 
DAPI (blue) and pictures were taken at 400x magnification. (C) 
Quantification of cells positive for γH2AX (≥ 5 foci per nucleus), 
excluding cells with pan-nuclear γH2AX staining. For each condition, 30 
fields were analyzed for each lung sections, n = 3 mice per treatment 
group. Experiments were repeated at least three times; representative 
results are shown. Significance is shown for one-way analysis of 
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3.3.9 NU7441 inhibition of NHEJ alters DNA repair proteins levels 
We next studied the impact of NU7441 on the levels of DNA repair 
proteins. Immunoblotting of lung lysates revealed lower γH2AX levels in 
naive mice exposed to NU7441 alone, which is consistent with 
previous studies showing that inhibition of DNA-PKcs can prevent 
phosphorylation of H2AX (Figure 3.09) (Jackson and Bartek, 2009). In 
contrast, HDM asthma mice treated with NU7441 showed an increase 
in the levels of γH2AX. While one might expect these DSBs are hard to 
be detected, given the fact that NU7441 inhibits DNA-PKcs’s ability to 
phosphorylate H2AX, results shown in Figure 3.09 are consistent with 
redundant PI3 kinase-related protein kinases (PIKKs) (e.g., Ataxia-
telangiectasia mutated (ATM)) that also phosphorylate H2AX, leading 
to a strong γH2AX signal under conditions where DSB levels are high. 
In addition, the levels of RAD51 were further elevated in NU7441-
treated HDM asthma mice (Figure 3.09), raising the possibility RAD51 
facilitates HR repair of DSBs when NHEJ pathway is inhibited 
(Shrivastav et al., 2009). Additionally, NU7441 reduced HDM-induced 
KU70 levels, which is consistent with the possibility that NU7441 
blocks a stabilizing interaction between DNA-PKcs and KU70, 
potentially leading to KU70 degradation (Davis et al., 2014). Finally, 
NU7441 had no effect on PARP-1 levels, which primarily impacts SSB 
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Figure 3.09 | DNA repair inhibitor induces DNA damage 
responses. Lung protein extracts from at least three mice from each 
treatment group were analyzed by immunoblotting for DNA repair 
proteins γH2AX, KU70, RAD51, and PARP-1. Experiments were 
repeated at least three times; representative blots are shown, and blots 
were quantified using Image J. * P < 0.01, # P < 0.05 indicate significant 




3.3.10  NU7441 augments HDM-induced cytokine production in 
bronchial epithelial cells 
NU7441 treatment inhibited DNA repair and caused persistent DNA 
DSB in cells (Figure 3.08, A). To study the biological significance of 
persistent DNA DSB, we measured inflammatory cytokine production in 
cells after NU7441 treatment. NU7441 significantly increased IL-4, IL-5, 
IL-13 and IL-33 production in BEAS-2B exposed to HDM, as compared 
to cells exposed to HDM alone (same concentration of DMSO was 
added as vehicle control) (Figure 3.10). These cytokines are epithelial 
cell-derived cytokines that promote Th2 responses in asthma 
(Allahverdian et al., 2008; Holgate, 2012; Lambrecht and Hammad, 
2012; Wu et al., 2010). IL-4 is crucial for allergic sensitization and IgE 
production, IL-5 promotes eosinophil survival, IL-13 has a central role 
in airway remodeling, while, IL-33 activates lung DC (Galli et al., 2008; 
Lambrecht and Hammad, 2012). Notably, HDM was unable to trigger 
the production of TSLP and IFN-γ in BEAS-2B cells, and NU7441 did 
not alter the level of these two cytokines. Nevertheless, this result 
suggests that inhibition of NHEJ repair pathway by NU7441 in BEAS-
2B potentiated inflammatory responses, highlighting the importance of 




















































































































































































































Figure 3.10 | NU7441 increases proinflammatory cytokines 
production in BEAS-2B exposed to HDM. Cells were exposed to 
HDM (2, 20, 200 µg/ml) with or without NU7441 (2.5 µM) pre-treatment, 
and the levels of cytokines in cell supernatant were quantified using 
ELISA. Same concentration of DMSO was added in cells exposed to 
HDM only, serving as vehicle control. All experiments were repeated 
for at least 3 times and values shown are mean ± SEM. * P < 0.01, # P 





3.3.11  NU7441 enhances HDM-induced cell death in bronchial 
epithelial cells 
Exposure to HDM concentration-dependently induced cell death in 
bronchial epithelial cells (Figure 3.11). Importantly, HDM-induced cell 
death was further enhanced by NU7441 (HDM + NU). NU7441 
treatment alone (NU alone) did not induce cell death, suggesting that 
DNA repair inhibition was fatal only when the cells were exposed to 
HDM. One possible explanation is that HDM induces DNA damage in 
bronchial epithelial cells and DNA damage activates DNA repair. When 
DNA repair was inhibited by NU7441, DNA damage induced by HDM 
was not efficiently repaired and hence activated the cell death pathway. 
We have shown that efficient DNA repair protected bronchial epithelial 
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Figure 3.11 | NU7441 enhances cell death in BEAS-2B exposed to 
HDM. Cells were exposed to HDM (2, 20, 200 µg/ml) for 6 or 20 hr in 
the presence or absence of NU7441 (2.5 µM). Cell death assay was 
performed using Annexin V/PI staining. Cells positive for Annexin V 
only or both Annexin V and PI were considered as early apoptotic and 
late apoptotic cells, respectively. Same concentration of DMSO was 
added in HDM only group as vehicle control. All experiments were 
repeated for at least 3 times and values shown are mean ± SEM. * P < 






3.3.12  NU7441 enhances allergic airway inflammation-induced 
caspase-3 activation and cell death   
To investigate the effects of NU7441 in asthma-induced lung cell death 
via apoptosis, we measured the levels of cleaved caspase-3 and 
caspase-activated DNase (CAD). HDM increased the lung levels of 
cleaved caspase-3 and CAD on 1 and 3 days post-challenge (Figure 
3.12, A). NU7441 treatment resulted in a small but consistent increase 
in the levels of cleaved caspase-3 in HDM mouse asthma (Figure 3.12, 
B). Further, analysis using TUNEL staining (Collins et al., 1997) 
showed much higher levels of apoptosis in HDM-challenged mice than 
control. NU7441 led to an even greater increase in HDM-induced lung 
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Figure 3.12 | Asthma-induced cell death is enhanced by NU7441 
treatment. (A) Immunoblotting of cleaved caspase-3 and CAD days 1, 
3, and 5 post-challenge (d.p.c). (B) Immunoblotting of cleaved 
caspase-3 in HDM asthma lungs with and without NU7441 treatment. 
(C) Analysis of apoptosis (analyzed by TUNEL; brown) in lung sections 
counterstained with methyl green. Negative control (-ve) indicates 
without TdT enzyme. Positive control (+ve) indicates treated with 
DNase I, prior to TUNEL staining. Representative images from three 
independent experiments were shown. (D) Quantification of apoptotic 
cells (TUNEL positive) was performed in a blinded fashion (20-30 
images from each condition were analyzed; n = 3 mice for each 
condition). Values shown are mean ± SEM from duplicate samples of 3 
separate experiments. P values were obtained by one-way analysis of 
variance. Significantly different from Saline (S) control (for Figure 3.12, 







Our studies showed that HDM exposure causes airway inflammation, 
oxidative damage, DNA damage and cell death in the airway. In 
addition, direct HDM exposure to bronchial epithelial cells in vitro 
induces DNA damage accompanied by increased ROS production. In 
human and mouse asthma lung tissue, we observed increased levels 
of DNA repair proteins and apoptosis. When HDM asthma mice were 
treated with a chemical inhibitor of DSB repair, DNA damage levels and 
apoptosis are further enhanced. In addition, when DSB NHEJ repair 
protein, DNA-PKcs was inhibited in bronchial epithelial cells in vitro, we 
observed significant increase in HDM-induced production of 
proinflammatory cytokines and cell apoptosis. These studies point to a 
potential role of DNA DSBs and DNA repair in regulating asthma 
pathophysiology.  
 
It is well established that asthma causes infiltration of immune cells, 
including eosinophils and neutrophils that are capable of producing 
high levels of RONS (Comhair and Erzurum, 2010). Lysosomal enzyme 
MPO, the most abundant protein stored in neutrophil granules, together 
with EPO from eosinophils, catalyze the oxidation of halides by H2O2 to 
form hypochlorous acid (HOCl) and hypobromous acid (HOBr) 
respectively (Comhair and Erzurum, 2010).  Hypohalous acids react 
with O2.- to form OH., an extremely reactive radical that is capable of 
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damaging cellular molecules (Comhair and Erzurum, 2010). The influx 
of neutrophils on day 1 post-challenge, followed by eosinophil influx 2 
days later, filled the HDM allergic airway with significant amount of 
MPO and EPO. We observed a sharp rise in ROS levels in BAL fluid 
and increased levels of RONS-induced damage to macromolecules in 
HDM allergic airway. These data suggest that during allergic airway 
inflammation, ROS produced by inflammatory cells could lead to 
oxidative damage in lungs. 
 
Although most RONS-induced DNA lesions involve base damage (such 
as 8-oxoG, 8-nitroG and deamination products), RONS can directly 
induce SSBs. Importantly, SSBs formed either chemically or 
enzymatically can be converted to DSBs if they are in close proximity 
with the opposing strands, or if they encountered a replication fork 
(Caldecott, 2008). The observation that asthma is associated with 
γH2AX foci is consistent with the induction of DSBs and possibly stalled 
replication forks (Ward and Chen, 2001). Our results have extended 
those reported by Chapmana et al. (Chapman et al., 2014), which 
showed that asthma could induce systemic genotoxicity, as measured 
by micronucleus formation and protein nitration in peripheral 
blood. Results described here indicate that HDM challenge induced 
DNA damage and repair both in both human bronchial epithelial cells, 
mouse asthmatic lung and in human lung tissues. However, due to the 
limited number of human asthma sample that is available commercially, 
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data presented here represents only one set of human sample. Despite 
that, these data suggest a potential role of DNA damage in clinical 
asthma development.  
 
To learn the potential biological relevance of asthma-induced DSBs, we 
explored the impact of DSB repair on asthma pathology by using the 
DNA DSB repair inhibitor NU7441. The catalytic activity of DNA-PKcs 
is essential for NHEJ pathway which is inhibited by NU7441 (Zhao et 
al., 2006). Indeed, DSB repair was greatly impaired in alveolar 
epithelial cells pre-treated with NU7441. In HDM asthma mouse treated 
with NU7441, we observed a significant increase in γH2AX, which is 
consistent with defective repair leading to increased levels of DSBs. In 
addition, NU7441 further increased apoptosis, in both mice asthmatic 
lungs and in vitro bronchial epithelial cells exposed to HDM. These 
studies point to a possible role for DNA repair in protecting against 
asthma-induced DNA damage and apoptosis. 
 
While the major focus of this work has been on DNA DSBs, SSBs also 
can play an important role in tissue pathology. SSBs are recognized by 
PARP, which can poly-ADP-ribosylate downstream substrates, 
depleting the NAD+ pool (Gibson and Kraus, 2012). Here, we observed 
that PARP activity was induced by asthma, as shown by the high levels 
of PAR. Excessive DNA damage leads to high levels of PAR, and the 
resultant energy depletion can lead to necroptosis (Vandenabeele et al., 
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2010). Interestingly, necroptosis during airway inflammation has 
recently been shown to contribute to severe asthma development 
(Kaczmarek et al., 2013; Persson, 2014). Our results are consistent 
with the possibility that RONS-induced SSBs trigger energy depletion 
and resultant pathologies. 
 
DSBs are formed not only by exposure to genotoxic agents, but they 
are also formed endogenously during V(D)J recombination by 
immature B- and T-lymphocytes, enabling hypermutation that is 
necessary for the adaptive immune response (Chen et al., 2000). 
However, V(D)J recombination only takes place in lymphoid tissues, 
such as the bone marrow, thymus and lymph nodes, and only after B 
and T lymphocytes have completed V(D)J recombination, mature 
lymphocytes will migrate into the lungs (Parkin and Cohen, 2001). In 
our experiments, we carefully trimmed lymph node and excess tissue 
and fat from lungs before freezing them, hence, it is unlikely that the 
DSBs observed in asthmatic lung are from V(D)J recombination. 
 
DNA-PK, not only plays a role in NHEJ repair, it is also crucial in 
maintaining lymphocytes V(D)J recombination and immunoglobulin 
class switching (Jackson and Bartek, 2009). Therefore, using animal 
model to study the effects of NU7441 on airway inflammation will have 
unavoidable confounding factor, as NU7441 affects T cell development 
(Ghonim et al., 2015). Hence, to directly elucidate the biological 
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consequences of persistent DNA damage as a result of DNA repair 
inhibition, specifically, in bronchial epithelial cell, we performed in vitro 
experiment and measured proinflammatory cytokine production by 
BEAS-2B cells. Studies have shown that unresolved DNA DSBs 
resulted in persistent DDR signaling and increased production of 
inflammatory cytokines such as IL-6 and IL-8 (Rodier et al., 2009). 
Here, we revealed that NU7441 significantly augmented the levels of 
IL-4, IL-5, IL-13 and IL-33 in BEAS-2B cells exposed to HDM. These 
cytokines play key roles in driving the important features of allergic 
airway inflammation and airway remodeling in asthma (Galli et al., 
2008; Holgate, 2012). Coincidence of increased cytokines production 
and cell death after NU7441 treatment in prolonged allergen exposure 
suggests that apoptotic cells may secrete cytokines, which has been 
demonstrated in human bronchial epithelial cells (16HBE), where 
apoptotic human bronchial epithelial cells released IL-4 (Hodge et al., 
2002). These data demonstrate that a defect in DNA repair could 
exacerbate the inflammatory response and promote cell death during 
allergen exposure. As the inflammatory response and bronchial 
epithelial cell death is well-established causes of asthma-induced 
pathology, these data provide direct evidence for the importance of 
DNA repair in suppressing asthma-induced pathology.  
 
After demonstrating the potential of DNA repair to suppress 
proinflammatory responses in bronchial epithelial cells, we wish to 
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learn about the potential importance of DNA repair during an acute 
asthmatic attack. We exposed animals to NU7441 and subsequently 
measured AHR in response to HDM (Supplementary Figure 3.1). 
Interestingly, we did not detect worsening of lung function in HDM-
induced asthma. AHR is caused by multiple factors and DNA damage 
may be just one of the many factors that regulate AHR. Another 
possible explanation for not observing an impact of NU7441 on AHR 
may be the short duration (only 4 days) of DNA repair inhibition. 
Moreover, this is an acute asthma model. Our data point to the 
relevance in a chronic asthma condition where persistent inflammation 
contributes to pathology, hence, further studies are warranted. 
 
Interestingly, two other studies by Ghonim et al. and Misha et al. have 
demonstrated that long-term inhibition of DNA-PK has beneficial effects 
on asthma (Ghonim et al., 2015; Mishra et al., 2015). Ghonim et al. 
showed that DNA-PK inhibition reduced airway inflammation and AHR 
(Ghonim et al., 2015). On the other hand, Mishra et al. showed that 
DNA-PK inhibition in dendritic cells reduced airway inflammation 
(Mishra et al., 2015). While both of these studies focused on the anti-
inflammatory aspect of DNA-PK inhibition, we focused on the acute 
effect of DNA-PK inhibition by NU7441. Specifically, we studied DNA 
damage in bronchial epithelium and revealed that efficient DNA repair 
is important in preventing DNA damage induced by asthma. We have 
shown that, in bronchial epithelial cells, defects in DNA repair 
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exacerbate inflammatory responses. We also examined lung cell death 
when DNA-PK is inhibited, both of which were not studied in these two 
papers. We observed that DNA-PK inhibition increased lung cell death 
in both HDM asthma mouse lung and isolated human bronchial 
epithelial cells exposed to HDM. This could be an important but 
unrecognized side effect of DNA-PK inhibitor. Indeed, long-term 
inhibition of DNA DSB repair in humans is known to increase the risk of 
disease development (McKinnon, 2012). For example, 70% of Ataxia 
Telangiectasia Mutated (ATM) patients, who suffer from chronic 
depletion of DNA repair, developed lung diseases, which are the main 
causes of death in ATM patients (Bott et al., 2007; McKinnon, 2012). 
Reversible airway obstruction, one of the characteristics of asthma, has 
also been reported in ATM patients (Berkun et al., 2010). This 
suggests that long-term inhibition of DNA DSB repair may have an 
adverse impact on airway function. 
 
DNA repair may also play a role in preventing asthma comorbidities. 
The observation that HDM induces DNA damage in epithelial cells 
raises the possibility that DNA damage contributes to defective 
epithelial tight junctions, which have been observed in asthmatic biopsy 
(Holgate, 2007). Being the first line of defense against pathogens, 
impairment of barrier function is thought to impact the susceptibility of 
asthmatic airways to respiratory viral or microbial infections (Busse et 
al., 2010). Further studies are warranted to learn more about the 
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possible roles of DNA repair in asthma pathogenesis. In addition to 
HDM allergen, other aeroallergens such as cockroach allergen extract, 
ragweed pollen extract and Aspergillus fumigatus fungal, have also 
demonstrated different degree of genotoxicity on bronchial epithelial 
cells (Chapter 4).  
 
Taken together, these studies show that HDM-induced airway 
inflammation is associated with increased RONS, increased DNA 
DSBs, changes in DNA repair protein expression, and increased 
apoptosis. Further, direct exposure to HDM leads to potentially 
cytotoxic levels of DNA damage in bronchial epithelial cell in both in 
vivo and in vitro. While further studies are needed to ascertain the 
specific impact of unrepaired DSBs, these studies point to the 
possibility that DNA repair plays a role in modulating susceptibility to 
asthma-associated pathologies. In particular, damage to DNA in 
epithelial cells raises the possibility that barrier function may be 
compromised. Finally, we have shown that the impact of asthma on 
DNA damage and apoptosis is conserved from mice to humans. Taken 
together, these studies suggest a possible role for DNA repair in 





























Supplementary Figure 3.1 | Effects of NU7441 on HDM-induced 
airway hyperresponsiveness (AHR). AHR of mechanically ventilated 
mice in response to aerosolized methacholine was measured 3 days 
after the last saline or HDM challenge with or without NU7441 
treatment. AHR is expressed as fold change over baseline level. (A) 
Lung resistance (Rl, n = 6 mice). Rl is defined as the pressure driving 
respiration divided by flow. (B) Dynamic compliance (Cdyn, n = 6 mice). 
Cdyn refers to the distensibility of the lung and is defined as the 




































































4 Chapter 4: Aeroallergens Induce ROS Production and DNA 




Background: Exposure to environmental allergens is a major risk 
factor for asthma development. Allergens possess proteolytic activity 
that is capable of disrupting airway epithelium. Although there is 
increasing evidence pointing to asthma as an epithelial disease, the 
underlying mechanism that drives asthma has not been fully elucidated. 
Here, we investigated the DNA damage potential of aeroallergens on 
human bronchial epithelial cells, BEAS-2B, and elucidated the 
underlying mechanism of damage.  
 
Methods: We exposed BEAS-2B to house dust mite (HDM) and 
measured DNA damage by CometChip and DNA double-strand breaks 
(DSBs) by γH2AX staining. Intracellular oxidative stress was evaluated 
by staining cells with CellROX and MitoTracker Red CM-H2Xros. 
Antioxidant genes expression was determined using RT-PCR. Cell 
proliferation was determined by XTT assay. Cell death was studied 
using flow cytometry. To elucidate the underlying mechanism, cells 
were treated with Toll-like receptor 4 (TLR4) agonist and antagonist or 




Results: BEAS-2B exposed to HDM showed enhanced DNA damage. 
HDM exposure stimulated cellular ROS production, increased 
mitochondrial oxidative stress and nitrite level. Notably, expression of 
Nrf2-dependent antioxidant genes was reduced immediately after HDM 
exposure, suggesting that HDM altered antioxidant responses. HDM 
exposure also reduced cell growth and induced cell death. Importantly, 
HDM-induced DNA damage can be prevented by antioxidants, 
suggesting that HDM-induced RONS can be neutralized by 
antioxidants.  
  
Conclusion: Direct exposure of bronchial epithelial cells to HDM leads 
to the production of RONS that damage DNA and induce cytotoxicity. 
Finally, results suggest that antioxidants can prevent HDM-induced 






Allergic disease continues to increase in prevalence worldwide，
affecting about 30-40% of the world population (Pawankar et al., 2011). 
It is a maladaptive immune response directed against non-infectious 
environmental substances known as allergens (Galli et al., 2008; 
Trompette et al., 2009). Allergic diseases caused by airborne allergens 
include rhinoconjunctivitis, eosinophilic bronchitis and allergic asthma. 
Allergic asthma is an inflammatory disorder of the airways towards 
airborne allergens such as house dust mite (HDM), animal dander, 
plant pollen and fungal spores (Lambrecht and Hammad, 2014). These 
aeroallergens may have deleterious impacts on bronchial epithelium, 
contributing to asthma development. The process of allergic 
sensitization of the airway cells to aeroallergen is well investigated, but 
the study on the damaging impacts of allergens on lung airway 
epithelial cells is lacking.  
 
Airway epithelial cells constitute the first line of defense against 
environmental stimuli and pathogen such as viruses, pollutants and 
allergens (Lambrecht and Hammad, 2012). Particularly, bronchial 
epithelium is a key regulator of airway allergen sensitization and 
remodeling. Allergens may damage epithelial integrity through their 
protease activity and cytotoxic potential (Lambrecht and Hammad, 
2014). Disruption of epithelial cell barrier and intercellular adhesion 
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enables easier access of pathogens into the airways, which could be 
one of the contributory factors in development of asthma (Holgate et al., 
2000). In addition, allergen-mediated activation of pattern recognition 
receptors (PRRs) and protease-activated receptors, and induction of 
reaction oxygen species (ROS) are critical steps to initiation of 
inflammatory responses (Lambrecht and Hammad, 2014).  
 
Oxidants are known to increase epithelial permeability by damaging 
tight junctions. Overproduction of reactive oxygen and nitrogen species 
(RONS) is harmful to cells, as they induce oxidative and nitrosative 
damage to cellular macromolecules such as the nucleic acid. RONS 
react with DNA to form a board range of DNA lesions including base 
damages, single-strand breaks (SSBs) and double-strand breaks 
(DSBs). DNA damage in cell triggers the activation of DNA damage 
response (DDR). DDR is a coordinated series of cellular pathways that 
detect, signal and repair DNA lesions to prevent the generation of 
potentially deleterious mutations (Soria et al., 2012). DDR includes the 
activation of cell cycle checkpoint mechanisms to arrest cell cycle for 
DNA damage repair, or activation of cell death pathway, if the damage 
is too severe to be repaired (Soria et al., 2012).  
 
To the best of our knowledge, this is the first demonstration that 
aeroallergen HDM directly induces DNA damage in human bronchial 
epithelial cells, through the production of genotoxic RONS with 
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associated increases in cellular nitrosative and mitochondrial oxidative 
stress. HDM exposure alters antioxidant responses in epithelial cells, 
induces apoptosis-inducing factor (AIF) nuclear translocation, triggers 
apoptosis and reduces cell proliferation. This highlights the cytotoxic 
potential of HDM on airway epithelium, which could be rescued by 
antioxidants such as glutathione and catalase in a concentration-
dependent manner, giving direct evidence that antioxidants protect 
airway cells from the damaging effects of aeroallergens. Our findings 
have direct implications in asthma disease etiology. A better 
understanding of the function of epithelial cells in maintaining the 
airway integrity and how its dysfunction contributes to asthma enables 
a deeper understanding of the mechanisms by which asthma is 
initiated, and provides a framework to identify new therapeutic 





4.3.1 Aeroallergens induce DNA damage in human bronchial 
epithelial cells.  
To elucidate the genotoxic potential of aeroallergens, bronchial 
epithelial cells, were exposed to HDM, cockroach allergen extract CAE, 
ragweed pollen extract RWE, Aspergillus fumigatus ASP or 
lipopolysaccharides (LPS). These aeroallergens that are commonly 
used to induce allergic asthma in murine model (Meyer-Martin et al., 
2014). Alkaline comet assay is a well-established tool to quantify a 
broad spectrum of DNA lesions including SSBs, alkali sensitive sites 
and abasic sites. CometChip is a modified comet assay that allows 
high throughput and automated data analysis, as reported previously 
(Ge et al., 2015; Ge et al., 2014; Weingeist et al., 2013; Wood et al., 
2010).  
 
We observed concentration-dependent increase in DNA damage in 
cells exposed to HDM, LPS or CAE, but not to ASP and RWE (Figure 
4.01, A). The level of DNA damage is indicated by the percentage of 
DNA in tail, as fragmented DNA migrates faster than intact DNA. 
Figure 4.01, B shows representative photos of comet of cells exposed 
to HDM  (2, 20 and 200 µg/ml). These results indicate that HDM can 
directly induce DNA damage, in addition to its ability to activate 












HDM = House dust mite 
LPS  = Lipopolysaccharide 
CAE = Cockroach allergen extract 
ASP = Aspergillus fumigatus 















































































































































































































Figure 4.01 | Aeroallergens induce DNA damage in human 
bronchial epithelial cells. (A) Cells were exposed to aeroallergens for 
6 hr and DNA damage was measured using alkaline comet assay. 
Percentage of DNA intensity in comet tail was quantified using in-house 
analysis software and plotted as shown. (B) Microphotos showed were 
representative images of comets from cells exposed to HDM (2, 20, 
200 µg/ml). Quantification of percentage of DNA in comet tail reveals 
level of DNA damage after HDM exposure. All experiments were 
repeated at least 3 times and data presented was mean ± SEM * P < 
0.01, # P < 0.05 indicate significant difference from untreated control.  
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4.3.2 HDM induces DNA DSBs in human bronchial epithelial cells 
DNA DSBs are one of the most significant damages to DNA, because it 
can lead to chromosomal translocations and even cell death if not 
repaired properly (Jeggo and Lobrich, 2007). Following formation of a 
DSB, H2AX is phosphorylated to form γH2AX, marking nucleosomes 
along megabases of DNA surrounding the DSB sites. Using 
immunocytochemistry, γH2AX nuclear foci can serve as a signal 
indicating the presence of DNA DSBs (Chapman et al., 2012). Here, 
we show that HDM concentration-dependently induced γH2AX foci as 
shown by increased immunofluorescence staining, which is consistent 
with the formation of DSBs (see inset for higher magnification)  (Figure 
4.02).   
 
Quantification of cells with more than 10 foci per nucleus showed that 
up to 50% of the cells displayed high level of DNA damage when 
exposed to 200 µg/ml HDM. Notably, the level of damage induced by 
HDM is similar to that induced by 100 µM hydrogen peroxide (H2O2), a 
highly genotoxic dose. Thus, we demonstrated that HDM aeroallergen 
can directly cause DNA DSBs in airway cells, even in the absence of 
immune cells that are known to secrete high levels of RONS. This 
implies that allergens that are generally perceived as being harmless 




































































































Figure 4.02 | Aeroallergen 
HDM induces DNA DSBs in 
human bronchial epithelial 
cells. BEAS-2B cells were 
exposed to Bleomycin (Bleo, 0.4 
U/ml) for 30 min to induce DNA 
DSBs and served as positive 
control (+ve); while, cells stained 
with secondary antibody only 
served as negative control (-ve). 
Cells were exposed to HDM (2, 
20, 200 μg/ml) for 6 hr and 
immune-stained for γH2AX and 
counterstained with nuclei stain, 
DAPI. Cells with ≥10 foci were 
counted as positive. 
Quantification was performed 
using Image J in 10 random 
images taken per set of 
treatment group per experiment.  
Micrographs were taken at 200x 
magnification. All experiments 
were repeated at least 3 times 
and data presented was mean ± 
SEM. * P < 0.01, # P < 0.05 
indicate significant difference 
from untreated control. 	
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4.3.3 HDM induces ROS level in human bronchial epithelial cells 
H2O2 (100 µM) induced intracellular ROS (green signal) production in 
human bronchial epithelial cells (Figure 4.03). HDM was able to trigger 
the production of ROS in a concentration-dependent manner, as shown 
by the increased green signal in cells. Mitochondrial respiratory chain is 
one of the major sites of ROS production (Lambeth, 2004). The 
mitochondrial electron transport chain contains redox centers that leak 
electrons to molecular oxygen, leading to the formation of O2·- in 
tissues (Orrenius et al., 2007).  To learn more about the origins of ROS, 
we measured mitochondrial ROS using MitoTracker Red CM-H2Xros, 
which stains mitochondria in live cells upon oxidation (Mah et al., 2010; 
Wang et al., 2013). HDM increased mitochondrial oxidative stress in 
BEAS-2B cells, as shown by the enhanced red fluorescence signal 
observed (Figure 4.04, A).  
 
The generation of ROS and the release of apoptotic proteins from the 
intermembrane space of mitochondria lead to the activation of cell 
death pathways (Orrenius et al., 2007). AIF is an intermembrane 
mitochondrial flavoprotein released from mitochondria into the cytosol 
during apoptosis. Translocation of AIF into the nucleus activates 
caspase-independent cell death pathway (Daugas et al., 2000). 
Immunofluorescence staining and quantification of AIF-positive nuclei, 
showed significant increase in the translocation of AIF (green signal) 





























































exposed to  HDM (200 µg/ml) (Figure 4.04, B) (see inset for higher 
magnification). This suggests that HDM exposure may activate AIF-










































Figure 4.03 | HDM triggers ROS 
production in cells. After 6 hr 
HDM (2, 20, 200 µg/ml) exposure, 
cells were stained with CellROX to 
measure oxidative stress level. 
Cells exposed to H2O2 (100 µM, 1 
hr) served as positive control 
(+ve); cells without CellROX 
staining served as negative 
control (-ve). Green signal 
indicates the presence of 
oxidative stress in cells. 
Percentage of CellROX-positive 
cells was quantified in 10 random 
fields per treatment group. All 
experiments were repeated at 
least 3 times and data presented 
was mean ± SEM * P < 0.01 
indicates significant difference 
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Figure 4.04 | HDM increases mitochondria oxidative stress. (A) 
Cells were stained with 500 nM Mitotracker Red CM-H2Xros to detect 
mitochondrial ROS (Red). (B) Cells were also stained with AIF (green) 
and DAPI (blue). Co-localization of AIF (green) with DAPI (blue) was 
indicated in white arrow, mainly in cells exposed to 200 µg/ml HDM. All 
experiments were repeated at least 3 times and representative photos 




4.3.4 HDM increases iNOS expression and nitrite (NO2-) secretion 
in bronchial epithelial cells 
The endogenous production of nitric oxide (NO) by nitric oxide 
synthase (NOS) has been implicated as pathophysiology events in 
asthma (Prado et al., 2011). NO has short half-life (< 5 s) (Tjalkens et 
al., 2011), and converts rapidly to physiologically stable nitrite (Shiva, 
2013). Hence, we measured the expression level of inducible NOS 
(iNOS) and the level of nitrite in cells. HDM induced significant 
increases in iNOS gene expression in BEAS-2B cells (Figure 4.05, 
right). In parallel, nitrite levels in BEAS-2B cells were increased 
following exposed to increasing concentrations of HDM, albeit not 









































































Figure 4.05 | HDM induces nitrosative stress in BEAS-2B.  Nitrite 
level in cell culture medium was measured after cells were exposed to 
HDM for 6 hr. iNOS gene expression in cells exposed to HDM was 
measured with RT-PCR. All experiments were repeated at least 3 times 
and data presented was mean ± SEM # P < 0.05 indicate significant 
difference from untreated control. 
 
 
4.3.5 HDM induces Nrf2 nuclear translocation and modulates 
antioxidant gene expression in bronchial epithelial cells. 
Nuclear erythroid 2-related factor 2 (Nrf2) is a key regulatory 
transcription factor that induces antioxidant genes to protect against 
deleterious effects of ROS (Sporn and Liby, 2012). To study the impact 
of HDM in regulating antioxidant responses, we measured the 
activation of Nrf2 by quantifying its nuclear translocation. 
Immunoblotting of nuclear protein lysate reveals that HDM induced 
Nrf2 nuclear translocation in BEAS-2B after 6 hr exposure (Figure 4.06, 
A). Interestingly, at the same time point, we observed a reduction in 
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antioxidant gene expressions, indicating that oxidant-antioxidant 
balance was disrupted despite the rise in nuclear Nrf2 (Figure 4.06, B, 
left). This observation is consistent with other reports that suggest that 
there is a defect in antioxidant capacity in asthmatic lungs (Corradi et 
al., 2003; De Raeve et al., 1997; Dworski, 2000). One possibility is that 
Nrf2 serves as a rescue response to restore the oxidant-antioxidant 
balance after disruption by HDM exposure. To test this hypothesis, we 
measured the antioxidant gene expression after 20 hr HDM exposure. 
As expected, the expression of many Nrf2-dependent genes including 
superoxide dismutase (SOD) 1, SOD3, glutathione S-transferase (GST) 
and glutathione-disulfide reductase (GSR) returned to basal level 
(Figure 4.06, B, right). More importantly, antioxidant genes SOD2, 
catalase (CAT), and NADPH dehydrogenase quinone 1 (NQO1) were 
































































2 HDM (µg/ml)   
20 HDM (µg/ml)   
200 HDM (µg/ml)   
Untreated 
2 HDM (µg/ml)   
20 HDM (µg/ml)   
200 HDM (µg/ml)   
Untreated    2       20     200    SFN 
6 hr HDM (µg/ml) 
NRF2 
LAMIN A/C 



























































Figure 4.06 | HDM alters antioxidant genes expression. (A) Nuclear 
NRF2 level was determined using immunobloting. (B) RNA extraction 
was performed and antioxidant genes expressions were measured 
using RT-PCR in cells exposed to HDM for 6 hr (left) or 20 hr (right). All 
experiments were repeated at least 3 times and data presented was 





4.3.6 HDM reduces cell proliferation and causes cell death  
To assess the impact of HDM on cell growth, XTT assay was 
performed.  XTT is a colorimetric assay used to measure cell viability 
and cell proliferation as a function of cell number based on metabolic 
activity. Low concentration of HDM (2 and 20 µg/ml) did not affect cell 
proliferation even after 30 hr of incubation. However, high 
concentration of HDM (200 µg/ml) reduced cell proliferation starting 
from 8 hr after exposure (Figure 4.07, A). To quantify cell death, we 
stained cells with Annexin V and PI. Apoptotic cells are stained positive 
for either Annexin V (early apoptotic) or both Annexin V and PI (late 
apoptotic). Cells exposed to HDM for 6 hr showed slightly elevated 
apoptosis as compared to untreated control. Prolonged exposure to 
HDM for 20 hr led to significant increase in apoptosis (Figure 4.07, B).  
This suggests that the decrease in proliferation in cells with prolonged 
HDM exposure may be due to apoptosis. Extensive bronchial epithelial 
cell death compromises the regeneration of bronchial epithelium in 
asthmatic patients. Failure to regenerate to replace damaged bronchial 
epithelial cells could result in the disruption of the lung barrier integrity 
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Figure 4.07 | HDM 
reduces cell 
proliferation and 
induces cell death. (A) 
Cell proliferation was 
determined using XTT 
assay, up to 30 hr of 
HDM (2, 20 200 µg/ml) 
treatment. (B) Cell death 
assay was performed 
using Annexin V/PI 
staining after 6 or 20 hr of 
HDM challenge. Cells 
positive for Annexin V 
only or both Annexin V 
and PI were considered 
as early apoptotic and 
late apoptotic cells, 
respectively. Data was 
collected using flow 
cytometry, and analyzed 
using FlowJo. All 
experiments were 
repeated at least 3 times 
and data presented was 
mean ± SEM * P < 0.01 
indicates significant 




4.3.7 Antioxidant suppresses HDM-induced DNA damage and 
cell death 
To study the protective effect of antioxidants in HDM-induced DNA 
damage in BEAS-2B cells, we co-incubated cells with glutathione or 
catalase during HDM exposure. Catalase treatment reduced 
intracellular ROS (green signal) in BEAS-2B cells exposed to HDM 
(Figure 4.08, A). In addition, we observed significant concentration-
dependent reduction in HDM-induced DNA damage in cells co-
incubated with antioxidants, as measured using alkaline comet assay 
(Figure 4.08, B). Most importantly, antioxidants are able to prevent 
HDM-induced bronchial epithelial cell death, as measured using 
Annexin V/PI staining (Figure 4.08, C). This suggests that HDM-
induced DNA damage and cytotoxicity can be prevented by antioxidant 
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Figure 4.08 | HDM-induced DNA damage and cell death can be 
prevented by antioxidant treatment. BEAS-2B cells were exposed to 
200 µg/ml HDM for 6 hr with or without antioxidants glutathione and 
catalase treatment, followed by CellROX staining, alkaline comet assay 
and cell death analysis. (A) Green signal indicates the presence of 
intracellular ROS in cells. (B) DNA damage in cells is indicated by the 
percentage of DNA in comet tail. (C) Cell death was analyzed using 
Annexin/PI staining and quantified using flow cytometry.Experiments 
were repeated for at least 3 times and mean score ± SEM was plotted. 





Exposure to HDM allergen is a major risk factor for allergic 
sensitization and asthma development (Arbes et al., 2003; Hales et al., 
2006). Fifty to eighty-five percent of asthmatics are found to be allergic 
to HDM (Gregory and Lloyd, 2011; Thomas et al., 2002). HDM is a 
complex biological allergen that displays strong allergenic potential, 
mainly through its ability to interact with the innate immune system 
(Fahlbusch et al., 2003; Gregory and Lloyd, 2011). Airway epithelium is 
the first line of defense for the lung tissue when exposed to 
environmental stimuli including aeroallergens. It plays a central role in 
activating immune response towards external stimuli (Lambrecht and 
Hammad, 2015). In this study, human bronchial epithelial cells, BEAS-
2B were exposed to HDM for 6 hr, a time point where cell viability was 
not significnatly altered by the highest concentration of HDM (as shown 
in the XTT assay, Figure 4.07, A). This is a time point where we can 
observe the biological impacts induced by HDM before causing 
cytotoxicity. We revealed that HDM could directly induce DNA damage 
in human bronchial epithelial cells by triggering RONS formation and by 
weakening of antioxidant responses. It can also reduce cell 
proliferation and induce cell death, potentially dampening the ability of 
cells to regenerate. We postulate that the DNA damaging potential of 





It has been shown that HDM activates bronchial epithelial cells and 
releases pro-Th2 cytokines such as GM-CSF, TSLP, IL-25 and IL-33 
(Lambrecht and Hammad, 2015). One possible path is through its 
pathogen-associated molecular patterns that can be recognized by 
PRRs expressed on the apical surface of airway epithelial cells. 
Proteolytic cleavage of host protein by the protease activity of allergens, 
tissue damage and metabolic changes induced by allergens, can also 
drive Th2 responses in cells (Post et al., 2012). In addition, allergen-
induced tissue damage releases damage-associated molecular 
patterns such as ATP and uric acid that serve as danger signals that 
alert immune system to tissue damage (Lambrecht and Hammad, 
2012).  
 
Increased ROS has been associated with allergic lung inflammation, 
lung injury and vascular remodeling. We observed elevated levels of 
ROS when BEAS-2B cells were exposed to HDM. Some allergens 
contain NAD(P)H oxidases and are able to induce oxidative stress in 
the airway epithelium (Bacsi et al., 2005; Boldogh et al., 2005), pointing 
to the possibility that HDM-induced oxidative stress may also be 
dependent on NADPH oxidase. DNA damage that was observed after 
HDM exposure may be a consequence of this excess ROS formation.   
 
It has been shown that RWE can cause oxidative damage to 
mitochondrial respiratory proteins (Aguilera-Aguirre et al., 2009). It can 
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also trigger ROS production from mitochondrial respiratory chain 
complex in human airway epithelial cells (Aguilera-Aguirre et al., 2009). 
Oxidative stress as a result of mitochondrial dysfunction has been 
associated with the development of allergic airway inflammation and 
airway remodeling (Kim et al., 2014; Mabalirajan et al., 2008). In line 
with these findings, we showed here that HDM increases mitochondrial 
ROS in BEAS-2B cells. O2·- being the main damaging by-product of 
mitochondrial oxidative phosphorylation, resides on the matrix side of 
the inner mitochondrial membrane (Ott et al., 2007). This may account 
for the strong oxidation potential within mitochondria as shown in our 
results.  
 
Our results further implicate the role of mitochondrial oxidative stress 
leading to AIF translocation and ultimately the activation of cell death 
pathway. Under metabolic stress, mitochondria-derived oxidants 
function as signaling molecules, such as in apoptotic pathways (Finkel 
and Holbrook, 2000). Impaired mitochondrial respiratory chain function 
affects ATP production and impacts cell viability (Fariss et al., 2005). 
Mitochondrial ROS mediate the release of pro-apoptotic cytochrome c 
and AIF into the cytosol leading to the activation of caspase-dependent 
and caspase-independent cell death pathways, respectively (Fariss et 
al., 2005; Norberg et al., 2010). The release of AIF from mitochondria 
into cytosol can also be attributed to oxidative modification by 
mitochondrial ROS that has changed its conformation (Norberg et al., 
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2010). In this study, after HDM exposure, we observed increased 
translocation of AIF into nucleus, which could then trigger chromatin 
condensation and DNA fragmentation. In parallel, we detected reduced 
cell proliferation and increased cell death (Figure 4.07). These are 
likely the consequences of the activation of mitochondria-dependent 
cell death.  
 
Genotoxic stress activates cell cycle checkpoints and cell-cycle 
progression resumes after damaged DNA is repaired.  Irreparable DNA 
lesions can lead to persistent cell-cycle arrest or programmed cell 
death (Branzei and Foiani, 2008). Interestingly, in our studies, we did 
not observe significant alteration in cell cycle of cells exposed to HDM 
suggesting that the HDM does not interfere cell cycle (Supplemetary 
Figure 4.1).  
 
The Nrf2 transcription factor provides an earliest antioxidant defense 
and cytoprotection from oxidative damage by inducing the expression 
of antioxidant genes (Gorrini et al., 2013). In animal models, disruption 
of Nrf2 enhances susceptibility to airway inflammation and exacerbates 
allergic inflammation induced by allergen (Li et al., 2013a; Li et al., 
2013b). We observed an increase in translocation of Nrf2 transcription 
factor into the nucleus, suggesting an immediate and first line oxidative 
stress response in cells exposed to HDM. Indeed, antioxidant gene 
expressions were dampened shortly after HDM exposure. 
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Nevertheless, increased antioxidant expression back to baseline, was 
evident after 20 hr of HDM exposure, indicating a rescue response by 
Nrf2-mediated transcriptional activity. Notably, SOD2 gene expression 
was significantly elevated after 20 hr HDM exposure. SOD2 is a 
mitochondrial matrix enzyme that scavenges oxygen radicals produced 
by mitochondrial during electron transport reactions (Wallace, 2012). 
This suggests the presence of mitochondrial oxidative stress in cells, 
hence requiring constant expression of SOD2.  
 
To investigate the potential of glutathione and catalase in preventing 
HDM-induced DNA damage, we added glutathione and catalase 
supplement into culture medium. Glutathione is a thiol compound, a 
major antioxidant present in cells to maintain a tight control of the redox 
status. In reduced state, glutathione scavenges a wide variety of ROS, 
including O2·-, hydroxyl radical (.OH-), protein- and DNA radicals, by 
donating electrons and oxidized to glutathione-thiyl radical (GS.) 
(Franco and Cidlowski, 2009). Catalase is an intracellular antioxidant 
enzyme that catalyzes the reaction that converts H2O2 to water and 
oxygen (Goyal and Basak, 2010). Replenishing of glutathione and 
catalase pool in cells scavenges and prevents the accumulation of 
ROS, as a result, reduces DNA damage in cells. Indeed, our findings 
demonstrated the ability of exogenous glutathione and catalase to 
reduce HDM-induced DNA damage and cell death in BEAS-2B cells. 
This highlights the importance and the ability of exogenous 
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antioxidants to protect lung cells from the genotoxic effect of 
aeroallergens, revealing a novel mechanism of antioxidants for treating 
asthma. Notably, we employed a TLR-4 specific agonist and antagonist 
to activate or to block the binding of HDM onto the TLR-4 on bronchial 
epithelial cells, respectively, and have shown that HDM-induced DNA 
damage is independent of TLR-4 activation (Supplementary Figure 
4.2). 
 
Excessive or irreparable DNA damage activates cell death pathways, 
and in asthma, airway epithelial cell death accounts for excessive 
epithelial loss, which is one of the contributing mechanisms for 
worsening symptoms in allergic asthma. Here, we have shown that 
HDM allergen is genotoxic to bronchial epithelial cells and affects cell 
proliferation. Bronchial epithelium that suffers from genotoxicity and 
cytotoxicity could be compromised structurally and functionally. This is 
an important yet understudied mechanism that drives asthma 
pathogenesis.   
 
Taken together, the present study reveals for the first time that HDM 
induces DNA damage in bronchial epithelial cells by triggering the 
production of genotoxic RONS. HDM exposure increases cellular 
oxidative and nitrosative stress and alters Nrf2 dependent antioxidant 
responses. In addition, HDM reduces cell proliferation and induces cell 
death, which could affect airway epithelium regeneration after cell injury 
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as a result of allergen exposure. Further, antioxidant treatment is able 
to protect cells from HDM-induced DNA damage, indicating that RONS 
are a major source of DNA damage in cells exposed to HDM. While 
further studies are needed to ascertain the specific mechanism on how 
HDM leads to increase ROS in cells, this studies point to the possibility 
that inhibition of oxidative stress or targeting oxidative mechanisms that 
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Supplementary Figure 4.1 | Effects of HDM exposure on cell cycle. 
Cell cycle analysis by quantitation of DNA content was performed using 
PI nucleic acid staining. HDM exposure led to low level of cell cycle 
arrest in the G0/G1 phase  However, the difference between untreated 
and HDM-treated cells was not statistically significant. All experiments 
















Supplementary 4.2 | HDM-induced DNA damage is independent of 
TLR-4 binding. TLR4 agonist (102, 103, 104 µg/ml) and TLR4 
antagonist (0.1, 1, 10 µg/ml) were co-incubated with or without HDM 
(200 µg/ml) for 6 hr, directly on cells in Alkaline Cometchip. Blocking of 
TLR4 binding does not reduce HDM-induced DNA damage; binding of 
TLR4 does not induce DNA damage. Experiments were repeated for at 
least 3 times and mean score ± SEM was plotted.  
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5 Chapter 5: Anti-malarial Drug Artesunate Protects Bronchial 
Epithelium from DNA Damage Induced by Asthma 
5.1 Abstract 
Background: Artesunate is a derivative of artemisinin, an anti-malarial 
drug. It has been shown to reduce airway inflammation and ameliorate 
oxidative stress in experimental murine asthma model. Sensitization to 
HDM is as a major risk factor for the development of asthma. HDM 
exposure in both in vivo and in vitro leads to DNA damage in bronchial 
epithelium, potentially through the formation of RONS. Unrepaired DNA 
damage such as the DNA DSB activates cell death pathway and may 
account for the bronchial epithelium shedding observed in patients with 
severe asthma.  
 
Methods: Genome protective effect of artesunate was studied in vivo 
using HDM-induced mouse asthma model and in vitro using BEAS-2B 
cells exposed to HDM. 
 
Results: Artesunate (30 mg/kg) treatment significantly reduces 
immune cells infiltration in BAL fluid of asthmatic mice. Importantly, 
artesunate is able to protect bronchial epithelium from DNA DSBs 
induced by asthma, as detected by the reduced level of γH2AX and 
53BP1 in the nucleus. This genome protective effect is evident even on 
day 1 post-challenge, when immune cells infiltration remained high. 
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Additionally, artesunate is also able to reduce cell death in asthmatic 
lung revealed by TUNEL assay and cleaved caspase-3 level. 
Interestingly, the levels of DNA repair proteins in artesunate-treated 
asthmatic mice are unchanged as compared to HDM-only 
mice, suggesting that artesunate treatment does not augment the level 
of DNA repair proteins. When human bronchial epithelial BEAS-2B 
cells were exposed to HDM in vitro, we observed an increase in the 
levels of DNA damage, measured with comet assay. Artesunate (30 
and 60 μM) co-incubated with HDM is not able to prevent direct DNA 
damage induced by the allergen.  
 
Conclusion: Together, these studies suggest that the genome 
protective effect of artesunate in vivo may be attributed to physiological 
effects (such as its anti-inflammatory and anti-oxidative stress effects) 
rather than serving to directly prevent DNA damage. This study 
highlights a novel role for artesunate in protecting bronchial epithelial 




The pathogenesis of allergic asthma is complex due to the interactions 
of several mechanisms such as airway inflammation, oxidative stress, 
altered antioxidant responses, DNA damage, DNA repair and cell death. 
In this chapter, we will focus on finding therapeutic measures to 
regulate DNA damage and repair, as a way to control asthma 
pathology. 
 
Repeat exposures to allergens cause injuries on airway epithelium 
(Lambrecht and Hammad, 2012). These injuries include the damage to 
DNA as observed in bronchial epithelium of HDM-challenged mouse 
lungs (Chapter 2) and in human bronchial epithelial cells exposed to 
HDM (Chapter 3). Irreparable damaged DNA has the potential to 
trigger auto-inflammatory response in mice (Karakasilioti et al., 2013), 
suggesting that asthma-induced DNA damage may be an important 
factor that contributes to asthma pathogenesis. Here, we explore the 
potential of artesunate, a semi-synthetic derivative of artemisinin, a 
sesquiterpene trioxane lactone isolated from herb Artemisia annua (Ho 
et al., 2014), in mitigating HDM-induced airway inflammation, DNA 
damage and cell death of bronchial epithelium of asthmatic airway.  
 
Recent advances in understanding the mechanisms that drive asthma 
development unveil new biologic targets that are potentially useful in 
treating complex asthma. One successful example is human 
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monoclonal immunoglobulin (Ig)-E-targeted antibody omalizumab that 
has shown promising effects in asthma patients with uncontrolled 
disease despite treatment with high dose of corticosteroids (Pelaia et 
al., 2012). Another major development is anti-cytokine therapy which 
uses blocking antibodies against IL-4, IL-5, IL-9, IL-13, IL-33 and 
thymic stromal lymphopoietin (TSLP) (Hansbro et al., 2011; Pelaia et 
al., 2012). These cytokines play key roles in chronic inflammation and 
airway remodeling. However, anti-cytokine treatments have shown 
contradicting results in asthmatic patients, illustrating the complexity of 
human asthma (Adcock et al., 2008). Hence, therapeutic strategies that 
target different pathways that contribute to asthma pathogenesis 
should be explored.  
 
Our laboratory has previously demonstrated the beneficial effects of 
artesunate in experimental murine eosinophilic inflammation, airway 
hyperresponsiveness and airway remodeling in ovalbumin (OVA)-
induced experimental asthma through the inhibition of phosphoinositide 
3-kinase (PI3K)/Akt signaling pathway (Cheng et al., 2011). This leads 
downstream inhibition of NF-κB activity and further reduction of 
proinflammatory cytokines, IL-4, IL-5, IL-13 and chemokines such as 
eotaxin, RANTES and adhesion molecules such as intercellular 
adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 
(VCAM-1) and E-selectin. We have also demonstrated that artesunate 
is able to ameliorate oxidative lung damages in asthma, by abating the 
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expression of pro-oxidant iNOS and NAD(P)H oxidase and through the 
regulation of Nrf2, a redox-sensitive transcription factor involved in the 
transcriptional regulation of many antioxidant genes (Ho et al., 2012). 
In addition, we have also shown that artesunate possesses anti-allergic 
action in experimental mast cell-mediated anaphylactic model (Cheng 
et al., 2013). Artesunate is able to prevent IgE-mediated vascular 
hyperpermeability and reduced mast cell degranulation, though the 
regulation of IP3-dependent Ca2+ influx in mast cell (Cheng et al., 2013). 
 
In addition to anti-inflammatory actions, in the present study, we 
observed a significant reduction in DNA DBS in the bronchial 
epithelium of the mouse asthmatic airway after treatment with 
artesunate, suggesting that artesunate possesses strong genome 
protective effect in asthma. Additionally, artesunate is able to reduce 
cell death in experimental asthmatic lung, a common 
pathophysiological feature in asthma. However, artesunate was unable 
to augment the level of DNA repair proteins, and only slight reduces 
DNA damage in human bronchial epithelial cells exposed to HDM 
directly in vitro, suggesting that the genome protective effect of 
artesunate may be attributed to its immunomodulatory effects rather 




5.3.1 Artesunate ameliorates airway inflammation in HDM-
induced experimental asthma model.  
Anti-inflammatory effect of artesunate was recapitulated using HDM-
induced airway inflammation mouse model.  Mouse lungs and BAL fluid 
were collected on day 1, 3 and 5 post-challenge. Analysis of BAL fluid 
revealed strong inflammation responses in the airway accompanying 
by increase in total infiltrated immune cells. Artesunate significantly 
suppressed eosinophils influx on day 3 and 5 post-challenge as 
compared to DMSO vehicle control (Figure 5.01, A). Eosinophilia is 
one of the hallmarks of Th2-type allergic inflammation (Rosenberg et 
al., 2013). We have shown that artesunate produced the same 
magnitude of efficacy as compared to dexamethasone (DEX), a 
glucocorticosteroid commonly used to treat severe asthma, which 
serves as a positive control in this study. Nevertheless, both artesunate 
and dexamethasone showed no effect in reducing immune cells 
infiltration on Day 1 post-challenge, which are mostly neutrophils, 
Analysis of tissue morphology through Hematoxylin and Eosin (H&E) 
staining and quantification of inflammation level showed that 
artesunate markedly reduced infiltration of inflammation cells into both 
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recruitment to the 
airway. (A) Total and 
differential immune cell 
counts were formed in 
BAL fluid obtained from 
mice on day 1, 3 and 5 
post-challenge (d.p.c). 
HDM represents mice 
with HDM-induced 
asthma (27 μg HDM i.t 
once a week for 3 
weeks); DMSO 
represents vehicle 
control (HDM mice 
treated with 5% DMSO); 
ART represents HDM 
asthma mice treated 
with artesunate (ART) 
(30 mg/kg); 
Dexamethasone (DEX) 
(1 mg/kg) serves as 
positive drug control. 
Value are mean ± SEM 
for n= 10 for Saline, 
n=7-9 for HDM, DMSO, 
ART and DEX. * P < 
0.01, # P < 0.05 indicate 
significant difference 



































































































Figure 5.01B | Artesunate reduces HDM-induced inflammatory cell 
recruitment to the airway. Representative histological images of 
H&E-stained lung sections were shown. Micrographs were taken at 
200x magnification.  Inflammation scoring of lung sections in at least 10 
different fields for each lung section on at least 3 mice per treatment 
group per time point was performed in a blind manner as described in 
the material and method. * P < 0.01 indicates significant difference 







5.3.2 Artesunate reduces lung DNA double-strand breaks (DSBs) 
induced by HDM exposure.  
Following DNA DSBs, the histone variant H2AX is phosphorylated to 
form γH2AX, which can be visualized in the form of foci using 
immunofluorescence (IF) staining. In our previous study, we have 
shown that HDM induces DNA DSBs in the bronchial epithelium in both 
in vivo and in vitro. Here, we report that artesunate is able to reduce 
DNA DSBs (as indicated by γH2AX staining) induced by HDM 
exposure in vivo, especially in the bronchial epithelium region, which is 
identifiable by red staining of Club Cell protein 10, CC10 (Figure 5.02, 
A). Quantification of γH2AX on day 1, 3 and 5 post-challenge showed a 
clear increase in the frequency of cells that have ≥5 γH2AX foci in 
HDM-treated lung, consistent with previously reported studies (Figure 
5.02, B). Artesunate successfully protected DNA of bronchial epithelial 
cell from damage induced by HDM. Importantly, the protective effect of 
artesunate was clearly observed as early as day 1 post-challenge, 
when immune cells infiltration was high. To confirm the finding, we 
performed immunoblotting of whole lung lysate. Consistent with the 
immunofluorescence staining result (Figure 5.02, A and B), 
immunoblotting results showed that artesunate completely diminished 
the formation of γH2AX in lungs on day 1, 3 and 5 post-challenge even 
when the level of immune cells infiltration was high on day 1 post-
challenge (Figure 5.02, C). This suggests that the genome protective 
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effect of artesunate is independent of its anti-inflammatory action. 
Artesunate has been reported to be able to diminish oxidative damage 
in asthma model and upregulate antioxidant responses by regulating 
Nrf2-transcriptional activity (Lee et al., 2012). Hence, one possible 
genome protective mechanism of artesunate may be through the 
upregulation of Nrf2-dependent antioxidant responses that neutralize 
the RONS secreted by immune cells such as the neutrophils, which 
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Figure 5.02, A, B and C | Artesunate reduces γH2AX foci formation 
in bronchial epithelium of asthmatic lungs. (A) Analysis of DNA 
DSBs marker, γH2AX (green), bronchial epithelial cell marker, CC10 
(red) and DAPI (blue) were performed on lung sections obtained from 
mice with HDM-induced asthma (HDM), mice with HDM-induced 
asthma treated with 5% DMSO (DMSO) and mice with HDM-induced 
asthma treated with 30 mg/kg artesunate (ART), on day 1, 3 and 5 
post-challenge (d.p.c). Samples from positive control (bleomycin) and 
secondary antibody alone (-ve) are indicated. (B) Quantification of cells 
with ≥ 5 γH2AX foci was performed in 10 pictures obtained from 
random spots in each lung, with n=3 per treatment group. (C) 
Immunoblotting of γH2AX using total protein extracts of lung tissues. β-
actin was used as an internal control. Experiments were repeated three 
times (n=3 mice) with similar pattern of results, and data presented 
was mean ± SEM. Significantly different from vehicle control (DMSO) * 
P < 0.01 
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To reassure the findings, we measured another DNA DSBs marker, 
p53-binding protein 1 53BP1 (also known as TP53BP1). DNA DSBs 
will activate a cascade of protein recruitment to the chromatin 
surrounding DNA lesions to initiate signaling and DNA damage repair. 
53BP1 is a one of the chromatin-associated factors that have been 
identified to bind DNA DSBs and promotes repair by non-homologous 
end joining (NHEJ) (Panier and Boulton, 2014). 53BP1 prevents DNA 
end resection, a process that is required for homologous recombination 
(HR) (Zimmermann and de Lange, 2014). The level of 53BP1-positive 
epithelial cells was evident after HDM challenge (Figure 5.02, D and 
E). Similar to γH2AX, artesunate almost completely diminished the 
formation of 53BP1 on all three time-points (day 1, 3 and 5 post-
challenge) showing strong genome protection effect. Taken together, 
artesunate significantly reduced DNA DSBs in bronchial epithelium of 
lung exposed to HDM challenge, and this effect may be attributed to its 
anti-oxidative stress action, on day 1 post-challenge, followed by anti-
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Figure 5.02, D and E | Artesunate reduces DNA DSBs marker 
53BP1 foci formation bronchial epithelium of asthmatic lungs. (D) 
Analysis of 53BP1 foci formation (green) and DAPI staining (blue) in 
lung sections obtained from mice with HDM-induced asthma (HDM), 
mice with HDM-induced asthma treated with 5% DMSO (DMSO) and 
mice with HDM-induced asthma treated with 30 mg/kg artesunate 
(ART), on day 1, 3 and 5 post-challenge (d.p.c). Samples from positive 
control (bleomycin) and secondary antibody alone (-ve) are indicated. 
(E) Quantification of cells with ≥ 1 53BP1 foci was performed on 10 
pictures obtained from random spots in each lung, with n=3 per 
treatment group. Data presented was mean ± SEM. Significantly 




5.3.3 Artesunate retains the levels of DNA repair proteins  
Increased DNA repair proteins level was observed in the lung of mice 
exposed to HDM (Chapter 3). To study the effect of artesunate in 
regulating DNA repair protein, we measured two DNA repair proteins, 
KU70 and RAD51. KU70 forms heterodimer with KU80 and bind to free 
double-strand DNA (dsDNA) ends and activate NHEJ pathway (Lieber 
et al., 2003). While, RAD51 facilitates homology search and DNA 
strand invasion during HR repair (Li and Heyer, 2008). HDM challenge 
resulted in a robust increase in both KU70 and RAD51 protein levels in 
mouse lungs. Artesunate showed minimal effect in regulating the 
proteins levels of KU70 and RAD51, suggests that artesunate 
prevention of DNA damage is not through induction of more DNA repair, 
rather artesunate works through other mechanism to prevent DNA 
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Figure 5.03 | Artesunate retains the levels of DNA repair protein in 
whole lung lysate of asthmatic mice. Immunoblotting of DNA repair 
proteins RAD51 and KU70 was performed using total protein lysate of 
whole lung tissues obtained from saline control (S), mice with HDM-
induced asthma (HDM), mice with HDM-induced asthma treated with 
5% DMSO as vehicle control (DMSO) and HDM-induced asthma 
treated with 30 mg/kg artesunate (ART), on day 1, 3 and 5 post-
challenge (d.p.c). Immunoblots were quantified using Image J, relative 
to saline control (S). The experiment was repeated at least 3 times, 




5.3.4 Artesunate decreases cell death and asthma-induced 
caspase-3 activation 
Lung cell death is an important pathophysiological feature of allergic 
asthma. To investigate the potential of artesunate in modulate asthma-
induced cell death, we analyzed the apoptosis frequency using TUNEL 
staining. HDM increased the frequency of TUNEL positive cells as 
compared to saline control, revealing high level of apoptotic cells in 
asthmatic lung especially on day 5 post-challenge (Figure 5.04, A). 
However, upon artesunate treatment, the number of apoptotic cells in 
lung section was reduced significantly, as compared to both HDM 
group and vehicle control (Figure 5.04, B). We also measured the 
protein level of cleaved caspase-3 in whole lung lysate obtained from 
mice on day 5 post-challenge. Analysis of protein level showed a clear 
increase in the level of cleaved caspase-3 in HDM-only asthma group 
as well as in vehicle control. Cleaved caspase-3 level was reduced in 
artesunate-treated asthmatic mice (Figure 5.04, C). These data 
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Figure 5.04 | Artesunate decreases asthma-induced cell death. (A) 
Analysis of apoptosis (TUNEL; brown) in lung sectioned from day 5 
post-challenge, counterstained with methyl green. Positive control 
(+ve) showed apoptotic cells that were stained brown; Negative control 
(-ve) stained without TdT. Representative images from three 
independent experiments were shown. (B) Quantification of apoptotic 
cells (TUNEL positive) was performed in a blinded fashion, 10 images 
from each treatment group were analyzed (n=3 mice per group). (C) 
Western analysis of cleaved caspase-3 on day 5 post-challenge. 
Exposure to HDM induced increased cleavage of caspase-3, which can 
be suppressed by artesunate treatment (ART). Immunoblots were 
quantified using Image J, relative to saline control (S). Data shown 




5.3.5 Artesunate is unable to protect bronchial epithelial from 
DNA damage induced by HDM in vitro  
To elucidate the direct genome protective effect of artesunate on 
bronchial epithelial cells, human bronchial epithelial cells, BEAS-2B 
was exposed to HDM extract (200 µg/ml) for 6 hr, and level of DNA 
damage in cells were quantified using alkaline comet assay, with or 
without artesunate (30 µM or 60 µM) co-treatment. When BEAS-2B 
cells were exposed to HDM, we observed high level of DNA damage in 
cells, as presented in the form of percentage of DNA in comet tail 
(Figure 5.05, A). However, we only observed slight reduction in 
percentage DNA in comet tail (damaged DNA) in cells treated with 60 
µM artesunate but not in cells treated with 30 µM artesunate. This 
suggests that the ability of artesunate to prevent bronchial epithelium 
DNA damage induced by HDM is not through direct interference of 
DNA damage formation in cells. Furthermore, to assure that this slight 
reduction is not due to reduced cell viability after artesunate treatment, 
we performed XTT cell viability assay and have shown artesunate (60 
µM) does not affect cell viability even up to 30 hr treatment (Figure 
5.05, B).  
 
Taken together, this study suggests that the genome protective effect 
of artesunate in experimental murine asthma model may be attributed 
to physiological effects such as anti-oxidative stress effects rather than 
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Figure 5.05 | Artesunate is not able to prevent DNA damage 
induced by HDM in BEAS-2B. (A) BEAS-2B cells were exposed to 
HDM (200µg/ml) with or without drug treatment for 6 hr. Treatment 
groups include H2O2 (positive control), DMSO (vehicle control, co-
incubated with HDM), 30 µM or 60 µM ART (artesunate co-incubated 
with HDM) and DEX (positive drug control, co-incubated with HDM). % 
Tail DNA indicates level of DNA damage in cells. (B) Cell viability after 
artesunate treatment was measured using XTT assay. Experiments 





The link between asthma and airway inflammation is long established. 
Airway inflammation with immune cells infiltration such as eosinophils 
and neutrophils is a characteristic feature of asthma. These immune 
cells secrete RONS that are potent inducers of DNA damage. Recent 
studies have reported that asthma is able to induce systemic 
genotoxicity, in both lung tissue cells and in peripheral blood, pointing 
to the potential contributing role of DNA damage in the development of 
asthma (Hasbal et al., 2010; Zeyrek et al., 2009). Here, we studied the 
efficacy of artesunate, a well-established anti-malarial drug that has 
shown to suppress experimental asthma, in preventing DNA damage 
induced by asthma. Consistent with studies reported previously, HDM-
challenge leads to airway inflammation with high level of immune cells 
infiltration into the airway. IF staining and western analysis of DNA 
DSBs markers reveal significant DNA damage in the lung tissue of 
HDM-challenged mice, especially in bronchial epithelium. Cell death 
analysis also reveals increased apoptosis in asthmatic lungs. 
Artesunate treatment suppresses airway inflammation, protected 
bronchial epithelial cells from DNA damage induced by asthma, 
reduces cell death in lung, but does not directly alter the level of DNA 
repair protein, and does not reduce human bronchial epithelial cells 
DNA damage induced by HDM exposure in vitro. This study provides 





This study suggests that the genome protective effect of artesunate in 
vivo may be attributed to physiological effect such as the anti-oxidative 
stress effect rather than directly preventing DNA damage on bronchial 
epithelium. The genome protective effect of artesunate can be also 
attributed to its ability to induce Nrf2 activation and antioxidant gene 
expression (Ho et al., 2012; Lee et al., 2012; Ng et al., 2014). In HDM 
model, high level of oxidative stress is observed (Ho et al., 2012). 
Immune cells such as neutrophils and eosinophils produce 
myeloperoxidase (MPO) and eosinophil peroxidase (EPO) respectively. 
MPO and EPO catalyze the formation of hypochlorous acid (HOCl) and 
hypobromous acid (HOBr) which are highly potent in causing oxidative 
damages to tissue (Comhair and Erzurum, 2010). The ability of 
artesunate in up-regulating Nrf2 transcriptional activity may be a key 
factor in protecting lung from oxidative damages in HDM-challenged 
mice. Artesunate treatment was started one day before, the actual day 
and the day after second HDM sensitization and last HDM challenge. 
Once administered, artesunate is rapidly metabolized to active 
metabolite, dihydroartemisinin (DHA) (Ho et al., 2014). Despite the 
short Tmax of 15 min, serum level of DHA persists up to 6 hr post-
administration (Supplementary Figure 5.1). Hence, the amount of 
artesunate-induced Nrf2-dependent antioxidants that presents in the 
blood should be sufficient to respond promptly to the sudden influx of 
neutrophils-derived oxidants on day 1 post-challenge, and to prevent 
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oxidative damages to tissue. This also explains the ability of artesunate 
to protect bronchial epithelial cells from DNA damage even on day 1 
post-challenge, even though the level of neutrophils is high in response 
to allergen challenge. On day 3 and 5 post-challenge, the complete 
suppression of inflammatory cells infiltration into the HDM-challenged 
lung by artesunate may be attributed to both its anti-inflammatory and 
anti-oxidative stress functions.  
 
It is well known that one of the anti-inflammatory actions of 
dexamethasone is through direct induction of eosinophil clearance 
(Druilhe et al., 2003). Artesunate reduced cleaved caspase-3 level and 
reduced cell death in HDM lung, as shown by TUNEL staining, 
suggesting that the mechanism of action of artesunate is different from 
dexamethasone. The mechanism of action of artesunate may be more 
upstream in the signaling pathways, aiming to prevent uncontrolled 
alteration in immune responses that bring more harm than benefit to 
the host.  
 
It was reported previously that artesunate is able to induce oxidative 
DNA damage in cancer cells (Berdelle et al., 2011). To test if 
artesunate can cause DNA damage in non-cancerous cell such as the 
BEAS-2B, an immortalized normal human bronchial epithelial cell, we 
treated BEAS-2B with artesunate for 6 hr and performed alkaline comet 
assay to measure DNA damage. We did not observed any DNA 
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damage induced by artesunate treatment, suggesting that the 
concentration and exposure time we used will not lead to any DNA 
damage in BEAS-2B cells.  
 
Artesunate has anti-cancer potential because of its ability to activate 
cell death in cancer cells in the presence of iron and through ROS 
formation (Hamacher-Brady et al., 2011). Cancer cells have a tendency 
to absorb high level of iron which is crucial in accelerating cancer cell 
growth (Torti and Torti, 2013). Artesunate activates mitochondrial 
apoptosis in cancer cells through iron-catalyzed lysosomal ROS 
production (Yang et al., 2014). Ferrous iron reacts with artesunate by 
cleaving the endoperoxide bridge presents in its structure, through a 
Fenton-type reaction. This leads to the generation of ROS, which is 
one of the mechanisms of action for artesunate to kill plasmodium 
parasite-infected red blood cells, which too, contain high level of 
ferrous iron because of the presence of hemoglobin (Ho et al., 2014). 
Artesunate cytotoxicity originates from interactions with heme-derived 
iron within the food vacuole created by malaria parasite. However, 
BEAS-2B is a non-cancerous cell and does not contain high level of 
Ferrous ion in cells, therefore, artesunate does not cause cytotoxicity in 
BEAS-2B cells. These suggest that the therapeutic potential of 
artesunate is highly dependent on the type of cells, the 






















DHA Cmax – 1376 ng/ml  
DHA Tmax – 15 mins
DHA AUC0-360 – 150446 ng/ml
Arts Cmax – 462 ng/ml  
Arts Tmax – 5 mins




Taken together, we have shown that artesunate processes genome 
protective function in bronchial epithelium of asthmatic lung. This 
genome protective effect is attributed to physiological effects such as 
its ability to upregulate anti-oxidant responses and its anti-inflammatory 
effects, rather than through direct scavenging of genotoxic compounds. 
This study highlights a novel role for artesunate in protecting bronchial 
epithelial cells from asthma-induced DNA damage. 



















Supplementary Figure 5.1 | Pharmacokinetics of artesunate and 
its active metabolite DHA in mouse serum. Single dosage of 
artesunate (Arts) (30 mg/kg) was administered via i.p injection and the 
concentrations of ART and DHA in serum were measured using Liquid-
Chromatography-Mass Spectrometry. Figure adapted from Ho 





6 Chapter 6: Conclusion, Limitations and Future Work  
6.1 Summary of Major Findings 
The aim of this thesis is to expand our current knowledge of the 
underlying pathogenesis mechanisms for asthma development, 
especially in relation to oxidative stress and DNA damage responses. 
In Chapter 3, I have shown that there is increased DNA damage in 
bronchial epithelium in mice exposed to HDM via intratracheal 
administration, and that DNA repair is crucial in preventing uncontrolled 
inflammatory responses and cell death in asthma. HDM challenge 
causes a drastic increase in oxidative damage in allergen-induced 
airway inflammation, highlighting the possibility of RONS in inducing 
DNA damage in asthmatic airways. The levels of DNA repair proteins 
such as KU70 and RAD51 are elevated in asthmatic lung, suggesting 
the involvement of NHEJ and HR DNA DSB repair pathways in asthma. 
Inhibition of DNA repair by NU7441, a DNA-PK inhibitor, leads to 
worsening of DNA damage in the bronchial epithelium and 
augmentation in lung cell apoptosis. I have also shown that defect in 
DNA repair exacerbates inflammatory responses and enhances cell 
death in allergen-challenged bronchial epithelial cells. My results 
suggest a possible role of DNA repair in preventing asthma 
pathophysiology. To the best of our knowledge, only four prior studies 
have tried to demonstrate the direct link between asthma and DNA 
damage (Chapmana et al., 2014; Dilek et al., 2015; Hasbal et al., 2010; 
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Zeyrek et al., 2009).  However, none of these studies shows evidence 
that HDM can directly induce bronchial epithelium DNA damage, both 
in vivo and in vitro.  
 
In my first project, I have demonstrated (1) the involvement of DNA 
DSBs in bronchial epithelium in asthma, and (2) DNA repair is 
important in suppressing allergen-induced inflammatory responses and 
cell death in bronchial epithelial cell. This project has illustrated the 
genotoxic potential of aeroallergens and leads me to further investigate 
it physiological consequences in Chapter 4.  This study has also 
unveiled that inefficient DNA repair may potentiate inflammation 
responses. Over time, genetically susceptible asthma patients who 
suffer from deficiency in DNA repair may have a higher tendency to 
develop severe asthma. Modulating DNA repair pathway could be a 
potential avenue to mitigate inflammation-associated DNA damage.  
 
Seeking to highlight the detrimental impact of DNA damaging 
aeroallergens on asthma in vitro, I investigated the DNA damage 
potential of direct HDM action on isolated human bronchial epithelial 
cells in Chapter 4. My studies reveal for the first time that HDM can 
directly induce DNA damage in human bronchial epithelial cells through 
the production of RONS with concurrent increases in cellular nitrosative 
and mitochondrial oxidative stresses. I have also observed that HDM 
exposure can dampen antioxidant responses in epithelial cells, and 
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prolonged HDM exposure can reduce cell viability and cause cell death. 
My findings highlight the direct genotoxic and cytotoxic potential of 
HDM on bronchial epithelial cells. More importantly, I have 
demonstrated that these DNA damaging effects of HDM can be 
prevented by treatment with antioxidants, such as the glutathione or 
catalase, thus supporting a therapeutic role for antioxidants in 
preventing aeroallergen-induced genotoxicity in airway cells.  
 
To test if antioxidant therapy can be a potential treatment option for 
asthma, I explored the use of artesunate, an anti-malarial drug with 
antioxidant property (Ho et al., 2014), to mitigate HDM-induced DNA 
damage in Chapter 5. I have observed that artesunate treatment can 
significantly reduce HDM-induced airway inflammation and more 
importantly, artesunate protects bronchial epithelium from DNA DSBs 
induced in asthma. Moreover, artesunate is able to decrease cell death 
in allergic airway, suggesting that artesunate may be able to prevent 
excessive epithelial cell loss in asthma. Artesunate does not alter the 
levels of DNA repair protein KU70 and RAD51 suggesting that 
artesunate does not directly regulate NHEJ and HR DNA DSB repair 
pathways. In vitro, artesunate is unable to prevent DNA damage 
induced by direct HDM exposure in bronchial epithelial cells. Hence, 
the genome protective effects of artesunate may be attributed to its 
immunomodulatory properties and via the reduction of oxidative stress 
and inflammation. This study reveals new usage of artesunate, which 
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potentially can be used to protect cells from the genotoxic effects of 
other environmental insults, such as chemical exposure or X-ray; 
hence, further studies are warranted.  
Table 6A: Summary of Key Findings from Project 1 
Chapter 3: House Dust Mite-induced Asthma Causes Oxidative 
Damage and DNA Double Strand Breaks in the Lungs 
We have demonstrated that: 
• HDM induces airway eosinophilic inflammation 
• HDM induces airway oxidative damage 
• DNA DSBs are evident in lung tissues from human asthma 
• HDM directly induces DNA DSBs in human bronchial epithelial 
cells 
• HDM induces ROS formation in human bronchial epithelial cells 
• Asthma increases lung levels of DNA repair proteins 
• NU7441 inhibition of NHEJ augments DNA DSBs in allergic 
airways 
• NU7441 inhibition of NHEJ altered DNA repair proteins level 
• NU7441 augments HDM-induced cytokine production in 
bronchial epithelial cells  
• NU7441 enhances HDM-induced cell death in bronchial epithelial 
cells 
• NU7441 enhances allergic airway inflammation-induced 




Table 6B: Summary of Key Findings from Project 2 
Chapter 4: Aeroallergens Induce ROS Production and DNA Damage, 
and Dampen Antioxidant Responses in Bronchial Epithelial Cells 
We have demonstrated that: 
• Aeroallergens induce DNA damage in human bronchial 
epithelial cells 
• HDM induces DNA DSBs in human bronchial epithelial cells 
• HDM induces ROS level in human bronchial epithelial cells 
• HDM increases iNOS expression and nitrite (NO2-) secretion in 
bronchial epithelial cells 
• HDM induces Nrf2 nuclear translocation and modulate 
antioxidant gene expression in bronchial epithelial cells 
• HDM reduces cell proliferation and causes cell death  






Table 6C: Summary of Key Findings from PhD Project 3 
Chapter 5: Anti-malaria Drug Artesunate Protects Bronchial Epithelium 
from DNA Damage Induced by Asthma 
We have demonstrated that: 
• Artesunate ameliorates airway inflammation in HDM-induced 
experimental asthma model 
• Artesunate reduces lung DNA DSBs induced by HDM exposure 
• Artesunate retains the levels of DNA repair proteins in whole 
lung lysate of asthmatic mice 
• Artesunate decreases cell death and asthma-induced caspase-3 
activation 
• Artesunate is unable to protect bronchial epithelial from DNA 




6.2 Limitations and Future Work 
It is important to point out some major limitations of our studies. There 
are five possible areas for improvement in term of our approaches to 
study the interaction between aeroallergens and host cells. In addition, 
we propose alternative models to further test our hypothesis. We 
believe that by overcoming those limitations, this newfound knowledge 
will be useful in identifying novel strategy against asthma. 
 
6.2.1 Animal model 
In my studies, I developed an acute asthma mouse model by exposing 
mouse to HDM once a week for three weeks. Acute asthma mouse 
model reproduces many key clinical asthma phenotypes such as the 
elevated level of IgE, airway inflammation, eosinophilia, mucus 
hypersecretion, smooth muscle thickening, Th-2 skewed immunity and 
airway hyperresponsiveness (Nials and Uddin, 2008). However, due to 
short-term nature of the acute model, many of the lesions observed in 
chronic asthma such as structural changes in the airway, subepithelial 
and airway wall fibrosis which also known as “airway remodeling” are 
not fully captured (Nials and Uddin, 2008). Asthma is a chronic 
inflammatory disease resulted from continued or intermittent allergen 
exposure, which can also be exacerbated by environmental factors 
such as respiratory virus infection or air pollutants (Barnes, 2008; Nials 
and Uddin, 2008). For example, viral infections by rhinovirus, 
				
193 
respiratory syncytial virus, adenovirus or influenza virus are common 
causes of asthma exacerbation (Lambrecht and Hammad, 2015). 
Virus-induced asthma exacerbation remains as a major problem for 
asthma therapy. Hence, to better understand oxidative damage, DNA 
damage and repair underlying chronic inflammation and airway 
remodeling, which are currently poorly understood, a chronic 
experimental asthma model or an asthma exacerbation model should 
be considered in the future.  
 
6.2.2 The paradox of using NU7441 as a DNA repair inhibitor  
A second aspect of our studies worthy of further consideration is the 
use of the DNA-PK inhibitor NU7441 to study DNA repair in the asthma 
mouse model (Chapter 3). In my studies, I used both in vivo and in vitro 
models to elucidate the effects of DNA repair inhibition on bronchial 
epithelial cells. Both approaches suggest the importance of DNA repair 
in maintaining the integrity of bronchial epithelium in asthma. 
 
1) In vivo, inhibition of DNA-PK by NU7441 increased DNA DSBs 
in bronchial epithelial cells. At the same time, the level of lung 





2) In vitro, NU7441 augmented Th2-cytokines productions in cells 
exposed to HDM. In addition, NU7441 enhanced HDM-induced 
bronchial epithelial cell death.  
 
However, in addition to its role in NHEJ repair of DNA DSBs, DNA-PK 
also plays crucial roles in maintaining lymphocytes V(D)J 
recombination and immunoglobulin class switch recombination 
(Jackson and Jeggo, 1995). Inhibition of DNA-PK not only inhibits both 
DNA repair but also inhibits T and B cell maturation. As these immune 
cells are the main players in asthma development (van der Burg et al., 
2009), it is not surprising that two other studies have revealed the 
inhibitory effects of NU7441 on airway inflammation and AHR, which 
are considered to be beneficial to asthma recovery (Ghonim et al., 
2015; Mishra et al., 2015). NU7441 could be inhibiting the development 
of T cells and the activation of dendritic cells, which subsequently 
attenuate Th2 inflammation (Ghonim et al., 2015; Mishra et al., 2015). 
However, these two studies primarily evaluated the potential 
immunomodulatory effects NU7441 on inflammatory response in 
asthma while, my studies focused on its DNA repair inhibitory effect in 
the asthmatic bronchial epithelium, inasmuch as the airway epithelium 
is the primary site for asthma development. 
 
Inhibition of DNA repair by NU7441 leads to bronchial epithelial cell 
death, potentially attributed to overwhelmed DNA damage as a result of 
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inefficient DNA repair. Extensive bronchial epithelium cell death could 
lead to impairment of barrier function (Erle and Sheppard, 2014). 
Knowing that airway epithelium is an important physical barrier in 
preventing the invasion of respiratory viruses, using NU7441 to treat 
asthma, may cause undesired side effects.  One possible side effect of 
long-term usage of NU7441 in asthma treatment could be the 
increased risk of asthma exacerbation by respiratory virus infection, 
due to easier penetration of virus into the airway. This could render its 
potential to be used as a long-term treatment regime in asthma.  
 
For future studies, I may consider using genetic modified mice, such as 
mice with targeted disruption in genes that encode DNA repair proteins 
DNA-PKcs, KU70 or KU80, to fully elucidate the impact of NHEJ 
deficiency in disease development. However, many of these mice have 
severe combined immunodeficiency (SCID) (Featherstone and Jackson, 
1999; Gu et al., 1997; Taccioli et al., 1998). Hence, it may not be the 
best option to use these mice to study inflammation-related disease. 
Using DNA repair-deficient lung epithelial cell lines is another plausible 
option used to study the role of DNA repair in asthma development, for 
example, the KU70-deficient lung epithelial cells (Koike et al., 2011). 
Another approach is to employ targeted genome editing technology 
such as the clustered, regularly interspaced, short palindromic repeat 
(CRISPR) to study the impact of DNA repair deficiency in specific cell 
type.  CRISPR-Cas9, which uses RNA-guided Cas9 nuclease, enables 
				
196 
easy and efficient modification of endogenous DNA repair genes in 
cells and in organism (Ran et al., 2013).   
 
6.2.3 Components in HDM 
 The exact components of the HDM that cause DNA damage are 
undetermined. However, it is known that the allergenic potential of 
HDM rests mainly with the mites themselves and with their fecal pellets 
(Gregory and Lloyd, 2011). The various components of HDM, and their 
associated fecal pellets and dust, can activate the immune system to 
initiate the inflammatory response. These components include allergen 
proteins that contain immunogenic epitopes, fungal spores, chitin, fecal 
pellets and LPS. In Chapter 4, I have demonstrated HDM induces DNA 
damage in human bronchial epithelial cells, potentially through the 
increased production of genotoxic RONS and weakening of antioxidant 
responses. However, the specific mechanism on how HDM leads to 
increase RONS production in cells remained to be elucidated. Despite 
the missing information gap, I have shown the possibility of using 
antioxidant to protect airway cells from genotoxic effects of HDM. One 
way to overcome this is to perform a component-resolved diagnosis of 
HDM extract to identify the exact component that contribute to the DNA 
damaging effects seen in bronchial epithelial cells. Another way is to 
obtain purified or recombinant Der p allergens (HDM is also known as 
Dermatophagoides pteronyssinus) and test their impacts in asthma 
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development. Knowing the exact HDM components that cause the 
genotoxicity in cells enables the design of better therapeutic strategy to 
counteract these damaging effects.  
 
6.2.4 Interaction between immune cells and epithelial cells 
The forth limitation is the use of in vitro systems that focus only on 
bronchial epithelial cells, hence, fail to fully reflect the complex 
interactions between the lung resident cells and the innate and 
adaptive immunity. During asthma attacks, the lung microenvironment 
is infiltrated with different immune cells, which are activated by 
cytokines or chemokine released by the epithelial cells, or activated 
directly by allergen (Lambrecht and Hammad, 2015). These immune 
cells secrete genotoxic RONS that are capable of damaging lung 
resident cells. Nevertheless, in my in vitro studies, I studied the direct 
impact of aeroallergen exposure on bronchial epithelial cells but not the 
effects of immune activation.  
 
In order to investigate the contribution of specific immune cells in 
causing bronchial epithelium damage as observed in vivo asthma lung 
tissue, I propose to employ a platform in which epithelial cells are co-
cultured with immune cells. Inflammatory cells such as eosinophils and 
neutrophils, both abundant in asthmatic lung are active producers of 
RONS (Hoshino et al., 2008). Human bronchial epithelial cells can be 
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co-cultured with human eosinophils or neutrophils (Liu et al., 2014; 
Wang et al., 2005). Even though catalase and glutathione have been 
shown to counter the DNA damaging effects of HDM in bronchial 
epithelial cells, it is unclear the intervention will still work in the 
presence of eosinophils or neutrophils. Thus, this platform would serve 
to test the effectiveness of antioxidants to protect bronchial epithelium. 
 
6.2.5 Artesunate dosage and solvent 
In Chapter 6, I studied the potential of artesunate in mitigating HDM-
induced DNA damage in bronchial epithelium in vivo and in vitro. In the 
study, I chose a single dose of artesunate (30 mg/kg), based on what 
has previously been shown to be efficient in reducing airway 
inflammation and ameliorate oxidative stress in experimental asthma 
model (Cheng et al., 2011; Ho et al., 2012). However, toxicology 
studies of artesunate have demonstrated good safety profile in animal, 
and minimal side effects can only be seen at dosage above 200 mg/kg. 
This means that our studies may not have leveraged the most effective 
dosage range of artesunate. In future studies, a dose-dependent study 
should be conducted, which includes a higher dosage of artesunate, to 
be used to study its therapeutic effects in disease models. 
 
Moreover, in my studies, artesunate is dissolved in DMSO, one of the 
most commonly used solvents in drug study. However, I have observed 
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that DMSO treatment alone contributes to some genome protective 
effects in asthma mouse model (Chapter 5, Figure 5.02). This suggests 
that using DMSO as drug solvent could be a potential confounding 
factor in my studies. Hence, for future studies, we may consider using 
another drug solvent, sodium bicarbonate to dissolve artesunate. When 
artesunate is administered to patients infected by falciparum malaria, 
as an anti-malarial agent, it is dissolved in sodium biocarbonate. Hence, 
using sodium bicarbonate to dissolve artesunate has proven to provide 
good safety and pharmacokinetic profiles. This is the next best option 
to study the genome protective effects of artesunate in asthma, at the 
same time, avoiding the confounding effects of using DMSO.  
 
6.3 Conclusions 
In conclusion, this thesis has shown the dynamic interaction between 
aeroallergen HDM and airway cells, especially the bronchial epithelium. 
I have proposed the potential mechanisms of DNA damage induced by 
HDM on airway cells, and the biological consequences of these 
genotoxic and cytotoxic effects on lung resident cells. Finally, I 
proposed that antioxidants could be effective in protecting airways from 
the damaging effects of HDM. This PhD thesis has provided insights 





Adcock, I.M., Caramori, G., and Chung, K.F. (2008). New targets for 
drug development in asthma. Lancet 372, 1073-1087. 
 
Aguilera-Aguirre, L., Bacsi, A., Saavedra-Molina, A., Kurosky, A., Sur, 
S., and Boldogh, I. (2009). Mitochondrial dysfunction increases allergic 
airway inflammation. Journal of immunology 183, 5379-5387. 
 
Ahlstrom-Emanuelsson, C.A., Greiff, L., Andersson, M., Persson, C.G., 
and Erjefalt, J.S. (2004). Eosinophil degranulation status in allergic 
rhinitis: observations before and during seasonal allergen exposure. 
The European respiratory journal 24, 750-757. 
 
Allahverdian, S., Harada, N., Singhera, G.K., Knight, D.A., and 
Dorscheid, D.R. (2008). Secretion of IL-13 by airway epithelial cells 
enhances epithelial repair via HB-EGF. Am J Respir Cell Mol Biol 38, 
153-160. 
 
Allen, S., Britton, J.R., and Leonardi-Bee, J.A. (2009). Association 
between antioxidant vitamins and asthma outcome measures: 
systematic review and meta-analysis. Thorax 64, 610-619. 
 
Anderson, G.P. (2008). Endotyping asthma: new insights into key 
pathogenic mechanisms in a complex, heterogeneous disease. Lancet 
372, 1107-1119. 
 
Andiappan, A.K., Puan, K.J., Lee, B., Nardin, A., Poidinger, M., 
Connolly, J., Chew, F.T., Wang, D.Y., and Rotzschke, O. (2014). 
Allergic airway diseases in a tropical urban environment are driven by 
dominant mono-specific sensitization against house dust mites. Allergy 
69, 501-509. 
 
Antczak, A., Nowak, D., Shariati, B., Krol, M., Piasecka, G., and 
Kurmanowska, Z. (1997). Increased hydrogen peroxide and 
thiobarbituric acid-reactive products in expired breath condensate of 
asthmatic patients. The European respiratory journal 10, 1235-1241. 
 
Aoshiba, K., Zhou, F., Tsuji, T., and Nagai, A. (2012). DNA damage as 
a molecular link in the pathogenesis of COPD in smokers. The 
European respiratory journal 39, 1368-1376. 
 
Arbes, S.J., Cohn, R.D., Yin, M., Muilenberg, M.L., Burge, H.A., 
Friedman, W., and Zeldin, D.C. (2003). House dust mite allergen in US 
beds: Results from the first National Survey of Lead and Allergens in 




Aylon, Y., and Kupiec, M. (2004). New insights into the mechanism of 
homologous recombination in yeast. Mutation research 566, 231-248. 
 
Aziz, K., Nowsheen, S., Pantelias, G., Iliakis, G., Gorgoulis, V.G., and 
Georgakilas, A.G. (2012). Targeting DNA damage and repair: 
embracing the pharmacological era for successful cancer therapy. 
Pharmacology & therapeutics 133, 334-350. 
 
Bacsi, A., Dharajiya, N., Choudhury, B.K., Sur, S., and Boldogh, I. 
(2005). Effect of pollen-mediated oxidative stress on immediate 
hypersensitivity reactions and late-phase inflammation in allergic 
conjunctivitis. The Journal of allergy and clinical immunology 116, 836-
843. 
 
Banerjee, M., Kang, K.H., Morrow, J.D., Roberts, L.J., and Newman, 
J.H. (1992). Effects of a novel prostaglandin, 8-epi-PGF2 alpha, in 
rabbit lung in situ. The American journal of physiology 263, H660-663. 
 
Bao, Z., Guan, S., Cheng, C., Wu, S., Wong, S.H., Kemeny, D.M., 
Leung, B.P., and Wong, W.S. (2009). A novel antiinflammatory role for 
andrographolide in asthma via inhibition of the nuclear factor-kappaB 
pathway. American journal of respiratory and critical care medicine 179, 
657-665. 
 
Baraldi, E., Carraro, S., Alinovi, R., Pesci, A., Ghiro, L., Bodini, A., 
Piacentini, G., Zacchello, F., and Zanconato, S. (2003). Cysteinyl 
leukotrienes and 8-isoprostane in exhaled breath condensate of 
children with asthma exacerbations. Thorax 58, 505-509. 
 
Baritaud, M., Cabon, L., Delavallee, L., Galan-Malo, P., Gilles, M.E., 
Brunelle-Navas, M.N., and Susin, S.A. (2012). AIF-mediated caspase-
independent necroptosis requires ATM and DNA-PK-induced histone 
H2AX Ser139 phosphorylation. Cell death & disease 3, e390. 
 
Barnes, P.J. (2008). Immunology of asthma and chronic obstructive 
pulmonary disease. Nature reviews Immunology 8, 183-192. 
 
Barnes, P.J. (2012). Severe asthma: advances in current management 
and future therapy. The Journal of allergy and clinical immunology 129, 
48-59. 
 
Barnes, P.J., Drazen, J.M., Rennard, S.I., Thomson, N.C., and 
Rahman, I. (2009). Asthma and COPD: Basic Mechanisms and Clinical 
Management. In Reactive Oxygen Species and Antioxidant 




Barnett, S.B., and Nurmagambetov, T.A. (2011). Costs of asthma in 
the United States: 2002-2007. The Journal of allergy and clinical 
immunology  127, 145-152. 
 
Bartek, J., and Lukas, J. (2007). DNA damage checkpoints: from 
initiation to recovery or adaptation. Current opinion in cell biology 19, 
238-245. 
 
Berdelle, N., Nikolova, T., Quiros, S., Efferth, T., and Kaina, B. (2011). 
Artesunate induces oxidative DNA damage, sustained DNA double-
strand breaks, and the ATM/ATR damage response in cancer cells. 
Molecular cancer therapeutics 10, 2224-2233. 
 
Berkun, Y., Vilozni, D., Levi, Y., Borik, S., Waldman, D., Somech, R., 
Nissenkorn, A., and Efrati, O. (2010). Reversible airway obstruction in 
children with ataxia telangiectasia. Pediatr Pulmonol 45, 230-235. 
 
Biernacki, W.A., Kharitonov, S.A., and Barnes, P.J. (2003). Increased 
leukotriene B4 and 8-isoprostane in exhaled breath condensate of 
patients with exacerbations of COPD. Thorax 58, 294-298. 
 
Biswas, S.K., and Rahman, I. (2009). Environmental toxicity, redox 
signaling and lung inflammation: the role of glutathione. Mol Aspects 
Med 30, 60-76. 
 
Blakey, J.D., Woolnough, K., Fellows, J., Walker, S., Thomas, M., and 
Pavord, I.D. (2013). Assessing the risk of attack in the management of 
asthma: a review and proposal for revision of the current control-
centred paradigm. Primary care respiratory journal : journal of the 
General Practice Airways Group 22, 344-352. 
 
Boldogh, I., Bacsi, A., Choudhury, B.K., Dharajiya, N., Alam, R., Hazra, 
T.K., Mitra, S., Goldblum, R.M., and Sur, S. (2005). ROS generated by 
pollen NADPH oxidase provide a signal that augments antigen-induced 
allergic airway inflammation. Journal of Clinical Investigation 115, 
2169-2179. 
 
Borish, L., and Culp, J.A. (2008). Asthma: a syndrome composed of 
heterogeneous diseases. Annals of allergy, asthma & immunology : 
official publication of the American College of Allergy, Asthma, & 
Immunology 101, 1-8; quiz 8-11, 50. 
 
Bott, L., Lebreton, J., Thumerelle, C., Cuvellier, J., Deschildre, A., and 
Sardet, A. (2007). Lung disease in ataxia-telangiectasia. Acta 




Bradding, P., Walls, A.F., and Holgate, S.T. (2006). The role of the 
mast cell in the pathophysiology of asthma. The Journal of allergy and 
clinical immunology 117, 1277-1284. 
 
Braman, S.S. (2006). The global burden of asthma. Chest 130, 4S-12S. 
 
Branzei, D., and Foiani, M. (2008). Regulation of DNA repair 
throughout the cell cycle. Nature reviews Molecular cell biology 9, 297-
308. 
 
Brennan, M.L., Wu, W., Fu, X., Shen, Z., Song, W., Frost, H., Vadseth, 
C., Narine, L., Lenkiewicz, E., Borchers, M.T., et al. (2002). A tale of 
two controversies: defining both the role of peroxidases in nitrotyrosine 
formation in vivo using eosinophil peroxidase and myeloperoxidase-
deficient mice, and the nature of peroxidase-generated reactive 
nitrogen species. J Biol Chem 277, 17415-17427. 
 
Brown, K.D., Lataxes, T.A., Shangary, S., Mannino, J.L., Giardina, J.F., 
Chen, J., and Baskaran, R. (2000). Ionizing radiation exposure results 
in up-regulation of Ku70 via a p53/ataxia-telangiectasia-mutated 
protein-dependent mechanism. J Biol Chem 275, 6651-6656. 
 
Bucchieri, F., Puddicombe, S.M., Lordan, J.L., Richter, A., Buchanan, 
D., Wilson, S.J., Ward, J., Zummo, G., Howarth, P.H., Djukanovic, R., 
et al. (2002). Asthmatic bronchial epithelium is more susceptible to 
oxidant-induced apoptosis. American journal of respiratory cell and 
molecular biology 27, 179-185. 
 
Bush, A., and Zar, H.J. (2011). WHO universal definition of severe 
asthma. Current opinion in allergy and clinical immunology 11, 115-121. 
 
Busse, W.W., Lemanske, R.F., Jr., and Gern, J.E. (2010). Role of viral 
respiratory infections in asthma and asthma exacerbations. Lancet 376, 
826-834. 
 
Caldecott, K.W. (2008). Single-strand break repair and genetic disease. 
Nature reviews Genetics 9, 619-631. 
 
Calderon, M.A., Linneberg, A., Kleine-Tebbe, J., De Blay, F., 
Hernandez Fernandez de Rojas, D., Virchow, J.C., and Demoly, P. 
(2015). Respiratory allergy caused by house dust mites: What do we 
really know? The Journal of allergy and clinical immunology 136, 38-48. 
 
Campbell, C., and Romero, D.P. (1998). Identification and 
characterization of the RAD51 gene from the ciliate Tetrahymena 




Castro, M., Rubin, A.S., Laviolette, M., Fiterman, J., De Andrade Lima, 
M., Shah, P.L., Fiss, E., Olivenstein, R., Thomson, N.C., Niven, R.M., 
et al. (2010). Effectiveness and safety of bronchial thermoplasty in the 
treatment of severe asthma: a multicenter, randomized, double-blind, 
sham-controlled clinical trial. American journal of respiratory and critical 
care medicine 181, 116-124. 
 
Caughey, G.H. (2007). Mast cell tryptases and chymases in 
inflammation and host defense. Immunological reviews 217, 141-154. 
 
Chapman, J.R., Taylor, M.R., and Boulton, S.J. (2012). Playing the end 
game: DNA double-strand break repair pathway choice. Mol Cell 47, 
497-510. 
 
Chapmana, A.M., Malkin, D.J., Camacho, J., and Schiestl, R.H. (2014). 
IL-13 overexpression in mouse lungs triggers systemic genotoxicity in 
peripheral blood. Mutation research 769, 100-107. 
 
Chen, H.T., Bhandoola, A., Difilippantonio, M.J., Zhu, J., Brown, M.J., 
Tai, X., Rogakou, E.P., Brotz, T.M., Bonner, W.M., Ried, T., et al. 
(2000). Response to RAG-mediated VDJ cleavage by NBS1 and 
gamma-H2AX. Science 290, 1962-1965. 
 
Cheng, C., Ho, W.E., Goh, F.Y., Guan, S.P., Kong, L.R., Lai, W.Q., 
Leung, B.P., and Wong, W.S. (2011). Anti-malarial drug artesunate 
attenuates experimental allergic asthma via inhibition of the 
phosphoinositide 3-kinase/Akt pathway. PloS one 6, e20932. 
 
Cheng, C., Ng, D.S., Chan, T.K., Guan, S.P., Ho, W.E., Koh, A.H., Bian, 
J.S., Lau, H.Y., and Wong, W.S. (2013). Anti-allergic action of anti-
malarial drug artesunate in experimental mast cell-mediated 
anaphylactic models. Allergy 68, 195-203. 
 
Chilosi, M., Carloni, A., Rossi, A., and Poletti, V. (2013). Premature 
lung aging and cellular senescence in the pathogenesis of idiopathic 
pulmonary fibrosis and COPD/emphysema. Translational research : 
the journal of laboratory and clinical medicine 162, 156-173. 
 
Chung, K.F., and Marwick, J.A. (2010). Molecular mechanisms of 
oxidative stress in airways and lungs with reference to asthma and 
chronic obstructive pulmonary disease. Ann N Y Acad Sci 1203, 85-91. 
 
Ciencewicki, J., Trivedi, S., and Kleeberger, S.R. (2008). Oxidants and 
the pathogenesis of lung diseases. The Journal of allergy and clinical 




Cohen, L., E, X., Tarsi, J., Ramkumar, T., Horiuchi, T.K., Cochran, R., 
DeMartino, S., Schechtman, K.B., Hussain, I., Holtzman, M.J., et al. 
(2007). Epithelial cell proliferation contributes to airway remodeling in 
severe asthma. American journal of respiratory and critical care 
medicine 176, 138-145. 
 
Collins, J.A., Schandi, C.A., Young, K.K., Vesely, J., and Willingham, 
M.C. (1997). Major DNA fragmentation is a late event in apoptosis. J 
Histochem Cytochem 45, 923-934. 
 
Comhair, S.A., Bhathena, P.R., Dweik, R.A., Kavuru, M., and Erzurum, 
S.C. (2000). Rapid loss of superoxide dismutase activity during 
antigen-induced asthmatic response. Lancet 355, 624. 
 
Comhair, S.A., and Erzurum, S.C. (2002). Antioxidant responses to 
oxidant-mediated lung diseases. Am J Physiol Lung Cell Mol Physiol 
283, L246-255. 
 
Comhair, S.A., and Erzurum, S.C. (2010). Redox control of asthma: 
molecular mechanisms and therapeutic opportunities. Antioxidants & 
redox signaling 12, 93-124. 
 
Cookson, W. (1999). The alliance of genes and environment in asthma 
and allergy. Nature 402, B5-11. 
 
Cookson, W. (2004). The immunogenetics of asthma and eczema: a 
new focus on the epithelium. Nature reviews Immunology 4, 978-988. 
 
Corradi, M., Folesani, G., Andreoli, R., Manini, P., Bodini, A., Piacentini,  
G., Carraro, S., Zanconato, S., and Baraldi, E. (2003). Aldehydes and 
glutathione in exhaled breath condensate of children with asthma 
exacerbation. American journal of respiratory and critical care medicine 
167, 395-399. 
 
Croisant, S. (2014). Epidemiology of asthma: prevalence and burden of 
disease. Advances in experimental medicine and biology 795, 17-29. 
 
Cui, H., Kong, Y., and Zhang, H. (2012). Oxidative stress, 
mitochondrial dysfunction, and aging. Journal of signal transduction 
2012, 646354. 
 
d'Adda di Fagagna, F. (2008). Living on a break: cellular senescence 
as a DNA-damage response. Nature reviews Cancer 8, 512-522. 
 
Daugas, E., Susin, S.A., Zamzami, N., Ferri, K.F., Irinopoulou, T., 
Larochette, N., Prevost, M.C., Leber, B., Andrews, D., Penninger, J., et 
al. (2000). Mitochondrio-nuclear translocation of AIF in apoptosis and 
				
206 
necrosis. FASEB journal : official publication of the Federation of 
American Societies for Experimental Biology 14, 729-739. 
 
Davis, A.J., Chen, B.P., and Chen, D.J. (2014). DNA-PK: a dynamic 
enzyme in a versatile DSB repair pathway. DNA Repair (Amst) 17, 21-
29. 
 
De Alba, J., Raemdonck, K., Dekkak, A., Collins, M., Wong, S., Nials, 
A.T., Knowles, R.G., Belvisi, M.G., and Birrell, M.A. (2010). House dust 
mite induces direct airway inflammation in vivo: implications for future 
disease therapy? Eur Respir J 35, 1377-1387. 
 
De Raeve, H.R., Thunnissen, F.B., Kaneko, F.T., Guo, F.H., Lewis, M., 
Kavuru, M.S., Secic, M., Thomassen, M.J., and Erzurum, S.C. (1997). 
Decreased Cu,Zn-SOD activity in asthmatic airway epithelium: 
correction by inhaled corticosteroid in vivo. The American journal of 
physiology 272, L148-154. 
 
De Zio, D., Bordi, M., Tino, E., Lanzuolo, C., Ferraro, E., Mora, E., 
Ciccosanti, F., Fimia, G.M., Orlando, V., and Cecconi, F. (2011). The 
DNA repair complex Ku70/86 modulates Apaf1 expression upon DNA 
damage. Cell Death Differ 18, 516-527. 
 
Deckers, J., Branco Madeira, F., and Hammad, H. (2013). Innate 
immune cells in asthma. Trends in immunology 34, 540-547. 
 
Dedon, P.C., and Tannenbaum, S.R. (2004). Reactive nitrogen species 
in the chemical biology of inflammation. Archives of biochemistry and 
biophysics 423, 12-22. 
 
Devereux, G. (2006). The increase in the prevalence of asthma and 
allergy: food for thought. Nature reviews Immunology 6, 869-874. 
 
Dilek, F., Ozkaya, E., Kocyigit, A., Yazici, M., Kesgin, S., Gedik, A.H., 
and Cakir, E. (2015). Effect of montelukast monotherapy on oxidative 
stress parameters and DNA damage in children with asthma. 
International archives of allergy and immunology 167, 119-126. 
 
Dohlman, A.W., Black, H.R., and Royall, J.A. (1993). Expired breath 
hydrogen peroxide is a marker of acute airway inflammation in pediatric 
patients with asthma. The American review of respiratory disease 148, 
955-960. 
 
Douwes, J., Gibson, P., Pekkanen, J., and Pearce, N. (2002). Non-





Druilhe, A., Letuve, S., and Pretolani, M. (2003). Glucocorticoid-
induced apoptosis in human eosinophils: mechanisms of action. 
Apoptosis : an international journal on programmed cell death 8, 481-
495. 
 
Dworski, R. (2000). Oxidant stress in asthma. Thorax 55 Suppl 2, S51-
53. 
 
Eiberger, W., Volkmer, B., Amouroux, R., Dherin, C., Radicella, J.P., 
and Epe, B. (2008). Oxidative stress impairs the repair of oxidative 
DNA base modifications in human skin fibroblasts and melanoma cells. 
DNA Repair (Amst) 7, 912-921. 
 
Ekstrand-Hammarstrom, B., Osterlund, C., Lilliehook, B., and Bucht, A. 
(2007). Vitamin E down-modulates mitogen-activated protein kinases, 
nuclear factor-kappaB and inflammatory responses in lung epithelial 
cells. Clinical and experimental immunology 147, 359-369. 
 
Elmore, S. (2007). Apoptosis: a review of programmed cell death. 
Toxicologic pathology 35, 495-516. 
 
Ennis, M. (2003). Neutrophils in asthma pathophysiology. Current 
allergy and asthma reports 3, 159-165. 
 
Ercan, H., Birben, E., Dizdar, E.A., Keskin, O., Karaaslan, C., Soyer, 
O.U., Dut, R., Sackesen, C., Besler, T., and Kalayci, O. (2006). 
Oxidative stress and genetic and epidemiologic determinants of oxidant 
injury in childhood asthma. The Journal of allergy and clinical 
immunology 118, 1097-1104. 
 
Erle, D.J., and Sheppard, D. (2014). The cell biology of asthma. The 
Journal of cell biology 205, 621-631. 
 
Ethier, C., and Davoine, F. (2013). A gap in cell death knowledge: is 
necroptosis of eosinophils involved in allergic airway inflammation? OA 
Inflammation 1, 9. 
 
Fahlbusch, B., Koch, A., Douwes, J., Bischof, W., Gehring, U., Richter, 
K., Wichmann, H.E., and Heinrich, J. (2003). The effect of storage on 
allergen and microbial agent levels in frozen house dust. Allergy 58, 
150-153. 
 
Fahy, J.V. (2009). Eosinophilic and neutrophilic inflammation in 
asthma: insights from clinical studies. Proceedings of the American 




Fahy, J.V. (2015). Type 2 inflammation in asthma--present in most, 
absent in many. Nature reviews Immunology 15, 57-65. 
 
Fahy, J.V., and Locksley, R.M. (2011). The airway epithelium as a 
regulator of Th2 responses in asthma. American journal of respiratory 
and critical care medicine 184, 390-392. 
 
Fariss, M.W., Chan, C.B., Patel, M., Van Houten, B., and Orrenius, S. 
(2005). Role of mitochondria in toxic oxidative stress. Molecular 
interventions 5, 94-111. 
 
Featherstone, C., and Jackson, S.P. (1999). DNA double-strand break 
repair. Current biology : CB 9, R759-761. 
 
Fedorov, I.A., Wilson, S.J., Davies, D.E., and Holgate, S.T. (2005). 
Epithelial stress and structural remodelling in childhood asthma. 
Thorax 60, 389-394. 
 
Finkel, T., and Holbrook, N.J. (2000). Oxidants, oxidative stress and 
the biology of ageing. Nature 408, 239-247. 
 
Franco, R., and Cidlowski, J.A. (2009). Apoptosis and glutathione: 
beyond an antioxidant. Cell death and differentiation 16, 1303-1314. 
 
Frosina, G. (2007). Gene prophylaxis by a DNA repair function. Mol 
Aspects Med 28, 323-344. 
 
Fulkerson, P.C., and Rothenberg, M.E. (2013). Targeting eosinophils in 
allergy, inflammation and beyond. Nature reviews Drug discovery 12, 
117-129. 
 
Galli, S.J., Tsai, M., and Piliponsky, A.M. (2008). The development of 
allergic inflammation. Nature 454, 445-454. 
 
Ge, J., Chow, D.N., Fessler, J.L., Weingeist, D.M., Wood, D.K., and 
Engelward, B.P. (2015). Micropatterned comet assay enables high 
throughput and sensitive DNA damage quantification. Mutagenesis 30, 
11-19. 
 
Ge, J., Prasongtanakij, S., Wood, D.K., Weingeist, D.M., Fessler, J., 
Navasummrit, P., Ruchirawat, M., and Engelward, B.P. (2014). 
CometChip: a high-throughput 96-well platform for measuring DNA 
damage in microarrayed human cells. Journal of visualized 
experiments : JoVE, e50607. 
 
Ghonim, M.A., Pyakurel, K., Ju, J., Rodriguez, P.C., Lammi, M.R., 
Davis, C., Abughazleh, M.Q., Mansy, M.S., Naura, A.S., and Boulares, 
				
209 
A.H. (2015). DNA-dependent protein kinase inhibition blocks asthma in 
mice and modulates human endothelial and CD4(+) T-cell function 
without causing severe combined immunodeficiency. The Journal of 
allergy and clinical immunology 135, 425-440. 
 
Ghosh, S., Hoselton, S.A., Dorsam, G.P., and Schuh, J.M. (2013). 
Eosinophils in fungus-associated allergic pulmonary disease. Frontiers 
in pharmacology 4, 8. 
 
Gibson, B.A., and Kraus, W.L. (2012). New insights into the molecular 
and cellular functions of poly(ADP-ribose) and PARPs. Nat Rev Mol 
Cell Biol 13, 411-424. 
 
Gorrini, C., Harris, I.S., and Mak, T.W. (2013). Modulation of oxidative 
stress as an anticancer strategy. Nature reviews Drug discovery 12, 
931-947. 
 
Goyal, M.M., and Basak, A. (2010). Human catalase: looking for 
complete identity. Protein & cell 1, 888-897. 
 
Gregory, L.G., and Lloyd, C.M. (2011). Orchestrating house dust mite-
associated allergy in the lung. Trends in immunology 32, 402-411. 
 
Gu, Y., Seidl, K.J., Rathbun, G.A., Zhu, C., Manis, J.P., van der Stoep, 
N., Davidson, L., Cheng, H.L., Sekiguchi, J.M., Frank, K., et al. (1997). 
Growth retardation and leaky SCID phenotype of Ku70-deficient mice. 
Immunity 7, 653-665. 
 
Hales, B.J., Martin, A.C., Pearce, L.J., Laing, I.A., Hayden, C.M., 
Goldblatt, J., Le Souef, P.N., and Thomas, W.R. (2006). IgE and IgG 
anti-house dust mite specificities in allergic disease. The Journal of 
allergy and clinical immunology 118, 361-367. 
 
Hamacher-Brady, A., Stein, H.A., Turschner, S., Toegel, I., Mora, R., 
Jennewein, N., Efferth, T., Eils, R., and Brady, N.R. (2011). Artesunate 
activates mitochondrial apoptosis in breast cancer cells via iron-
catalyzed lysosomal reactive oxygen species production. The Journal 
of biological chemistry 286, 6587-6601. 
 
Hammad, H., Chieppa, M., Perros, F., Willart, M.A., Germain, R.N., and 
Lambrecht, B.N. (2009). House dust mite allergen induces asthma via 
Toll-like receptor 4 triggering of airway structural cells. Nat Med 15, 
410-416. 
 
Hammad, H., and Lambrecht, B.N. (2008). Dendritic cells and epithelial 
cells: linking innate and adaptive immunity in asthma. Nature reviews 




Hansbro, P.M., Kaiko, G.E., and Foster, P.S. (2011). Cytokine/anti-
cytokine therapy - novel treatments for asthma? British journal of 
pharmacology 163, 81-95. 
 
Hasbal, C., Aksu, B.Y., Himmetoglu, S., Dincer, Y., Koc, E.E., 
Hatipoglu, S., and Akcay, T. (2010). DNA damage and glutathione level 
in children with asthma bronchiale: effect of antiasthmatic therapy. 
Pediatr Allergy Immunol 21, e674-678. 
 
Hayashi, T., Ishii, A., Nakai, S., and Hasegawa, K. (2004). 
Ultrastructure of goblet-cell metaplasia from Clara cell in the allergic 
asthmatic airway inflammation in a mouse model of asthma in vivo. 
Virchows Archiv : an international journal of pathology 444, 66-73. 
 
Henchcliffe, C., and Beal, M.F. (2008). Mitochondrial biology and 
oxidative stress in Parkinson disease pathogenesis. Nature clinical 
practice Neurology 4, 600-609. 
 
Henricks, P.A., and Nijkamp, F.P. (2001). Reactive oxygen species as 
mediators in asthma. Pulmonary pharmacology & therapeutics 14, 409-
420. 
 
Hirano, T., Yamagata, T., Gohda, M., Yamagata, Y., Ichikawa, T., 
Yanagisawa, S., Ueshima, K., Akamatsu, K., Nakanishi, M., 
Matsunaga, K., et al. (2006). Inhibition of reactive nitrogen species 
production in COPD airways: comparison of inhaled corticosteroid and 
oral theophylline. Thorax 61, 761-766. 
 
Ho, W.E. (2014). Investigation of Anti-inflammatory Mechanims of Anti-
Malarial Drug Artesunate in Allergic Asthma. In Saw Swee Hock School 
of Public Health (ScholarBank@NUS: National University of Singapore), 
pp. 231. 
 
Ho, W.E., Cheng, C., Peh, H.Y., Xu, F., Tannenbaum, S.R., Ong, C.N., 
and Wong, W.S. (2012). Anti-malarial drug artesunate ameliorates 
oxidative lung damage in experimental allergic asthma. Free radical 
biology & medicine 53, 498-507. 
 
Ho, W.E., Peh, H.Y., Chan, T.K., and Wong, W.S. (2014). Artemisinins: 
pharmacological actions beyond anti-malarial. Pharmacology & 
therapeutics 142, 126-139. 
 
Hock, A.K., and Vousden, K.H. (2012). Tumor suppression by p53: fall 




Hodge, S., Hodge, G., Flower, R., Reynolds, P.N., Scicchitano, R., and 
Holmes, M. (2002). Up-regulation of production of TGF-beta and IL-4 
and down-regulation of IL-6 by apoptotic human bronchial epithelial 
cells. Immunology and cell biology 80, 537-543. 
 
Hogg, J.C. (1993). Pathology of asthma. The Journal of allergy and 
clinical immunology 92, 1-5. 
 
Holgate, S.T. (2007). Epithelium dysfunction in asthma. The Journal of 
allergy and clinical immunology 120, 1233-1244; quiz 1245-1236. 
 
Holgate, S.T. (2008). The airway epithelium is central to the 
pathogenesis of asthma. Allergol Int 57, 1-10. 
 
Holgate, S.T. (2012). Innate and adaptive immune responses in 
asthma. Nature medicine 18, 673-683. 
 
Holgate, S.T., Lackie, P., Wilson, S., Roche, W., and Davies, D. (2000). 
Bronchial epithelium as a key regulator of airway allergen sensitization 
and remodeling in asthma. American journal of respiratory and critical 
care medicine 162, S113-S117. 
 
Hoshino, T., Okamoto, M., Takei, S., Sakazaki, Y., Iwanaga, T., and 
Aizawa, H. (2008). Redox-regulated mechanisms in asthma. 
Antioxidants & redox signaling 10, 769-783. 
 
Huen, M.S., and Chen, J. (2008). The DNA damage response 
pathways: at the crossroad of protein modifications. Cell research 18, 
8-16. 
 
Ira, G., Pellicioli, A., Balijja, A., Wang, X., Fiorani, S., Carotenuto, W., 
Liberi, G., Bressan, D., Wan, L., Hollingsworth, N.M., et al. (2004). 
DNA end resection, homologous recombination and DNA damage 
checkpoint activation require CDK1. Nature 431, 1011-1017. 
 
Jackson, S.P., and Bartek, J. (2009). The DNA-damage response in 
human biology and disease. Nature 461, 1071-1078. 
 
Jackson, S.P., and Durocher, D. (2013). Regulation of DNA damage 
responses by ubiquitin and SUMO. Molecular cell 49, 795-807. 
 
Jackson, S.P., and Jeggo, P.A. (1995). DNA double-strand break repair 
and V(D)J recombination: involvement of DNA-PK. Trends in 
biochemical sciences 20, 412-415. 
 
Jankov, R.P., Kantores, C., Pan, J., and Belik, J. (2008). Contribution 
of xanthine oxidase-derived superoxide to chronic hypoxic pulmonary 
				
212 
hypertension in neonatal rats. Am J Physiol Lung Cell Mol Physiol 294, 
L233-245. 
 
Jazayeri, A., Falck, J., Lukas, C., Bartek, J., Smith, G.C., Lukas, J., and 
Jackson, S.P. (2006). ATM- and cell cycle-dependent regulation of 
ATR in response to DNA double-strand breaks. Nature cell biology 8, 
37-45. 
 
Jeggo, P.A., and Lobrich, M. (2007). DNA double-strand breaks: their 
cellular and clinical impact? Oncogene 26, 7717-7719. 
 
Jiang, Q. (2014). Natural forms of vitamin E: metabolism, antioxidant, 
and anti-inflammatory activities and their role in disease prevention and 
therapy. Free radical biology & medicine 72, 76-90. 
 
Jobsis, Q., Raatgeep, H.C., Hermans, P.W., and de Jongste, J.C. 
(1997). Hydrogen peroxide in exhaled air is increased in stable 
asthmatic children. The European respiratory journal 10, 519-521. 
 
Kaczmarek, A., Vandenabeele, P., and Krysko, D.V. (2013). 
Necroptosis: the release of damage-associated molecular patterns and 
its physiological relevance. Immunity 38, 209-223. 
 
Kalesnikoff, J., and Galli, S.J. (2008). New developments in mast cell 
biology. Nature immunology 9, 1215-1223. 
 
Karakasilioti, I., Kamileri, I., Chatzinikolaou, G., Kosteas, T., Vergadi, 
E., Robinson, A.R., Tsamardinos, I., Rozgaja, T.A., Siakouli, S., 
Tsatsanis, C., et al. (2013). DNA damage triggers a chronic 
autoinflammatory response, leading to fat depletion in NER progeria. 
Cell metabolism 18, 403-415. 
 
Kass, E.M., and Jasin, M. (2010). Collaboration and competition 
between DNA double-strand break repair pathways. FEBS letters 584, 
3703-3708. 
 
Kelly, E.A., Busse, W.W., and Jarjour, N.N. (2000). Increased matrix 
metalloproteinase-9 in the airway after allergen challenge. American 
journal of respiratory and critical care medicine 162, 1157-1161. 
 
Kephart, G.M., Alexander, J.A., Arora, A.S., Romero, Y., Smyrk, T.C., 
Talley, N.J., and Kita, H. (2010). Marked deposition of eosinophil-
derived neurotoxin in adult patients with eosinophilic esophagitis. The 




Kharitonov, S.A., and Barnes, P.J. (2001). Exhaled markers of 
pulmonary disease. American journal of respiratory and critical care 
medicine 163, 1693-1722. 
 
Kharitonov, S.A., Yates, D., Robbins, R.A., Logan-Sinclair, R., 
Shinebourne, E.A., and Barnes, P.J. (1994). Increased nitric oxide in 
exhaled air of asthmatic patients. Lancet 343, 133-135. 
 
Kim, S.R., Kim, D.I., Kim, S.H., Lee, H., Lee, K.S., Cho, S.H., and Lee, 
Y.C. (2014). NLRP3 inflammasome activation by mitochondrial ROS in 
bronchial epithelial cells is required for allergic inflammation. Cell death 
& disease 5, e1498. 
 
Kiraly, O., Gong, G., Olipitz, W., Muthupalani, S., and Engelward, B.P. 
(2015). Inflammation-induced cell proliferation potentiates DNA 
damage-induced mutations in vivo. PLoS genetics 11, e1004901. 
 
Kiziltepe, T., Yan, A., Dong, M., Jonnalagadda, V.S., Dedon, P.C., and 
Engelward, B.P. (2005). Delineation of the chemical pathways 
underlying nitric oxide-induced homologous recombination in 
mammalian cells. Chemistry & biology 12, 357-369. 
 
Kobayashi, N., Yamada, Y., Ito, W., Ueki, S., Kayaba, H., Nakamura, 
H., Yodoi, J., and Chihara, J. (2009). Thioredoxin reduces C-C 
chemokine-induced chemotaxis of human eosinophils. Allergy 64, 
1130-1135. 
 
Koike, M., Yutoku, Y., and Koike, A. (2011). Establishment of ku70-
deficient lung epithelial cell lines and their hypersensitivity to low-dose 
x-irradiation. The Journal of veterinary medical science / the Japanese 
Society of Veterinary Science 73, 549-554. 
 
Krejci, L., Altmannova, V., Spirek, M., and Zhao, X. (2012). 
Homologous recombination and its regulation. Nucleic Acids Res 40, 
5795-5818. 
 
Krishna, S., Bustamante, L., Haynes, R.K., and Staines, H.M. (2008). 
Artemisinins: their growing importance in medicine. Trends in 
pharmacological sciences 29, 520-527. 
 
Kuhl, K., and Hanania, N.A. (2012). Targeting IgE in asthma. Current 
opinion in pulmonary medicine 18, 1-5. 
 
Kuo, L.J., and Yang, L.X. (2008). Gamma-H2AX - a novel biomarker for 




Kuwano, K. (2007). Epithelial cell apoptosis and lung remodeling. 
Cellular & molecular immunology 4, 419-429. 
 
Lambeth, J.D. (2004). NOX enzymes and the biology of reactive 
oxygen. Nature reviews Immunology 4, 181-189. 
 
Lambrecht, B.N., and Hammad, H. (2009). Biology of Lung Dendritic 
Cells at the Origin of Asthma. Immunity 31, 412-424. 
 
Lambrecht, B.N., and Hammad, H. (2012). The airway epithelium in 
asthma. Nature medicine 18, 684-692. 
 
Lambrecht, B.N., and Hammad, H. (2014). Allergens and the airway 
epithelium response: gateway to allergic sensitization. The Journal of 
allergy and clinical immunology 134, 499-507. 
 
Lambrecht, B.N., and Hammad, H. (2015). The immunology of asthma. 
Nature immunology 16, 45-56. 
 
Langelier, M.F., Planck, J.L., Roy, S., and Pascal, J.M. (2012). 
Structural basis for DNA damage-dependent poly(ADP-ribosyl)ation by 
human PARP-1. Science 336, 728-732. 
 
Lee, I.S., Ryu, D.K., Lim, J., Cho, S., Kang, B.Y., and Choi, H.J. (2012). 
Artesunate activates Nrf2 pathway-driven anti-inflammatory potential 
through ERK signaling in microglial BV2 cells. Neuroscience letters 509, 
17-21. 
 
Lee, I.T., and Yang, C.M. (2012). Role of NADPH oxidase/ROS in pro-
inflammatory mediators-induced airway and pulmonary diseases. 
Biochemical pharmacology 84, 581-590. 
 
Lee, K.S., Kim, S.R., Park, H.S., Park, S.J., Min, K.H., Lee, K.Y., Choe, 
Y.H., Hong, S.H., Han, H.J., Lee, Y.R., et al. (2007). A novel thiol 
compound, N-acetylcysteine amide, attenuates allergic airway disease 
by regulating activation of NF-kappaB and hypoxia-inducible factor-
1alpha. Experimental & molecular medicine 39, 756-768. 
 
Lee, M., Kim, S., Kwon, O.K., Oh, S.R., Lee, H.K., and Ahn, K. (2009). 
Anti-inflammatory and anti-asthmatic effects of resveratrol, a 
polyphenolic stilbene, in a mouse model of allergic asthma. 
International immunopharmacology 9, 418-424. 
 
Lees-Miller, S.P., and Meek, K. (2003). Repair of DNA double strand 




Leino, M.S., Loxham, M., Blume, C., Swindle, E.J., Jayasekera, N.P., 
Dennison, P.W., Shamji, B.W., Edwards, M.J., Holgate, S.T., Howarth, 
P.H., et al. (2013). Barrier disrupting effects of alternaria alternata 
extract on bronchial epithelium from asthmatic donors. PloS one 8, 
e71278. 
 
Li, B., Zhang, R., Li, J., Zhang, L., Ding, G., Luo, P., He, S., Dong, Y., 
Jiang, W., Lu, Y., et al. (2008). Antimalarial artesunate protects sepsis 
model mice against heat-killed Escherichia coli challenge by 
decreasing TLR4, TLR9 mRNA expressions and transcription factor 
NF-kappa B activation. International immunopharmacology 8, 379-389. 
 
Li, J., Li, L., Chen, H., Chang, Q., Liu, X., Wu, Y., Wei, C., Li, R., Kwan, 
J.K., Yeung, K.L., et al. (2014). Application of vitamin E to antagonize 
SWCNTs-induced exacerbation of allergic asthma. Scientific reports 4, 
4275. 
 
Li, N., Parrish, M., Chan, T.K., Yin, L., Rai, P., Yoshiyuki, Y., 
Abolhassani, N., Tan, K.B., Kiraly, O., Chow, V.T., et al. (2015). 
Influenza infection induces host DNA damage and dynamic DNA 
damage responses during tissue regeneration. Cellular and molecular 
life sciences : CMLS 72, 2973-2988. 
 
Li, N., Wang, M., Barajas, B., Sioutas, C., Williams, M.A., and Nel, A.E. 
(2013a). Nrf2 deficiency in dendritic cells enhances the adjuvant effect 
of ambient ultrafine particles on allergic sensitization. Journal of innate 
immunity 5, 543-554. 
 
Li, X., and Heyer, W.D. (2008). Homologous recombination in DNA 
repair and DNA damage tolerance. Cell research 18, 99-113. 
 
Li, Y.J., Kawada, T., and Azuma, A. (2013b). Nrf2 Is a Protective 
Factor against Oxidative Stresses Induced by Diesel Exhaust Particle 
in Allergic Asthma. Oxidative Medicine and Cellular Longevity. 
 
Lieber, M.R. (2010). The mechanism of double-strand DNA break 
repair by the nonhomologous DNA end-joining pathway. Annual review 
of biochemistry 79, 181-211. 
 
Lieber, M.R., Ma, Y., Pannicke, U., and Schwarz, K. (2003). 
Mechanism and regulation of human non-homologous DNA end-joining. 
Nature reviews Molecular cell biology 4, 712-720. 
 
Lin, M.T., and Beal, M.F. (2006). Mitochondrial dysfunction and 




Liu, G., Zhou, W., and Christiani, D.C. (2005). Molecular epidemiology 
of non-small cell lung cancer. Semin Respir Crit Care Med 26, 265-272. 
 
Liu, Y., Shao, L.L., Pang, W., Lan, X.M., Lu, J.X., Cong, Y.L., and 
Wang, C.B. (2014). Induction of adhesion molecule expression in co-
culture of human bronchial epithelial cells and neutrophils suppressed 
by puerarin via down-regulating p38 mitogen-activated protein kinase 
and nuclear factor kappaB pathways. Chinese journal of integrative 
medicine 20, 360-368. 
 
Lloyd, C.M., and Saglani, S. (2010). Asthma and allergy: the emerging 
epithelium. Nature medicine 16, 273-274. 
 
Lotvall, J., Akdis, C.A., Bacharier, L.B., Bjermer, L., Casale, T.B., 
Custovic, A., Lemanske, R.F., Jr., Wardlaw, A.J., Wenzel, S.E., and 
Greenberger, P.A. (2011). Asthma endotypes: a new approach to 
classification of disease entities within the asthma syndrome. The 
Journal of allergy and clinical immunology 127, 355-360. 
 
Mabalirajan, U., Dinda, A.K., Kumar, S., Roshan, R., Gupta, P., 
Sharma, S.K., and Ghosh, B. (2008). Mitochondrial structural changes 
and dysfunction are associated with experimental allergic asthma. 
Journal of immunology 181, 3540-3548. 
 
Mah, L.J., El-Osta, A., and Karagiannis, T.C. (2010). gammaH2AX: a 
sensitive molecular marker of DNA damage and repair. Leukemia 24, 
679-686. 
 
Marcinkiewicz, J., and Kontny, E. (2014). Taurine and inflammatory 
diseases. Amino acids 46, 7-20. 
 
Marechal, A., and Zou, L. (2013). DNA damage sensing by the ATM 
and ATR kinases. Cold Spring Harbor perspectives in biology 5. 
 
Marklund, S.L. (1992). Regulation by cytokines of extracellular 
superoxide dismutase and other superoxide dismutase isoenzymes in 
fibroblasts. The Journal of biological chemistry 267, 6696-6701. 
 
Martinez, F.D., and Vercelli, D. (2013). Asthma. Lancet 382, 1360-1372. 
 
McDonald, R.J., Pan, L.C., St George, J.A., Hyde, D.M., and Ducore, 
J.M. (1993). Hydrogen peroxide induces DNA single strand breaks in 
respiratory epithelial cells. Inflammation 17, 715-722. 
 
McDougall, C.M., and Helms, P.J. (2006). Neutrophil airway 




McKinnon, P.J. (2012). ATM and the molecular pathogenesis of ataxia 
telangiectasia. Annual review of pathology 7, 303-321. 
 
McKinnon, P.J., and Caldecott, K.W. (2007). DNA strand break repair 
and human genetic disease. Annual review of genomics and human 
genetics 8, 37-55. 
 
Meyer-Martin, H., Reuter, S., and Taube, C. (2014). Mouse models of 
allergic airway disease. Methods in molecular biology 1193, 127-141. 
 
Mishra, A., Brown, A.L., Yao, X., Yang, S., Park, S.J., Liu, C., Dagur, 
P.K., McCoy, J.P., Keeran, K.J., Nugent, G.Z., et al. (2015). Dendritic 
cells induce Th2-mediated airway inflammatory responses to house 
dust mite via DNA-dependent protein kinase. Nature communications 6, 
6224. 
 
Monteseirin, J. (2009). Neutrophils and asthma. Journal of 
investigational allergology & clinical immunology 19, 340-354. 
 
Monteseirin, J., Camacho, M.J., Bonilla, I., De la Calle, A., Guardia, P., 
Conde, J., and Sobrino, F. (2002). Respiratory burst in neutrophils from 
asthmatic patients. The Journal of asthma : official journal of the 
Association for the Care of Asthma 39, 619-624. 
 
Montuschi, P., Barnes, P.J., and Roberts, L.J., 2nd (2004). 
Isoprostanes: markers and mediators of oxidative stress. FASEB 
journal : official publication of the Federation of American Societies for 
Experimental Biology 18, 1791-1800. 
 
Montuschi, P., Collins, J.V., Ciabattoni, G., Lazzeri, N., Corradi, M., 
Kharitonov, S.A., and Barnes, P.J. (2000a). Exhaled 8-isoprostane as 
an in vivo biomarker of lung oxidative stress in patients with COPD and 
healthy smokers. American journal of respiratory and critical care 
medicine 162, 1175-1177. 
 
Montuschi, P., Kharitonov, S.A., Ciabattoni, G., Corradi, M., van 
Rensen, L., Geddes, D.M., Hodson, M.E., and Barnes, P.J. (2000b). 
Exhaled 8-isoprostane as a new non-invasive biomarker of oxidative 
stress in cystic fibrosis. Thorax 55, 205-209. 
 
Moreno-Macias, H., and Romieu, I. (2014). Effects of antioxidant 
supplements and nutrients on patients with asthma and allergies. The 
Journal of allergy and clinical immunology 133, 1237-1244; quiz 1245. 
 
Morita, N., Shimoda, K., Traber, M.G., Westphal, M., Enkhbaatar, P., 
Murakami, K., Leonard, S.W., Traber, L.D., and Traber, D.L. (2006). 
				
218 
Vitamin E attenuates acute lung injury in sheep with burn and smoke 
inhalation injury. Redox Rep 11, 61-70. 
 
Murphy, M.P. (2013). Mitochondrial dysfunction indirectly elevates ROS 
production by the endoplasmic reticulum. Cell metabolism 18, 145-146. 
 
Murray, M.A., and Chotirmall, S.H. (2015). The Impact of 
Immunosenescence on Pulmonary Disease. Mediators of inflammation 
2015, 692546. 
 
Mutamba, J.T., Svilar, D., Prasongtanakij, S., Wang, X.H., Lin, Y.C., 
Dedon, P.C., Sobol, R.W., and Engelward, B.P. (2011). XRCC1 and 
base excision repair balance in response to nitric oxide. DNA Repair 
(Amst) 10, 1282-1293. 
 
Nadeem, A., Chhabra, S.K., Masood, A., and Raj, H.G. (2003). 
Increased oxidative stress and altered levels of antioxidants in asthma. 
The Journal of allergy and clinical immunology 111, 72-78. 
 
Nakamura, A.J., Rao, V.A., Pommier, Y., and Bonner, W.M. (2010). 
The complexity of phosphorylated H2AX foci formation and DNA repair 
assembly at DNA double-strand breaks. Cell cycle 9, 389-397. 
 
Neofytou, E., Tzortzaki, E.G., Chatziantoniou, A., and Siafakas, N.M. 
(2012). DNA damage due to oxidative stress in Chronic Obstructive 
Pulmonary Disease (COPD). Int J Mol Sci 13, 16853-16864. 
 
Ng, D.S., Liao, W., Tan, W.S., Chan, T.K., Loh, X.Y., and Wong, W.S. 
(2014). Anti-malarial drug artesunate protects against cigarette smoke-
induced lung injury in mice. Phytomedicine : international journal of 
phytotherapy and phytopharmacology 21, 1638-1644. 
 
Nials, A.T., and Uddin, S. (2008). Mouse models of allergic asthma: 
acute and chronic allergen challenge. Disease models & mechanisms 
1, 213-220. 
 
Norberg, E., Orrenius, S., and Zhivotovsky, B. (2010). Mitochondrial 
regulation of cell death: processing of apoptosis-inducing factor (AIF). 
Biochem Biophys Res Commun 396, 95-100. 
 
Novak, Z., Nemeth, I., Gyurkovits, K., Varga, S.I., and Matkovics, B. 
(1991). Examination of the role of oxygen free radicals in bronchial 
asthma in childhood. Clinica chimica acta; international journal of 
clinical chemistry 201, 247-251. 
 
Nurmatov, U., Devereux, G., and Sheikh, A. (2011). Nutrients and 
				
219 
review and meta-analysis. Journal of Allergy and Clinical Immunology 
127, 724-U359. 
 
Olive, P.L., and Banath, J.P. (2006). The comet assay: a method to 
measure DNA damage in individual cells. Nature protocols 1, 23-29. 
 
Orrenius, S., Gogvadze, V., and Zhivotovsky, B. (2007). Mitochondrial 
oxidative stress: implications for cell death. Annual review of 
pharmacology and toxicology 47, 143-183. 
 
Ott, M., Gogvadze, V., Orrenius, S., and Zhivotovsky, B. (2007). 
Mitochondria, oxidative stress and cell death. Apoptosis : an 
international journal on programmed cell death 12, 913-922. 
 
Panier, S., and Boulton, S.J. (2014). Double-strand break repair: 
53BP1 comes into focus. Nature reviews Molecular cell biology 15, 7-
18. 
 
Panier, S., and Durocher, D. (2013). Push back to respond better: 
regulatory inhibition of the DNA double-strand break response. Nat Rev 
Mol Cell Biol 14, 661-672. 
 
Parkin, J., and Cohen, B. (2001). An overview of the immune system. 
Lancet 357, 1777-1789. 
 
Pasparakis, M., and Vandenabeele, P. (2015). Necroptosis and its role 
in inflammation. Nature 517, 311-320. 
 
Pattison, D.I., and Davies, M.J. (2004). Kinetic analysis of the reactions 
of hypobromous acid with protein components: implications for cellular 
damage and use of 3-bromotyrosine as a marker of oxidative stress. 
Biochemistry 43, 4799-4809. 
 
Pawankar, R., Canonica, G.W., Holgate, S.T., and Lockey, R.F. (2011). 
WAO white book on allergy. Milwaukee, WI: World Allergy Organization 
3, 156-157. 
 
Peh, H.Y., Ho, W.E., Cheng, C., Chan, T.K., Seow, A.C., Lim, A.Y., 
Fong, C.W., Seng, K.Y., Ong, C.N., and Wong, W.S. (2015). Vitamin E 
Isoform gamma-Tocotrienol Downregulates House Dust Mite-Induced 
Asthma. Journal of immunology 195, 437-444. 
 
Pelaia, G., Vatrella, A., and Maselli, R. (2012). The potential of 





Persson, C. (2014). Primary lysis of eosinophils in severe 
desquamative asthma. Clin Exp Allergy 44, 173-183. 
 
Post, S., Nawijn, M.C., Hackett, T.L., Baranowska, M., Gras, R., van 
Oosterhout, A.J., and Heijink, I.H. (2012). The composition of house 
dust mite is critical for mucosal barrier dysfunction and allergic 
sensitisation. Thorax 67, 488-495. 
 
Postel-Vinay, S., Vanhecke, E., Olaussen, K.A., Lord, C.J., Ashworth, 
A., and Soria, J.C. (2012). The potential of exploiting DNA-repair 
defects for optimizing lung cancer treatment. Nature reviews Clinical 
oncology 9, 144-155. 
 
Prado, C.M., Leick-Maldonado, E.A., Kasahara, D.I., Capelozzi, V.L., 
Martins, M.A., and Tiberio, I.F. (2005). Effects of acute and chronic 
nitric oxide inhibition in an experimental model of chronic pulmonary 
allergic inflammation in guinea pigs. Am J Physiol Lung Cell Mol 
Physiol 289, L677-683. 
 
Prado, C.M., Leick-Maldonado, E.A., Yano, L., Leme, A.S., Capelozzi, 
V.L., Martins, M.A., and Tiberio, I.F. (2006). Effects of nitric oxide 
synthases in chronic allergic airway inflammation and remodeling. 
American journal of respiratory cell and molecular biology 35, 457-465. 
 
Prado, C.M., Martins, M.A., and Tiberio, I.F. (2011). Nitric oxide in 
asthma physiopathology. ISRN allergy 2011, 832560. 
 
Rahman, I. (2009). Chapter 25 - Reactive Oxygen Species and 
Antioxidant Therapeutic Approaches. In Asthma and COPD (Second 
Edition), P.J.B.M.D.I.R.C. Thomson, ed. (Oxford: Academic Press), pp. 
293-312. 
 
Rai, P., Parrish, M., Tay, I.J., Li, N., Ackerman, S., He, F., Kwang, J., 
Chow, V.T., and Engelward, B.P. (2015). Streptococcus pneumoniae 
secretes hydrogen peroxide leading to DNA damage and apoptosis in 
lung cells. Proceedings of the National Academy of Sciences of the 
United States of America 112, E3421-3430. 
 
Ran, F.A., Hsu, P.D., Wright, J., Agarwala, V., Scott, D.A., and Zhang, 
F. (2013). Genome engineering using the CRISPR-Cas9 system. 
Nature protocols 8, 2281-2308. 
 
Rangasamy, T., Guo, J., Mitzner, W.A., Roman, J., Singh, A., Fryer, 
A.D., Yamamoto, M., Kensler, T.W., Tuder, R.M., Georas, S.N., et al. 
(2005). Disruption of Nrf2 enhances susceptibility to severe airway 
inflammation and asthma in mice. The Journal of experimental 




Reddy, P.H. (2011). Mitochondrial Dysfunction and Oxidative Stress in 
Asthma: Implications for Mitochondria-Targeted Antioxidant 
Therapeutics. Pharmaceuticals 4, 429-456. 
 
Renkawitz, J., Lademann, C.A., and Jentsch, S. (2014). Mechanisms 
and principles of homology search during recombination. Nature 
reviews Molecular cell biology 15, 369-383. 
 
Ricciardolo, F.L., Sterk, P.J., Gaston, B., and Folkerts, G. (2004). Nitric 
oxide in health and disease of the respiratory system. Physiological 
reviews 84, 731-765. 
 
Rich, T., Allen, R.L., and Wyllie, A.H. (2000). Defying death after DNA 
damage. Nature 407, 777-783. 
 
Robertson, A.B., Klungland, A., Rognes, T., and Leiros, I. (2009). DNA 
repair in mammalian cells: Base excision repair: the long and short of it. 
Cellular and molecular life sciences : CMLS 66, 981-993. 
 
Rodier, F., Coppe, J.P., Patil, C.K., Hoeijmakers, W.A., Munoz, D.P., 
Raza, S.R., Freund, A., Campeau, E., Davalos, A.R., and Campisi, J. 
(2009). Persistent DNA damage signalling triggers senescence-
associated inflammatory cytokine secretion. Nature cell biology 11, 
973-979. 
 
Romieu, I., Varraso, R., Avenel, V., Leynaert, B., Kauffmann, F., and 
Clavel-Chapelon, F. (2006). Fruit and vegetable intakes and asthma in 
the E3N study. Thorax 61, 209-215. 
 
Roos, W.P., and Kaina, B. (2006). DNA damage-induced cell death by 
apoptosis. Trends in molecular medicine 12, 440-450. 
Rosenberg, H.F., Dyer, K.D., and Foster, P.S. (2013). Eosinophils: 
changing perspectives in health and disease. Nature reviews 
Immunology 13, 9-22. 
 
Royce, S.G., Dang, W., Yuan, G., Tran, J., El Osta, A., Karagiannis, 
T.C., and Tang, M.L. (2011). Resveratrol has protective effects against 
airway remodeling and airway hyperreactivity in a murine model of 
allergic airways disease. Pathobiology of aging & age related diseases 
1. 
 
Saccucci, P., Verrotti, A., Giannini, C., Verini, M., Chiarelli, F., Neri, A., 
and Magrini, A. (2014). p53 Codon 72 Genetic Polymorphism in 
Asthmatic Children: Evidence of Interaction With Acid Phosphatase 




Sadatsafavi, M., and FitzGerald, J.M. (2014). The Global Asthma 
Report 2014. 
 
Saffar, A.S., Ashdown, H., and Gounni, A.S. (2011). The molecular 
mechanisms of glucocorticoids-mediated neutrophil survival. Current 
drug targets 12, 556-562. 
 
Sahiner, U.M., Birben, E., Erzurum, S., Sackesen, C., and Kalayci, O. 
(2011). Oxidative stress in asthma. The World Allergy Organization 
journal 4, 151-158. 
 
Saleh, D., Barnes, P.J., and Giaid, A. (1997). Increased production of 
the potent oxidant peroxynitrite in the lungs of patients with idiopathic 
pulmonary fibrosis. American journal of respiratory and critical care 
medicine 155, 1763-1769. 
 
Schleimer, R.P., Kato, A., Kern, R., Kuperman, D., and Avila, P.C. 
(2007). Epithelium: at the interface of innate and adaptive immune 
responses. The Journal of allergy and clinical immunology 120, 1279-
1284. 
 
Scott, T.L., Rangaswamy, S., Wicker, C.A., and Izumi, T. (2014). 
Repair of oxidative DNA damage and cancer: recent progress in DNA 
base excision repair. Antioxidants & redox signaling 20, 708-726. 
 
Shanmugasundaram, K.R., Kumar, S.S., and Rajajee, S. (2001). 
Excessive free radical generation in the blood of children suffering from 
asthma. Clinica chimica acta; international journal of clinical chemistry 
305, 107-114. 
 
Shiva, S. (2013). Nitrite: A Physiological Store of Nitric Oxide and 
Modulator of Mitochondrial Function. Redox biology 1, 40-44. 
 
Shrivastav, M., Miller, C.A., De Haro, L.P., Durant, S.T., Chen, B.P., 
Chen, D.J., and Nickoloff, J.A. (2009). DNA-PKcs and ATM co-regulate 
DNA double-strand break repair. DNA Repair (Amst) 8, 920-929. 
 
Singapore_Health_Promotion_Board (2015). What All Parents Need to 
Know about Childhood Asthma. 
 
Singh, G., and Katyal, S.L. (1997). Clara cells and Clara cell 10 kD 
protein (CC10). Am J Respir Cell Mol Biol 17, 141-143. 
 
Sleiman, P.M., Flory, J., Imielinski, M., Bradfield, J.P., Annaiah, K., 
Willis-Owen, S.A., Wang, K., Rafaels, N.M., Michel, S., Bonnelykke, K., 
et al. (2010). Variants of DENND1B associated with asthma in children. 




Smith, L.J., Houston, M., and Anderson, J. (1993). Increased levels of 
glutathione in bronchoalveolar lavage fluid from patients with asthma. 
The American review of respiratory disease 147, 1461-1464. 
 
Smith, L.J., Shamsuddin, M., Sporn, P.H., Denenberg, M., and 
Anderson, J. (1997). Reduced superoxide dismutase in lung cells of 
patients with asthma. Free radical biology & medicine 22, 1301-1307. 
 
Sonoda, E., Sasaki, M.S., Buerstedde, J.M., Bezzubova, O., Shinohara, 
A., Ogawa, H., Takata, M., Yamaguchi-Iwai, Y., and Takeda, S. (1998). 
Rad51-deficient vertebrate cells accumulate chromosomal breaks prior 
to cell death. EMBO J 17, 598-608. 
 
Soria, G., Polo, S.E., and Almouzni, G. (2012). Prime, repair, restore: 
the active role of chromatin in the DNA damage response. Molecular 
cell 46, 722-734. 
 
Sporn, M.B., and Liby, K.T. (2012). NRF2 and cancer: the good, the 
bad and the importance of context. Nature reviews Cancer 12, 564-571. 
 
Stracker, T.H., and Petrini, J.H. (2011). The MRE11 complex: starting 
from the ends. Nature reviews Molecular cell biology 12, 90-103. 
 
Sugiura, H., and Ichinose, M. (2008). Oxidative and nitrative stress in 
bronchial asthma. Antioxidants & redox signaling 10, 785-797. 
 
Sugiura, H., and Ichinose, M. (2011). Nitrative stress in inflammatory 
lung diseases. Nitric Oxide 25, 138-144. 
 
Sugiura, H., Ichinose, M., Oyake, T., Mashito, Y., Ohuchi, Y., Endoh, N., 
Miura, M., Yamagata, S., Koarai, A., Akaike, T., et al. (1999). Role of 
peroxynitrite in airway microvascular hyperpermeability during late 
allergic phase in guinea pigs. American journal of respiratory and 
critical care medicine 160, 663-671. 
 
Sugiura, H., Ichinose, M., Tomaki, M., Ogawa, H., Koarai, A., Kitamuro, 
T., Komaki, Y., Akita, T., Nishino, H., Okamoto, S., et al. (2004). 
Quantitative assessment of protein-bound tyrosine nitration in airway 
secretions from patients with inflammatory airway disease. Free radical 
research 38, 49-57. 
 
Sugiura, H., Liu, X., Kobayashi, T., Togo, S., Ertl, R.F., Kawasaki, S., 
Kamio, K., Wang, X.Q., Mao, L., Shen, L., et al. (2006). Reactive 
nitrogen species augment fibroblast-mediated collagen gel contraction, 
mediator production, and chemotaxis. American journal of respiratory 
cell and molecular biology 34, 592-599. 
				
224 
Surova, O., and Zhivotovsky, B. (2013). Various modes of cell death 
induced by DNA damage. Oncogene 32, 3789-3797. 
 
Sussan, T.E., Rangasamy, T., Blake, D.J., Malhotra, D., El-Haddad, H., 
Bedja, D., Yates, M.S., Kombairaju, P., Yamamoto, M., Liby, K.T., et al. 
(2009). Targeting Nrf2 with the triterpenoid CDDO-imidazolide 
attenuates cigarette smoke-induced emphysema and cardiac 
dysfunction in mice. Proceedings of the National Academy of Sciences 
of the United States of America 106, 250-255. 
 
Taccioli, G.E., Amatucci, A.G., Beamish, H.J., Gell, D., Xiang, X.H., 
Torres Arzayus, M.I., Priestley, A., Jackson, S.P., Marshak Rothstein, 
A., Jeggo, P.A., et al. (1998). Targeted disruption of the catalytic 
subunit of the DNA-PK gene in mice confers severe combined 
immunodeficiency and radiosensitivity. Immunity 9, 355-366. 
 
Takahashi, T., Miura, M., Katsumata, U., Ichinose, M., Kimura, K., 
Inoue, H., Takishima, T., and Shirato, K. (1993). Involvement of 
superoxide in ozone-induced airway hyperresponsiveness in 
anesthetized cats. The American review of respiratory disease 148, 
103-106. 
 
Tarsounas, M., Davies, A.A., and West, S.C. (2004). RAD51 
localization and activation following DNA damage. Philos Trans R Soc 
Lond B Biol Sci 359, 87-93. 
 
Teramoto, S., Shu, C.Y., Ouchi, Y., and Fukuchi, Y. (1996). Increased 
spontaneous production and generation of superoxide anion by blood 
neutrophils in patients with asthma. The Journal of asthma : official 
journal of the Association for the Care of Asthma 33, 149-155. 
 
Thomas, W.R., Smith, W.A., Hales, B.J., Mills, K.L., and O'Brien, R.M. 
(2002). Characterization and immunobiology of house dust mite 
allergens. International archives of allergy and immunology 129, 1-18. 
 
Tjalkens, R.B., Carbone, D.L., and Wu, G. (2011). Detection of nitric 
oxide formation in primary neural cells and tissues. Methods Mol Biol 
758, 267-277. 
 
Torti, S.V., and Torti, F.M. (2013). Iron and cancer: more ore to be 
mined. Nature reviews Cancer 13, 342-355. 
 
Trautmann, A., Kruger, K., Akdis, M., Muller-Wening, D., Akkaya, A., 
Brocker, E.B., Blaser, K., and Akdis, C.A. (2005). Apoptosis and loss of 
adhesion of bronchial epithelial cells in asthma. International archives 




Trautmann, A., Schmid-Grendelmeier, P., Kruger, K., Crameri, R., 
Akdis, M., Akkaya, A., Brocker, E.B., Blaser, K., and Akdis, C.A. (2002). 
T cells and eosinophils cooperate in the induction of bronchial epithelial 
cell apoptosis in asthma. J Allergy Clin Immunol 109, 329-337. 
 
Trompette, A., Divanovic, S., Visintin, A., Blanchard, C., Hegde, R.S., 
Madan, R., Thorne, P.S., Wills-Karp, M., Gioannini, T.L., Weiss, J.P., et 
al. (2009). Allergenicity resulting from functional mimicry of a Toll-like 
receptor complex protein. Nature 457, 585-588. 
 
Truong-Tran, A.Q., Grosser, D., Ruffin, R.E., Murgia, C., and Zalewski, 
P.D. (2003). Apoptosis in the normal and inflamed airway epithelium: 
role of zinc in epithelial protection and procaspase-3 regulation. 
Biochemical pharmacology 66, 1459-1468. 
 
Valavanidis, A., Vlachogianni, T., and Fiotakis, C. (2009). 8-hydroxy-2' 
-deoxyguanosine (8-OHdG): A critical biomarker of oxidative stress and 
carcinogenesis. Journal of environmental science and health Part C, 
Environmental carcinogenesis & ecotoxicology reviews 27, 120-139. 
 
van Bronswijk, J.E., and Sinha, R.N. (1971). Pyroglyphid mites (Acari) 
and house dust allergy. The Journal of allergy 47, 31-52. 
 
van der Burg, M., van Dongen, J.J., and van Gent, D.C. (2009). DNA-
PKcs deficiency in human: long predicted, finally found. Current opinion 
in allergy and clinical immunology 9, 503-509. 
 
van Veen, I.H., Ten Brinke, A., Gauw, S.A., Sterk, P.J., Rabe, K.F., and 
Bel, E.H. (2009). Consistency of sputum eosinophilia in difficult-to-treat 
asthma: a 5-year follow-up study. The Journal of allergy and clinical 
immunology 124, 615-617, 617 e611-612. 
 
Vandenabeele, P., Galluzzi, L., Vanden Berghe, T., and Kroemer, G. 
(2010). Molecular mechanisms of necroptosis: an ordered cellular 
explosion. Nature reviews Molecular cell biology 11, 700-714. 
 
Vasquez-Vivar, J., Kalyanaraman, B., Martasek, P., Hogg, N., Masters, 
B.S., Karoui, H., Tordo, P., and Pritchard, K.A., Jr. (1998). Superoxide 
generation by endothelial nitric oxide synthase: the influence of 
cofactors. Proceedings of the National Academy of Sciences of the 
United States of America 95, 9220-9225. 
 
Vignais, P.V. (2002). The superoxide-generating NADPH oxidase: 
structural aspects and activation mechanism. Cellular and molecular 




Vignola, A.M., Chiappara, G., Siena, L., Bruno, A., Gagliardo, R., 
Merendino, A.M., Polla, B.S., Arrigo, A.P., Bonsignore, G., Bousquet, J., 
et al. (2001). Proliferation and activation of bronchial epithelial cells in 
corticosteroid-dependent asthma. The Journal of allergy and clinical 
immunology 108, 738-746. 
 
Vispe, S., Cazaux, C., Lesca, C., and Defais, M. (1998). 
Overexpression of Rad51 protein stimulates homologous 
recombination and increases resistance of mammalian cells to ionizing 
radiation. Nucleic Acids Res 26, 2859-2864. 
 
Wallace, D.C. (2012). Mitochondria and cancer. Nature reviews Cancer 
12, 685-698. 
 
Walsh, E.R., Stokes, K., and August, A. (2010). The role of eosinophils 
in allergic airway inflammation. Discovery medicine 9, 357-362. 
 
Wan, H., Winton, H.L., Soeller, C., Tovey, E.R., Gruenert, D.C., 
Thompson, P.J., Stewart, G.A., Taylor, G.W., Garrod, D.R., Cannell, 
M.B., et al. (1999). Der p 1 facilitates transepithelial allergen delivery by 
disruption of tight junctions. Journal of Clinical Investigation 104, 123-
133. 
 
Wang, C.B., Wong, C.K., Ip, W.K., Li, M.L., Tian, Y.P., and Lam, C.W. 
(2005). Induction of IL-6 in co-culture of bronchial epithelial cells and 
eosinophils is regulated by p38 MAPK and NF-kappaB. Allergy 60, 
1378-1385. 
 
Wang, L., Yeung, J.H., Hu, T., Lee, W.Y., Lu, L., Zhang, L., Shen, J., 
Chan, R.L., Wu, W.K., and Cho, C.H. (2013). Dihydrotanshinone 
induces p53-independent but ROS-dependent apoptosis in colon 
cancer cells. Life sciences 93, 344-351. 
 
Ward, I.M., and Chen, J. (2001). Histone H2AX is phosphorylated in an 
ATR-dependent manner in response to replicational stress. J Biol 
Chem 276, 47759-47762. 
 
Weingeist, D.M., Ge, J., Wood, D.K., Mutamba, J.T., Huang, Q., 
Rowland, E.A., Yaffe, M.B., Floyd, S., and Engelward, B.P. (2013). 
Single-cell microarray enables high-throughput evaluation of DNA 
double-strand breaks and DNA repair inhibitors. Cell cycle 12, 907-915. 
 
Wenzel, S. (2012a). Severe asthma: from characteristics to phenotypes 
to endotypes. Clinical and experimental allergy : journal of the British 




Wenzel, S.E. (2012b). Asthma phenotypes: the evolution from clinical 
to molecular approaches. Nature medicine 18, 716-725. 
 
Weterings, E., and Chen, D.J. (2008). The endless tale of non-
homologous end-joining. Cell research 18, 114-124. 
 
White, S.R. (2011). Apoptosis and the airway epithelium. Journal of 
allergy 2011, 948406. 
 
Williams, G.J., Lees-Miller, S.P., and Tainer, J.A. (2010). Mre11-
Rad50-Nbs1 conformations and the control of sensing, signaling, and 
effector responses at DNA double-strand breaks. DNA Repair (Amst) 9, 
1299-1306. 
 
Williams, M.A., Rangasamy, T., Bauer, S.M., Killedar, S., Karp, M., 
Kensler, T.W., Yamamoto, M., Breysse, P., Biswal, S., and Georas, 
S.N. (2008). Disruption of the transcription factor Nrf2 promotes pro-
oxidative dendritic cells that stimulate Th2-like immunoresponsiveness 
upon activation by ambient particulate matter. Journal of immunology 
181, 4545-4559. 
 
Wood, D.K., Weingeist, D.M., Bhatia, S.N., and Engelward, B.P. (2010). 
Single cell trapping and DNA damage analysis using microwell arrays. 
Proceedings of the National Academy of Sciences of the United States 
of America 107, 10008-10013. 
 
Wood, L.G., Garg, M.L., Smart, J.M., Scott, H.A., Barker, D., and 
Gibson, P.G. (2012). Manipulating antioxidant intake in asthma: a 
randomized controlled trial. The American journal of clinical nutrition 96, 
534-543. 
 
Woolley, J.F., Stanicka, J., and Cotter, T.G. (2013). Recent advances 
in reactive oxygen species measurement in biological systems. Trends 
in biochemical sciences 38, 556-565. 
 
Wu, C.A., Peluso, J.J., Zhu, L., Lingenheld, E.G., Walker, S.T., and 
Puddington, L. (2010). Bronchial epithelial cells produce IL-5: 
implications for local immune responses in the airways. Cellular 
immunology 264, 32-41. 
 
Wu, J., Dong, F., Wang, R.A., Wang, J., Zhao, J., Yang, M., Gong, W., 
Cui, R., and Dong, L. (2013). Central role of cellular senescence in 
TSLP-induced airway remodeling in asthma. PloS one 8, e77795. 
 
Xiao, C., Puddicombe, S.M., Field, S., Haywood, J., Broughton-Head, 
V., Puxeddu, I., Haitchi, H.M., Vernon-Wilson, E., Sammut, D., Bedke, 
				
228 
N., et al. (2011). Defective epithelial barrier function in asthma. The 
Journal of allergy and clinical immunology 128, 549-556 e541-512. 
 
Yamada, Y., Limmon, G.V., Zheng, D., Li, N., Li, L., Yin, L., Chow, V.T., 
Chen, J., and Engelward, B.P. (2012). Major shifts in the spatio-
temporal distribution of lung antioxidant enzymes during influenza 
pneumonia. PloS one 7, e31494. 
 
Yang, N.D., Tan, S.H., Ng, S., Shi, Y., Zhou, J., Tan, K.S., Wong, W.S., 
and Shen, H.M. (2014). Artesunate induces cell death in human cancer 
cells via enhancing lysosomal function and lysosomal degradation of 
ferritin. The Journal of biological chemistry 289, 33425-33441. 
 
Yano, T., Shoji, F., Baba, H., Koga, T., Shiraishi, T., Orita, H., and 
Kohno, H. (2009). Significance of the urinary 8-OHdG level as an 
oxidative stress marker in lung cancer patients. Lung cancer 63, 111-
114. 
 
Yukawa, T., Read, R.C., Kroegel, C., Rutman, A., Chung, K.F., Wilson, 
R., Cole, P.J., and Barnes, P.J. (1990). The effects of activated 
eosinophils and neutrophils on guinea pig airway epithelium in vitro. 
American journal of respiratory cell and molecular biology 2, 341-353. 
 
Zeyrek, D., Cakmak, A., Atas, A., Kocyigit, A., and Erel, O. (2009). 
DNA damage in children with asthma bronchiale and its association 
with oxidative and antioxidative measurements. Pediatr Allergy 
Immunol 20, 370-376. 
 
Zhao, Y., Thomas, H.D., Batey, M.A., Cowell, I.G., Richardson, C.J., 
Griffin, R.J., Calvert, A.H., Newell, D.R., Smith, G.C., and Curtin, N.J. 
(2006). Preclinical evaluation of a potent novel DNA-dependent protein 
kinase inhibitor NU7441. Cancer Res 66, 5354-5362. 
 
Zhu, D.Y., Huang, B.S., Chen, Z.L., Yin, M.L., Yang, Y.M., Dai, M.L., 
Wang, B.D., and Huang, Z.H. (1983). [Isolation and identification of the 
metabolite of artemisinine in human]. Zhongguo yao li xue bao = Acta 
pharmacologica Sinica 4, 194-197. 
 
Zimmermann, M., and de Lange, T. (2014). 53BP1: pro choice in DNA 
repair. Trends in cell biology 24, 108-117. 
 
Zimmermann, M., Lottersberger, F., Buonomo, S.B., Sfeir, A., and de 
Lange, T. (2013). 53BP1 regulates DSB repair using Rif1 to control 5' 
end resection. Science 339, 700-704. 
 
Zimmermann, N., Hershey, G.K., Foster, P.S., and Rothenberg, M.E. 
(2003). Chemokines in asthma: cooperative interaction between 
				
229 
chemokines and IL-13. The Journal of allergy and clinical immunology 
111, 227-242; quiz 243. 
 
Zong, W.X., Ditsworth, D., Bauer, D.E., Wang, Z.Q., and Thompson, 
C.B. (2004). Alkylating DNA damage stimulates a regulated form of 
necrotic cell death. Genes & development 18, 1272-1282. 
 
 
 
